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Abstract
The two main aims of this thesis have been;
1. To examine the structural changes which alter the binding of the protein Intrinsic Factor to the 
Co corrinoid Vitamin B12 (cyanocobalamin, CN-Cbl). The alteration in binding was assessed by 
changes in the magnitude of the equilibrium constants for the formation of the IF-(CN-Cbl) 
adduct including conjugates of CN-Cbl with the enzyme horse radish peroxidase HRP and the 
oligopeptide calcitonin.
2 .T0  compare the transport of IF adducts of CN-Cbl, its analogues and conjugates and of HRP 
across filter grown monolayers of Caco-2 cells (a cell line derived from a human colonic 
carcinoma which provides an in vitro model for ileal epithelial cells). The Caco-2 cells were used 
to investigate the feasibility of exploiting the IF-(CN-Cbl) pathway for the delivery of molecules, in 
particular drugs, across the ileal epithelial cell barrier.
Conjugates with both HRP (MW 40K) and calcitonin (with 32 amino acid residues) were prepared 
by carbodiimide condensation with the carboxylic acid groups (a) produced by hydrolysis of the 
amide side-chain d and (b) placed on the Co as the organo-ligand Co(CH2)3C02H. A detailed 
study of the conjugate of HRP and (C02H-d-)CN-Cbl showed that the stoichiometry in the 
conjugate is 1:1. The enzymic activity of the conjugate is the same (98%) as that of the native 
enzyme,
Equilibrium constants K for the binding of corrinoids by the commercially available (Sigma) 
porcine IF were determined at 4°C by published methods involving ^^co-labelled CN-Cbl.
These data provided a quantitative measurement of binding ability and the binding curves 
provided a qualitative assessment. A value of K = 3 x 10''® M"'' was determined for CN-Cbl itself 
and was consistent over a wide concentration range, indicating similar values of K for the 
different isoproteins. Consistent values and simple binding curves were also observed for 
hydroxocobalamin (Bi2a) and the d monocarboxylic acid, but anomalous curves were observed 
for several organocobalamins, indicating slight differences (A log K < 2) in their binding to the 
different isoproteins. Little change in the value of K was produced by attaching HRP either to 
the p-ligand (A log K < 2), supporting previous conclusions that this ligand position is exposed 
to the solvent, or to side-chain d (A log K < 2), demonstrating that this site is also not attached to 
the protein.
To examine the specificity of IF for the cobalamins (corrinoids possessing the full nucleotide 
side chain moiety as in CN-Cbl itself), values of K were determined for the corrinoid lacking the 
nucleotide side-chain {viz. cobinamide Cbi) alone and for the side-chain moiety (a-ribazole and 
ribazole-3-phosphate) alone and the two combined together. No siginificant binding (K < 10^
M*'') was observed for Cbi a-ribazole or ribazoie-3-phosphate alone, i.e. they do not 
competitively inhibit the binding of CN-Cbl to IF. A similar and siginificant degree of binding 
was, however, observed for Cbi in the presence of either a-ribazole or ribazole-3 -phosphate 
(i.e. the phosphate plays no role in binding) and a more detailed study of the interaction of Cbi 
with a-ribazole showed that IF bound Cbi with K = 2.5 x 10  ^M"'', which was dependent only on 
the concentration of Cbi provided that the concentration of a-ribazole was ^ 10'® M. It is 
suggested that IF can exist in several significantly different conformations (P1-P3 ) and that 
binding occurs in at least two major stages; that the resting Pi cannot bind Cbi but must first 
bind a-ribazole to form Pa-Rib., which is then able to bind Cbi to form Cbi.P3 .Rib which finally 
loses the weakly bound a-ribazole to leave Cbi.Pa (or Cbi.P^) as the final product; and that the 
nucleotide side-chain plays the same initiating role in the binding of CN-Cbl. This appears to be 
the first detailed study of the cooperative interaction in the binding of a co-factor or iigand 
dissected Into two (or more) segments and suggests that the specificity of IF for the cobalamins 
is at least partly a kinetic effect, depending on an essentially catalytic role of the a-ribazole 
moiety (whether free or bound in the nucleotide side-chain).
Studies of the rate of transport by functionally tight and polarised monolayers of Caco-2  cells of 
HRP, CN-Cbl and various analogues and conjugates revealed the existence of a well-defined 
'HRP' path which was saturable (attaining a maximum flux of 0.6 fmol min'l at a concentration of 
12 nM HRP), bidirectional and unaffected by the presence of IF, in addition to the previously 
reported 'CN-Cbl' pathway involving the IF-(CN-Cbl) complex, which was also saturable (with a 
lower flux of 0.01 fmol min"^  attained at the far lower concentration of 16 pM CN-Cbl) but 
unidirectional. For the HRP-Cbl conjugate linked through side-chain d it was shown that the CN- 
Cbi and HRP parts were transported at similar rates (i.e. probably remained linked together), that 
the maximum flux was similar to that of HRP and that transport was bidirectional, i.e. the HRP-Cbl 
conjugate was transported using the HRP pathway; The rate of flux was lowered by the addition 
of IF to that observed for IF-(CN-Cbl) and lowered further by the addition of IF-(CN-Cbl) in a 
manner consistent with simple competition for a single site favouring CN-Cbl over the HRP-Cbl 
conjugate by a factor of 60, close to the ratio (40) of their binding constants for IF, i.e. the IF- 
(HRP-Cbl) complex is transported v/athe 'CN-Cbl' pathway. This shows that both the HRP and 
CN-Cbl pathways can be used for 'piggy-back' transport of other compounds (though the 
transport of CN-Cbl by the far larger HRP Is trivial compared to the transport of the HRP protein 
by the Cbl-IF complex) and that the same compound {viz. the HRP-Cbl conjugate) can be 
switched from one pathway to the other by the presence or absence of IF.
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CHAPTER 1
INTRODUCTION
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Figure 1.1 The structure of vitamin B12 . also known as cyanocobalamin (CN-Cbl);
1 is the point where cleavage occurs with the hydrolysis used to produce cobinamide and a- 
ribazole.
1
1.1 The History of CN-Cbl
Cyanocobalamin, (CN-Cbl) is a red crystalline solid,1*2 and is an important vitamin, as a deficiency 
leads to anaemia and peripheral nervous system malfunction which are symptoms of pernicious 
anaemia 3 The reversal of pernicious anaemia was first described as being due to the so-called 
'anti-pemicious anaemia factor" present in liver and was described by Minot and Murphy in 
1926.^ This factor was identified as CN-Cbl when it was first isolated from liver cell homogenates 
almost simultaneously by Rickes in the USA and Smith in the UK in 1 9 4 7 / 4 8 When CN-Cbl 
was administered to patients suffering from pernicious anaemia and tested using a 
microbiological assay the haematologicaP and microbiological  ^activity was identical to that 
associated with the liver cell homogenates containing the "anti-pernicious anaemia factor". The 
isolation of crystalline CN-Cbl led to improvements in the treatment of pernicious anaemia and 
parenteral injections are now routinely given in doses of 1 mg or less depending upon the 
frequency of administration.®
Absorption of CN-Cbl from the gastrointestinal tract, in particular the ileum, is dependent upon 
not only CN-Cbl but also another molecule. CN-Cbl and the other molecule are known as the 
Extrinsic and Intrinsic Factors respectively, as CN-Cbl®® is supplied by exogenous sources and 
the Intrinsic Factor is supplied intemally.^ The Intrinsic Factor (IF) has been identified as a 
glycoprotein, which is secreted into the stomach and in particular by the gastric mucosa in 
humans.^
The identification of a Co-C tx>nd in CN-Cbi and the structural determination^"^® were 
significant developments in coordination chemistry, both in general terms and specifically for 
the field of CN-Cbl chemistry. There is more known about the absorption of CN-Cbl than 
any other compound which is probably due to the complexity of the process. The process has 
been studied in vivo, and in vitro where loops of isolated ileal tissue, isolated ileal epithelial cells 
and membrane fractions from many species, including human and porcine, have been used 
(see 5.1). The recent development of cell lines, which exhibit the characteristics of mature ileal
epithelial ce l ls ,has  provided a convenient model for the study of the IF-mediated cobalamin 
pathway. The cell line used as the in vitro model is the Caco-2 cell line, which is derived from a 
colonic carcinoma (see 1.5 and 5.4)."*® This thesis describes a study of the binding of CN-Cbl to 
IF and the IF-mediated pathway through Caco-2 cells.
Although the structure of the isolated vitamin has a -CN ligand in the p-position (see figure 1.1) 
there are several p-position derivatives which are more abundant in nature. It is possible that the 
p-position is occupied by a -CN ligand due to the isolation procedure. The structures found in 
living tissues are S'-deoxyadenosylcobalamin (Ado-Cbl), also known as Coenzyme B12, 
Methylcobalamin (MeCbl), and Hydroxocobalamin (OH-Cbl). W  Ado-Cbl is the most common 
form of the vitamin found in living tissue,"* ® and was first isolated in 1958 from Clostridium 
tetanomorphum, during studies of glutamate metabolism."*  ^ These cobalamin derivatives were 
also identified in plasma "*® and a quantitative assessment of plasma showed that MeCbl was the 
most common derivitative.®  ^ MeCbl acts as the methyl group donor for methionine synthesis in 
the cobalamin dependent pathway. The presence of a Co-C bond in Ado-Cbl and MeCbl has 
been established using X-ray crystallography ."*®
1.2 Structure of CN-Cbl
The structure of CN-Cbl was determined and found to contain a Co-C bond, which was later 
confirmed by X-ray crystallography 6a,6b,l3,l4 There is a macrocyclic corrin ring, with a centrally 
located cobalt atom, a dimethylbenzimidazole group, a ribose, a phosphate, a (D)-1-amino-2 
propanol,"* ® and a cyano group. "* "* The cobalt is usually in a (+3) oxidation state and is 
coordinated via four nitrogen atoms to the macrocycle. The fifth and sixth, a  and p, axial ligand 
positions are occupied by a nitrogen of the dimethyl benzimidazole and the cyano group 
respectively. The corrin macrocycle is also joined to the ribose of the nucleotide via an N, a- 
glycosidic bond. The corrin ring system contains a series of conjugated double bonds in rings 
A-D. The link between rings A and D involves tetrahedral carbon atoms and therefore 
introduces a distortion into the system."*  ^ Apart from this distortion the system is planar and
resembles the porphyrin structure. More similarities between the porphyrin and corrin system 
are found if the side chains, labelled a-g, see figure 1.1, are taken into consideration. The 
arrangement of the side chains in a porphyrin is alternately short-long-short, for all of the side 
chains, and this pattern is found in the corrin macrocycle except in the side chains joined to the 
* D ring where the order is long-short.
,CH
= N HN
CH CH
NH
CH
,CH
NH
CH
Porphyrin ring Corrin ring
Figure 1.2 The structure of Porphyrin and Corrin rings
The absolute configuration of the CN-Cbl molecule is known as the configurations of both the 
ribose and the D-1-amino-2 propanol have been determined."*  ^ In a neutral solution, the CN-Cbl 
has no overall charge as the positive charge due to the Co(lll) is balanced out by the negative 
charges of the corrin ring, phosphate and cyanide groups. The structure of CN-Cbl is shown in 
figure 1.1.
1.3 Nomenclature of Cobalamins
CN-Cbl and its derivatives are part of a larger group of compounds called corrinoids. All 
corrinoids contain four reduced pyrrole rings joined into a macrocyclic ring by links between their 
«-positions, as seen in figure 1.2. Corrinoids have a central cobalt atom, which is coordinated via 
the four nitrogen atoms to the macrocyclic ring.20a
A cobalamin is a cobamide, which is a hexamide as seen in figure 1.1. The 5', 6'-dimethylbenz- 
imidazole is the aglycan attached from its N-1 to C-1 of the ribose and by a bond from its N-3 to 
the cobalt atom and therefore occupies the a-ligand position. The accepted nomenclature for 
the cobalamin derivitives used In this work is listed below 21 in table 1.1. B i2a
aqua/hydroxocobalamln (OH2-Cbl and OHCbl), which has a pKa of 7.8; pH of 7.4, used
for the binding and transport assays, both forms will be present in the proportions of 0 H2Cbl 
28.5% and OH-Cbl 71.5%. For convenience, the notation OH-Cbl will be used in this thesis to 
describe both aqua and hydroxocobalamin.
Table 1.1 Nomenclature of cobalamins and associated abbreviations 21
Systematic name Trivial name Abtxeviated formula 
of trivial name
Coa-[a-(5',6'-Dimethylbenzimidazolyl)]-
Co-p-cyanocobamide
Cyanocobalamin CN-Cbl
Coa-[a-{5',6'-Dimettiylbenzimidazolyl)]-
Co-p-aquacobamide
Aquacobalamin OHaCbl
Coa-[a-(5',6'-Dimetliylbenzimidazolyl)]-
Co-p-tiydroxocobamide
Hydroxocobalamin OH-Cbl
Coa-[a-(5',6'-Dimethylbenzimidazolyl)]-
Co-p-methylcobamide
Mettiylcobalamln MeCbl
Coa-[a-(5’,6'-Dimettiylbenzimidazolyl)]-
Co-p-5'deoxyadenosylcobamide
5'Deoxyadenosyl
cobalamin
AdoCbl
(Cyano,aqua)cobinamide (CN.aq)cobinamide (CN,aq)Cbi
Coa-[a-(5',6'-Dimettiylbenzimidazolyl)]- 
CN-Cbl(monoadd-b-)Co-p-aqua 
cobamic add,a,c,d,e,g, pentamide
cyano(monocarboxylic
add-b-)cobalamin
(CN-Cbl-COaH-b-)
Coa-Ia-(5’,6'-Dimethylbenzimidazolyl)]- 
CN-Cbl(monoadd-d-)Co-p-aquacobamic acid 
,a,b,c,e,g,pentamide
cyano(monocarboxylic
add-d-)cobalamin
(CN-Cbl-C02H-d-)
Systematic name Trivial name Abbreviated formula
Coa-[a-(5’6’-Dimethylbenzimidazolyl)]- cyano ( mo nocarboxy li c (CN-Cbl-C02H-e-)
CN-Cbl(monoacid-e-)Co-p-aquacobamic acid acid-e-)cobalamin
,a,b,c,d,g, pentamide
Coa-[a-(Aden-9-yl)]-Cop-hydroxocobamide hydroxopseudo vita mi n 
Bi2
(Ade)OH-Cba
Intrinsic Factor IF
(gastric binding protein)
Transcobalamln II TCII
(plasma and tissue binding protein)
Haptocorrin
(Salivary and gastric binding protein)
He
1.4 Reduced Cobalamins
Cobalamins in which the cobalt has an oxidation state of (I) or (II) rather than (III) are obtained by 
reducing a Co(lll) cobalamin using anaerobic conditions. Several methods have been used. 
These include zinc dust in acetic acid, thiols in alkaline solution and aqueous b o r o h y d r i d e . 2 2 - 2 6  
Co(l) and Co(ll) are sensitive to aerobic oxidation and oxidise to form Co(ll) and Co(lll). Each 
oxidation state Is characterised by a different UV-Vis spectrum, see figure 1.2.
1.5 Organocobalamins.^^
These are compounds in which the p-position is occupied by an alkyl group . Naturally occuiing 
organocobalamins are MeCbl and Ado-Cbl, but many more examples have been synthesised.
All organocobalamins contain a Co-C a bond, which when first discovered was surprising as 
carbon-metal bonds of the first series transition metals are usually unstable. The 
organocobalamins used in this work are all stable as solids and in solution, when kept in the dark.
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Figure 1.3 The three oxidation states of Co in Cobalamins are characterised by different X 
maxima; Co(l) 386 nm, Co(ll) 473 nm and Co(lll) 350 nm.
Organocobalamins are prepared by the reduction of a cobalamin, usually OH-Cbl, to Co{l), which 
is a strong nucleophile. This is then reacted with alkyl halides, epoxides, alkenes, or alkynes, to 
produce the organocobalamin. The reaction with alkyl halides proceeds via an 8^2
mechanism 22-26 g^d the use of series of alkyl halides has established reactivity sequences 
which are characteristic of nucleophilic displacement reactions. The reactivity for Co(l)cobalamin 
with alkyl halides is as follows:CH3Bn>C2 H5Br>(CH3)2CHBr and CH3 l>CH3Br>CH3CI .2® The 
nucleophilicity is not affected by the nature of the ligand in the a-position and the reaction 
proceeds similarly for Co(l)cobalamin and model Co(l) c o m p o u n d s . 2 2 - 2 6
1.6 Requirements and Occurrence of CN-Cbl in nature 6b
All organisms are classified into three groups according to their anabolic capacity of, and 
requirement for, CN-Cbl. The first group is entirely made up of microorganisms, which require 
CN-Cbl as a coenzyme for metabolic reactions and fulfil this requirement by the synthesis of CN- 
Cbl. The second group also requires CN-Cbl to act as a coenzyme, but members of this group 
are unable to synthesise CN-Cbl. Animals are in this group and are reliant on exogenous 
sources of CN-Cbl; these exogenous sources are dietary . Ruminants obtain CN-Cbl from the 
microflora resident in the rumen. For humans yeast and red meat, especially liver which is the 
major storage organ for cobalamins, are rich sources of the vitamin. Group three consists of 
organisms which have no requirement for CN-Cbl, which are plants. All of the reported sources 
of CN-Cbl can be traced to have a microbial origin. The range of microorganisms which can 
synthesise CN-Cbl Includes bacteria of the soil and intestines and yeast. Some of the bacteria 
and actinomycetes naturally produce CN-Cbl surplus to their requirement and are exploited to 
produce CN-Cbl on a commercial basis. These include Streptomyces griseus and 
Propionibacterium shermanii.
1.7 Biosvnthesis of CN-Cbl 28
The CN-Cbl pathway involves several major stages which are; the synthesis of 
uroporphyrinogen III, side chain modification, formation of the corrin macrocycle and cobalt
insertion, and addition of the nucleoside and 5',6'-dimethylbenzimidazole groups. These steps 
are outlined in figure 1.3 showing the important steps from acetylcoenzyme A to CN-Cbl. Some 
microorganisms are capable of all the stages listed whilst others are only capable of selected 
stages. Escherichia coll cannot fabricate the corrin ring, but can carry out the subsequent 
stages, whereas some microorgansims make use of other interrriediates of the synthetic 
pathway such as cobyrinic acid.
1.8 Uptake mechanism for CN-Cbl
The following description of uptake is based upon studies of the human system, but the 
porcine, guinea-pig, rat, dog, and rabbit systems all have similar binding proteins to the human. 
The binding proteins and ileal cells of some of these different species are compatible with each 
other.Gd, 29-31 This particularly applies to the porcine, human and guinea-pig systems where 
non-native binding proteins have been shown to be interchangeable with the native binding 
proteins.29-31 in humans cobalamin is available from dietary sources, and is predominantly in the 
form of AdoCbl and OH-Cbl derived from meat sources and MeCbl from dairy sources.
The cobalamins reach the circulation by a mechanism which involves a series of binding 
proteins. These are Haptocorrin (He), Intrinsic Factor (IF), and Transcobalamln II (TCII).^ He 
and IF are found in association with the gastrointestinal tract and their function is thought to be 
the transportation of cobalamin through the gastrointestinal tract and into the ileal epithelial cells. 
TCII is found in the blood and storage organs of the body, where its role appears to be one of 
transportation of cobalamin from one organ to another as required.22 He and IF are both 
glycoproteins containing the same type of carbohydrates, ^3 although He contains
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approximately twice as much carbohydrate as IF. The carbohydrate may be fulfilling a protective 
role against degradation within the gastrointestinal tract. Carbohydrates, in particular sialic acid 
residues, have been found to fullfill a protective role for secretory glycoproteins in the blood 
stream. Serum glycoproteins in which the terminal sialic acid residues have been removed have 
shortened half lives in the circulation, This not only applies to serum glycoproteins as the 
removal of the sialic acid residues from the erythrocyte membrane results in the removal of 
erythrocytes from the circulation. ^6 For IF and He the difference in the amount of carbohydrate 
is common to both the porcine ^7 and the human glycoproteins, ^8 indicating that the proteins 
in different species are similar. He and IF are also similar in total amino acid content ^7-40 with a 
coefficient of correlation of 0.96; the amino terminal sequences of human ^8-39 and porcine 
proteins are almost identical. The similarities in the composition of He and IF can be explained 
by the fact that they both occupy the same physiological environment and have to withstand the 
same low pH conditions. However TCII is different from He and IF as it contains no cartx)hydrate 
and is relatively insoluble when compared to He and IF .^ ' ’ -^ ^  j c i l  has a different function which 
is reflected by its distribution in vivo. TCII is found in the plasma Ga,42 gnd various storage 
organs where the pH range is limited to 7.3-7.5, unlike the digestive tract where the pH varies 
from 2 to 9. This could account for the differences in carbohydrate and amino acid content when 
compared to He and IF. 37.41
He is secreted into the saliva in the mouth and is also found in the stomach, plasma, milk and 
leucocytes.®® He has a greater affinity for cobalamins at a low pH when compared to IF ,^  and 
hence is thought to bind to cobalamin in the stomach. IF is secreted into the stomach, and in 
humans is secreted by the gastric mucosa.^*^® IF derived from the mucosa, as compared to 
that found in gastric juice samples, has been found to consist of fewer i s o p r o t e i n s . ^ 7 - 4 8  This 
decrease in isoproteins correlates with a decrease in the carbohydrate content and in particular a 
reduction in the number of sialic acid residues.'^ ®*®® This is an example of the storage of 
molecules in the form of precursors, which then undergo further glycosylation just prior to 
secretion from the cell The sialic acid residues occur exclusively in terminal positions of 
carbohydrate chains in glycoproteins. ®3-54 The sequential addition of carbohydrate residues
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onto the protein as it follows the intracellular pathway after synthesis at the ribosome, is 
supported by the different distribution of glycosyl transferases within the different organeiles. 
The rough endoplasmic reticulum is enriched in enzymes required for internal sugar transfer ®® 
whereas those catalysing the transfer of residues which form terminal trisaccharides including 
sialic acid are concentrated within the golgi subcellular fraction.
The function of IF is to transport the cobalamins into the ileal epithelial cell ®® and it is only the IF- 
Cbl complex which is recognised by the ileal r e c e p t o r . 3 8 . 6 0  6 3  This receptor is located in the 
microvillus pits of the ileal epithelial cells, and the binding of the IF-Cbl complex requires 
calcium ions. 3 0 , 6 6 , 6 7
A schematic representation of the cobalamin uptake pathway is outlined in figure 1.3. Evidence 
for this pathway is found from both in vitro and in vivo studies (see chapter 5). In vitro studies of 
the binding of cobalamins to He and IF have shown that cobalamins are preferentialiy bound to 
He at pH 2  .®6'®3 It was also shown that at pH 2 and pH 8  the cobalamin is not transferred to IF, 
indicating that pH alone is not the only factor controlling the binding of cobalamins to He or IF. ^  
The incubation of Hc-(CN-Cbl) with pancreatic proteases leads to partial degradation of the He 
and a rapid transfer of the CN-Cbl from He to IF.®®'72
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Figure 1.5 The uptake pathway of cobalamins from food into the circulation 
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He has been shown to bind a wide spectrum of corrinoid derivatives, while IF is specific for 
c o b a l a m i n s . G 8 . 4 2  j f  is the most sensitive of the corrinoid binding proteins to changes in the 
cobalamin structure. 8 8 , 6 9 , 4 2  ^  possible function of He may be to bind corrinoids other than 
cobalamins and to prevent corrinoids interfering with the binding of cobalamins to IF as well as 
fulfilling a protective role for cobalamins in the stomach. In patients who have pancreatic 
insufficiency and consequently cobalamin malabsorption |( |g possible to eliminate 
cobalamin malabsorption by administration of an analogue of cobalamin, viz. cobinamide (Cbi), 
which does not bind to IF but does bind He. 43 The administration of 100 nmol of Cbi completely 
corrects the malabsorption of CN-Cbl, These results, in conjunction with In vitro studies where 
the binding of He to CN-Cbl was reduced when treated with trypsin, show the vital role of the 
pancreatic proteases. These enzymes degrade the He causing the cobalamin to 
dissociate and become available to bind to IF. On binding Cbl the IF molecule shrinks by 4 nm
( s e e  s e c t i o n  4.1).7 4
The first step of uptake is the attachment to the receptor at the ileal cell surface, and the IF-(CN- 
Cbl) complex has an increased affinity for the receptor when compared to IF alone, which is not 
taken up by the receptor to any measurable extent. GO. 75-79 yhe binding requires calcium but is 
not dependent upon metabolic energy.G1 The receptor is made up of two subunits, a  and p. 75- 
78 The a subunit is hydrophilic and contains the IF-(CN-Cbl) binding site, whereas the p subunit 
is hydrophobic 76-79 g^d is an integral part of the cell membrane possibly spanning the entire 
width of the membrane. 79
1.9 Passage Across the Ileal Epithelial Cell
This is the stage in the uptake pathway about which least is known. The ileal epithelial cell has 
two distinct surfaces: the luminal membrane is the surface in contact with the ileal lumen and the 
basolateral membrane is the one in contact with the serosum. The luminal membrane contains 
the IF-(CN-Cbl) receptor. The receptor and the IF-(CN-Cbl) complex are internalised into the 
cell, which was observed using giunea-pig ileal cells and electron microscopic 
autoradiography.GG This step is calcium dependent G8 and requires metabolic e n e r g y  G”* *82 but
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not the de-novo synthesis of new protein by the cell.G2.84 yhg internalisation of the entire IF- 
(CN-Cbl) complex can be detected within five minutes of complex addition to isolated 
enterocytes at 37° C. G5 The CN-Cbl is released from the IF complex in vivo over a period of five 
hours and is bound to a macromolecule antigenically like TC II.Gg The fate of IF is unclear, 
although there is indirect evidence that both the IF and receptor, possibly bound together, 
return to the luminal s u r f a c e . G 5 . 8 6  The IF would then be ready to bind CN-Cbl from the ileal 
l u m e n . G 2  in vivo experiments have shown that if successive doses of CN-Cbl are administered 
at hourly intervals each dose is taken up with the same efficiency as a single dose, and the CN- 
Cbl accumulates within the c e l l . G G  The ability to bind the hourly doses does not require any 
protein synthesis by the cell, indicating that the receptor and IF are not broken down. This is 
evidence for the recycling of both IF and receptor . 8 0 , 8 6
The receptor which internalises IF-(CN-Cbl) has not been found in the basolateral cell membrane 
and is not responsible for transporting the CN-Cbl into, across and out of the cell .go After 
release from IF the pathway could involve several sub-cellular organelles, including lysomes.
The sub-cellular fractionation of ileal-epithelial cells which have iiiternalised IF-(CN-Cbl) showed 
that after 2  h the CN-Cbl was located in the lysosomal fraction ( see c h a p t e r  5 ).G7.88
Ileal-epithelial cells would be expected to have the capacity to alter the p-position ligand in the 
CN-Cbl. This is due to the fact that the predominant form of cobalamin in the blood is TCil bound 
MeCbl, and is 65% of the total cobalamins found in p l a s m a . G b . 8 9  The cobalamins taken in dietary 
form are mainly AdoCbl and OH-Cbl Gb which have to be altered to MeCbl prior to release into 
the circulation. All the intracellular events outlined above are illustrated in figure 1.4, but the 
actual order and steps are by no means certain.
L1Q The Intracellular Role of Cobalamins Ga-6d
Cobalamins in the form of MeCbl, AdoCbl and OH-Cbl function as coenzymes in a variety of 
enzyme catalysed reactions. All of the reactions are fundamental to cellular metabolism, hence 
the importance of cobalamins. AdoCbl acts as coenzyme for many different enzyme reactions.
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The most important of these are the isomérisation reactions including carbon skeleton 
rearrangements, amine group migration, and conversion of diols and amino alcohols to 
aldehydes. AdoCbl is also coenzyme for the reduction of ribonucleotides to 2 '-deoxyribonucleo 
tides in some organisms. MeCbl is a coenzyme for the methionine, acetate, and methane 
synthesis pathways. These pathways are essential to cellular metabolism and although some, 
such as methionine synthesis in E  coli, have a cobalamin-dependent and a cobalamin 
independent pathway, this duplication is not common to all of the cobalamin dependent 
pathways. In humans, AdoCbl is involved in the carbon skeleton rearrangement catalysed by 
methylmalonyl CoA mutase, whilst MeCbl is required for methionine biosynthesis. The 
involvement of cobalamins in these pathways explains why a deficiency in humans manifests 
with the megaloblastic anaemia, and neurological deterioration associated with pernicious 
anaemia.
1.11 The Caco-2 Cells
The Caco-2 cell line, used as a model for the IF-mediated transcellular transport pathway of CN- 
Cbl, was established in 1974 and is derived from a colonic c a r c i n o m a . in culture these cells are 
able to express characteristics associated with differentiated enterocytes which have not been
present in cultured normal cells of the small intestine or colon.80.91
The characteristics common to Caco-2  cells and normal epithelial cells of the distal ileum are: 
presence of tight junctions,G2.93 gq apical brush border and associated enzymes, 82,94 
transport of amino adds, ^5 büe acid transport 84,96 g^d IF mediated Cbl transport.G4,87,ioo 
Tight junctions are assodated with a functionally tight monolayer of cells and were detected in 
the monolayers of Caco-2 cells by two methods. Firstly, the tight junctions were shown to be 
Impermeable to large macromolecules at 4°, 20° and 37°C. 82,93 j^ e  second method was to 
measure the transcellular resistance,^80-103 which had been previously shown to be due to 
tight junctions and not transmembrane resistance. '•83
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The apical brush border was observed using electron microscopy, which showed an uneven 
distribution of microvilli over the surface of a cell population 84 The enzymes commonly 
associated with brush borders (sucrase-isomaltase, lactase,82 N-dipeptidylpeptidase-IV and 
alkaline phosphatase) were detected at similar levels to those detected in the small intestine. ^2 
The enzyme activity reached maximum levels after 30 days in culture. 82,93,104 The transport of 
phenylalanine, ^85 foiic add and sugars 80 across Caco-2  cells has been observed which is 
consistent with the cells being highly differentiated. Another property consistent with 
differentiated ileal epithelial cells is the transport of taurocholic acid, which is unidirectiona|83.84 
from the apical to the basolateral side of filter grown Caco-2 cells. Taurocholic acid binding ^86 
and uptake is saturable with a Km value similar to that obtained for human brush border 
membranes ‘'86  and taurocholic acid is transported against a concentration gradient. 84
The transport of CN-Cbl across Caco-2  cells is receptor mediated, as is the transport of CN-Cbl 
across normal ileal c e l l s . 8 ‘' ' i 0 7  caco-2 cells bind IF-(CN-Cbl) onto the apical surface and 
internalise this complex 81.89 another feature in common with the normal ileal c e l l . 8 3  The 
specific binding of (IF-CN-Cbl) shows a polarity of expression which alters with the age of the 
culture.8 i Initially the basolateral surface has twice the binding ability of the apical surface, but 
this decreases to almost zero by day 14 and remains at this level until day 30. The binding ability 
of the apical surface is initially lower than that of the basolateral surface, but increases slightly 
from day 14 to day 30. Cells grown on filters for 28 days or longer only have receptors on the 
apical surface of the monolayer and this distribution restricts the transport of cobalamin to being 
unidirectional. The transport of the IF-(CN-Cbl) is unidirectional and when IF-(G7co)CN-Cbl is 
used its transport is inhibited by an excess of IF-(CN-Cbl),8i.89 showing that transport is receptor 
mediated and saturable. The uptake and transport of IF-(CN-Cbl) is not inhibited by an excess of 
free CN-Cbl, indicating that the free CN-Cbl does not cross the Caco-2  cells by the same 
r o u t e . 8 7 ’ 8 9  The receptors for IF(-CN-Cbl) become more abundant upon the apical cell 
membrane of filter grown Caco-2  cells after 14 days culture and the cells secrete a TCII-like 
protein exclusively into the basolateral media after 20 days in culture. 84 The Caco-2  system is 
the only known in vitro cell system to date which internalises IF and transports CN-Cbl.86.89 The 
number of IF-(CN-Cbl) receptors per cell is 900.86,89 The number of molecules of CN-Cbl
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Internalised per cell over 24 hours is 2.4 x 1 0^, CN-Cbl transported is 1.8 x 10 ,^ the TCII 
secreted is 2.2 x 10®. 84 with the number of receptors estimated at 900 per cell, the turnover 
rate for the receptor is 0.01 molecules per minute per cell. The uptake of unbound CN-Cbl by 
the basolateral membrane and limited apical to basolateral transport of the free CN-Cbl is 
probably due to the presence of TCII receptors on the membranes.8i'i80 jq h  receptors would 
be more abundant upon the basolateral membrane, which is the membrane which shows the 
greatest uptake of free C N -C b l.''The  necessary supply of TCII could be found in the serum, 
which is in the culture media of Caco-2 cells.
Although Caco-2 cells exhibit many characteristics associated with differentiated normal distal 
ileal cells, they also exhibit characteristics more usually associated with foetal colonic tissue.''84 
In particular, these have very high resistance when grown in monolayers and the storage of 
glycogen. 84 These factors, together with the malignant colonic origin, have to be considered 
when assessing the data and its applicability to the in vivo situation.
1.12 The Aims of This Thesis
The work was undertaken with two aims:
1 . To examine the factors which influence the binding of CN-Cbl analogues to IF and hence to 
provide evidence for the basis of the molecular recognition of IF for cobalamins.
2 . To assess the IF-mediated CN-Cbl pathway, in terms of providing ’piggy-back’ transport for 
drug molecules across the ileal epithelial cell. An in vitro system was used to assess the 
potential exploitation of this pathway, using monolayers of Caco-2  cells. Two molecules, 
calcitonin and horse radish peroxidase (HRP), were attached to cobalamins and used as probes. 
Calcitonin is an oligopeptide with 17 amino acid residues and HRP is an enzyme.
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This thesis can be divided into three parts:
1 . The preparation and characterisation of the analogues and conjugates of CN-Cbl, in particular 
conjugates with calcitonin and HRP (Chapter 3).
2. Determination of binding constants of the analogues and conjugates to IF, assessment of 
their ability to replace CN-Cbl, and discussion of molecular recognition between IF and 
cobalamins (Chapter 4).
3. The study of the rate of transport of CN-Cbl in the conjugates and HRP using Caco-2  cells 
(Chapters).
The synthesis of the starting materials for the conjugates is described in Chapter 3 and starts 
with p-position analogues, followed by the monocarboxylic acid CN-Cbls. The next step is the 
synthesis of the conjugates using the p-butyrateCbl and monocaitoxylic acid-d-Cbl in order to 
compare the different sites within the CN-Cbl molecule. The conjugates of HRP and calcitonin 
were synthesised to provide four conjugates, two of each type. HRP and calcitonin were 
chosen to provide a contrast as they are very different in size. HRP has a MW of 40 K and 
Calcitonin has a MW of 3.4 K. Once these conjugates were made they were assessed for their 
ability to bind IF. Many other molecules were assessed in the same way, using the IF 
competition assay to provide information about the recognition site for IF within the CN-Cbl 
molecule (Chapter 4).
Finally, the IF-mediated pathway for CN-Cbl transport across Caco-2  cells was probed to gain 
information as to the different steps which are involved and whether or not this pathway is 
exploitable for the purpose of drug delivery (Chapter 5). The (C0 2 -d-)Cbl derivative has already 
been shown to be capable of delivering molecules across the gut so that they can exert their 
biological effect upon the o r g a n i s m . ^88 This was shown using conjugates of Neomycin, LHRH 
and BSA and it was the biological effect of these molecules which was monitored in mice. This 
work attempted to determine the path taken by conjugates and whether it was in fact the IF-
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mediated pathway taken by the IF adducts of conjugates of cobalamin. Another important 
aspect was the possibility of attaching drugs targeted to the ileal epithelial cells, because if the p- 
position is altered within the ileal epithelial cell then conjugating drugs at that site would be a 
specific means of delivery.
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CHAPTER 2
MATERIALS AND METHODS
All of the methods used for the synthesis and purification of cobalamins, cobalamin analogues and 
conjugates are described in this chapter. A more detailed account of the synthesis and in particular 
characterisation of the analogues and conjugates is given in chapter 3 where the synthesis of p- 
(CH2 )3 (C0 2 H)Cbl, the b.d and e isomers of (C0 2 H)CN-Cbl, HRP and calcitonin conjugates are 
described in detail. The growth of Caco-2  cells on plastic substratum and filters and associated 
methods are also described in this chapter.
2.1 Materials
OH-Cbl was purchased from British Drug Houses (BDH, Dorset, England). CN-Cbl was purchased 
from Calbiochem (Cambridge U.K.) and (G^Co)CN-Cbl with an activity of 10.5 pCi ml'"' and 0.0447 pg 
mH was purchased from Amersham International (Amersham, Bucks., U.K.). The alkyl halides, 
iodomethane, iodoethane, 1-bromobutyric acid, bromoacetic acid, 2 -brorhoethylamine 
hydrobromide were all purchased from Aldrich Chemical Co. (Gillingham, Dorset, U.K.). Where 
possible reagents were used which were >99% pure. The following were also purchased from 
Aldrich: 3,5-diaminobenzoic acid dihydrochloride and 3’,3',S',S'- tetramethylbenzidine. Phosphate 
buffered saline (PBS) was purchased from Sigma chemical Co. (Poole, Dorset, U.K.) in a dry form 
which was rehydrated to give the following composition:120 mM sodium dihydrogen 
orthophosphate and dipotassium hydrogen orthophosphate and 7.4 mM sodium chloride, pH 7.4. 
Cerium(lll)nitrate hexahydrate (Ce(N0 3 )3 .6 H2 0 ) was purchased from Sigma.
The ion-exchange celluloses diethylaminoethyl cellulose and carboxymethyl cellulose were 
purchased from Whatman Labsales (Parkwood, Maidstone, Kent, U.K.). The other ion-exchange 
column media was the acetate form of AG-1 X2, which was purchased from Bio-Rad (Watford,
Herts.). Two types of thin-layer chromatography (TLC) plates were used for identification. These
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were plastic sheets coated with a layer of MN300 cellulose, 'Merck' (5577), 0.1 mm thickness and 
aluminium sheets coated with a layer of silica-gel 6 OF254 'Merck' (5554). All of the TLC plates were 
purchased from BDH. Gel filtration chromatography was carried out using two types of Sephadex 
columns. These were prepared using G-25 and G-175 Sephadex,purchased from Pharmacia LKB 
Biotechnology (Central Milton Keynes, Bucks, U.K.). IF was obtained as a lyophilised powder as 
100 units, where 1 unit binds 1 ng of CN-Cbl. The 1-ethyl 3 (3dimethylaminopropyl carbodiimide) 
hydrochloride (EDAC), Norit-A charcoal. Trypsin, Ethylenediaminetetracetic acid (EDTA), glutamine, 
dextran T-500, Tween-20, BSA, IF and horse radish peroxidase type II were purchased from Sigma.
The Caco-2  cells were purchased by Ciba-Geigy Pharmaceuticals from the American Tissue Culture 
Collection (Rockville, Maryland, USA). The culture media was based upon Dulbecco's modified 
Eagle's medium (DMEM). The DM EM, 6 -well plates and culture flasks were purchased from 
Northumbria Biologicals (Cramlington, Northumberland, U.K.). The non-essential amino acids, 
penicillin/streptomycin, porcine serum and foetal calf serum were purchased from GIBCO-BRL 
(Paisley, Scotland, U.K.). The filters used to grow the monolayers of Caco-2 cells were Millicell HA 
Inserts, 30 mm in diameter containing filters of 0.45 pm pore size and were purchased from Millipore 
(U.K.) (Harrow, Middlesex, U.K.). The Millex-GX filters used to sterilise solutions, were also 
purchased from Millipore. The goat anti-rabbit-HRP antisera was purchased from Nordic 
Immunologicals (Maidenhead, Berks. U.K.).
2.2 Rotarv Evaporation and F ree ze -d ry in g '*88
A Buchi rotary evaporator was used to concentrate samples, with a water pump connected to 
provide the vacuum and the water bath temperature maintained between 40°C and 50°C.
However, a lower temperature was often found to be sufficient. The freeze-drying apparatus used 
was a refrigerated chamber model. Freeze-drying gave a very dry non-crystalline, powdered solid.
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2.3 Phenol/1.1.1-Trichloroethane Extraction 110-111
This procedure is used to purify cobalamin analogues and was originally described using 
phenolitrichloromethane 1:1 (w/v). Trichloromethane is, however, a known carcinogen so 1,1,1- 
trichloroethane was used as an alternative.
For organocobalamins, which are light sensitive, this procedure was carried out under red light. The 
aqueous organocobalamin was transferred to a separating funnel containing phenol:1 ,1,1 
trichloroethane (1:2, w/v), the mixture shaken and allowed to separate into two layers. The lower 
organic layer was removed and the above extraction procedure repeated until all of the colour had 
been removed from the aqueous layer. The combined organic fractions were washed with water to 
remove any inorganic impurities and partitioned between water and diethyl ether (approx 1 :1 0 , v/v). 
The cobalamin, being insoluble in the organic layer once the diethyl ether had been added, 
migrated to the aqueous layer and the extraction was repeated three times. The aqueous washes 
were pooled, re-extracted with diethyl ether to remove any organic impurities and concentrated 
under reduced pressure using a rotary evaporator at a water bath temperature of between 40°C and 
50°C. Alternatively the product was subjected to freeze-drying, which yielded a non-crystalline 
powdered solid.
2.4 lon-Exchanoe Column Chromatographv 109.1 H 
Three different ion-exchange supports were utilised :
1 . Diethylaminoethyl cellulose (DEAE) is a weakly basic anion exchanger containing the R-O-CH2 - 
(NH)Et2+ terminal groups.
2 . Carboxymethyl cellulose (CM) is a weakly acidic cation exchanger containing R-0 -CH2 C0 0 " 
groups where R is cellulose
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3. AG-1X2 in the acetate form which has quaternary ammonium groups.
DE32 and CM32 are the microgranular forms of these two ion exchange celluloses and were 
purchased in a dry inactive form , which required activation. This involved preparing acidic and basic 
aqueous slurries of the cellulose. Twenty grams of cellulose was stirred into 15 vols of first 
treatment acid or base and left for 30 min. The supernatant was filtered off, and the cellulose 
washed with distilled water until the effluent reached the intermediate pH (see table 2.1). The ion- 
exchanger was then stirred into 15 vols of second treatment acid or base and left for 30 min. The 
first and second treatment acids and bases are detailed in table 2 .1 .
Table 2.1 The first and second treatments for the DE32 and CM32 ion-exchange celluloses
Ion-Exchange First treatment Intermediate pH Second Treatment
DEAE 0.5 MHCI 4.0 0.5 M NaOH
.C M 0.5 M NaOH 8 .0 0.5 M HCI
The supernatant was filtered off and the cellulose washed until the effluent was neutral. The 
second treatment was then repeated and, after the cellulose had been washed and a pH of 7.0 was 
reached, the ion-exchanger was dispersed in water, (30 ml of water per g of dry ion-exchanger).
The slurry was allowed to settle and stand for 20 min; the fines, (which cause blocking of the sinter 
and reduce the flow-rates), were removed by décantation of the supernatant. More water was 
added to the slurry prior to packing the column. A 15 cm x 1.5 cm or 30 cm x 2.5 cm column was 
used to pack the column, depending upon the scale of the required preparation. All the columns 
were fitted with a size 1 sinter and were packed under gravity. Concentrated solutions of cobalamin 
were applied to the top of the columns using a pasteur pipette or microsyringe. Sample volumes for 
the smaller columns were usually 0.5 - 1 .0 ml and for the larger columns a maximum volume of 2  ml 
was used. For the DEAE columns water was the eluting solvent. Water was also the initial eluting 
solvent used for CM columns. Once an organocobalamin had been separated from any starting
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material on the CM column the eluting solvent was changed to 10*6 M perchloric acid. This allowed 
separated bands to be collected more rapidly .
The separation of the corrinoids using the ion-exchange celluloses depends upon the overall 
charge on the molecule and on changes effected at specific sites within the molecule such as the /? 
-position and the side chains a-g. The cobalamins -OH, -CH3 and -(CH2 )CH3Cbl all have no overall 
charge when eluted from the ion-exchange columns and are consequently not retained by DEAE 
cellulose, but are selectively retained by CM cellulose. The elution pattern is determined by the 
individual pKa of the cobalamin. Those with a high pKa will be eluted more slowly ‘*89. This allows 
the separation of organocobalamins from OH-Cbl, which has a lower pka than the organocobalamins 
prepared for this work. Organocobinamldes such as (CN2)Cbi, (H2 0 ,0 H)Cbi and (CH3 ,0 H)Cbi 
were not retained by DEAE cellulose, but were variously retained by CM cellulose.
The purification and separation of the (C0 2 H)CN-Cbl b,d,and e isomers were separated using an 
AG-1X2 column (see section 3.3). This packing has functional quaternary groups and was prepared 
as a slurry in water which was poured into a column 50 cm x 3 cm. A series of sodium acetate buffers 
were used to elute the sample. A second column was prepared and a different pH buffer used to 
separate out the three (C0 2 )CN-Cbl isomers (see section 3.3).
2.5 Thin-laver Chromatograohv (TLC) 109.113,114
This was carried out using cellulose-coated plastic sheets, 20 x 20 cm. These were cut to smaller 
sizes of 10 X 20 cm and 5 cm x 20 cm where necessary. The solvent systems used were:
1. Solvent I .Butan-2 -o 1/0.88 ammonia/water, 9/0.675/4 (v/v/v)
2. Solvent II .The upper layer of the following mixture: n-butanol/water/glacial acetic acid, 4/5/1, 
(v/v/v), which was in effect an acidic saturated solution of butanol.
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The plates were placed inside a TLC tank 50 cm x 30 cm in which the eluting solvent had already 
been placed, so that the atmosphere of the tank was saturated with the solvent vapour. The plates 
were run for 3 h and the samples always compared with the OH-Cbl and CN-Cbl. All the cobalamins 
were applied to the TLC plate using a microsyringe and as the cobalamins are intensely coloured 
visual detection is easy. Comparison with the CN-Cbl took the form of calculating RB12 values, 
where the Rf of the cobalamin is compared to that of CN-Cbl (see below). This was necessary as Rf 
values had previously been shown to vary with slight alterations in experimental conditions, in
particular temperature, development time, thickness of cellulose layer and solvent composition. 
1 0 9 , 1 1 3 , 1 1 4
RB12 = Rf of the sample corrinoid/Rf of cyanocobalamin
2.6 UV-Visible S p e c t r a  ^^6
These were measured using a Phillips SP8000 Spectrophotometer. The solvent used, unless 
otherwise stated, was water. Concentrations of 10  ^M to 10 '^ M were commonly used, as these 
gave identifiable absorbances on all of the distinctive peaks associated with the spectra of 
corrinoids. The spectra were taken from 250 nm to 700 nm, although for the cobalamin analogues 
the usual range was from 300 to 600 nm only. Spectra were taken using silica and quartz cells with 
a1 .0 cm path length. Cell temperature was thermostatically controlled and was maintained at 20°C.
2 J -PhQtQ!ysis
Photolysis was used to establish the presence of the Co-C bond in the p-position of the 
organocobalamins. The Co-C bond was demonstrated by the product of photolysis which is OH- 
Cbl. Samples for photolysis were place at a distance of 15 cm from a 60 W tungsten lamp and 
irradiated for a period of 5 toi 0 min.
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2.8 Gel Filtration G
Two columns were used to separate unreacted cobalamin from conjugate. Separation was 
achieved by using exclusion chromatography where molecules are separated on a basis of 
molecular size. The columns used were Sephadex G-25 and G-175. The G-25 column gave a 
quantitative separation of molecules within the molecular weight range of 1K-5K and the larger 
molecular weights were excluded in the void volume. Using the G-25 column, the HRP-Cbl, (MW 
40K), eluted in the void volume. The cobalamin, (MW 1.4K), was within the fractionation range of 
the column and was, therefore, separated from the conjugate. The G-175 column gave a 
separation of molecules between 5K and 175K and this column was used to separate excess of 
HRP from the HRP-Cbl-IF complex.
The Sephadex media was suspended in water to give a slurry, stirred to ensure all of the media was 
wet and then left to settle under gravity. The supernatant was decanted off, removing any fines, 
and the slurry was poured into a glass column 2.5 x 30 cm, which had a glass sinter at the base and 
was allowed to pack under gravity. The columns were run at 4°C and 20°C depending upon the 
sample under purification and the time taken to elute samples from the column.
2.9 IF-Cbl binding Assay (see section 4.6) 117-119
The assay used is that devised by Gottlieb 7^ which was modified by Elsenhans"* ‘*8 so that 
(G7co)CN-Cbl and the cobalamin analogue competed for the available IF. The assays were carried 
out using PBS and Dulbecco's modified Eagles medium (DMEM) as diluent.
A volume of 50 pi of a 1 0 'G to 10’8 M solution of the analogue under test, in PBS buffer pH 7.4, 
was measured into an LP3 plastic test tube and incubated at 4°C. The (G7co)CN-Cbl concentration 
used was 3.25 x lO’”*® m in DMEM and 50 pi was added to the analogue sample. The competing 
cobalamin molecules were mixed thoroughly. The IF was diluted using PBS buffer pH 7.4 to a 
concentration of 2.7 units/ml and 150 pi was added to the Cbl mixture and thoroughly mixed 
together. This mixture was incubated at 4°C for 1 h in the dark. A suspension of 0.5% (w/v) of
activated and filtered Noiit A charcoal and 0.05% T500 dextran (w/v) in modified Eagles media/
0.1% BSA was prepared and vigorously stirred. A 500 pi aliquot of the charcoal/dextran solution 
was added to the samples, which were thoroughly mixed and further incubated at 4°C for 10 min. 
The total volume of the samples was 750 pi and the samples were centrifuged at 2500 g for 10 min. 
All of the unbound (G7co)CN-Cbl was adsorbed onto the charcoal which was pelleted down on 
c e n t r i f u g a t i o n . 1 1 7  The supernatant contained unbound IF and IF-(G7co)CN-Cbl and IF-X where X is 
the analogue added. A volume of 500 pi was removed and counted for for 1 min using an 
LKB multi y counter. The fmoles of IF-(G7co)CN-Cbl were calculated by first multiplying the counted 
cpm by 1.5 to give cpm in the total volume and then divided by 525, as 525 cpm = 1 fmole.
2.10 The Preparation of the IF-Cbl-orotein Complex
The same procedure as described in 2.9 was followed to prepare the complex for the transport 
experiments, but only one cobalamin, analogue or conjugate was incubated with the IF in each 
sample. After centrifugation, the supernatant was removed from the charcoal pellet and sterile 
filtered through a 0.22 pm Millex-GV filter. A small sample (5 pi) was removed and assayed for HRP 
activity so that the number of moles added to the cells was known.
2.11 HRP Assay 1^2°
This assay was carried out on samples from preparations of the conjugates and media samples from 
transport experiments. The samples were assayed in 96-well plates and the optical density read at 
450 nm using a Dynatech plate reader.
The assay substrate was prepared from 7.3 pi of 30% H2 O2 , 20 ml of 0.21 M potassium citrate 
buffer of pH 3.95 and 1 ml of a 21 mM solution of 3,3', 5,5' tetramethylbenzidine in 90% methanol 
and 1 0% acetone. A 100  pi aliquot of the substrate was added to 10 pi of sample in each well.
Each sample was assayed in triplicate, and the plate agitated to ensure thorough mixing of sample 
and substrate. The plate was incubated at a constant temperature of 25°C for 30 min. The reaction
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was stopped by adding 100 pi of 0.1 M sulphuric acid and the optical density was read within 1 h of 
adding the acid. A standard curve of 0-20 pg was run in conjunction with each batch of samples.
2.12 HRP Assay
This assay is an immuno-assay and was used to determine whether the serum in the media was 
interfering with the HRP assay I. The results obtained for the transport experiment where both HRP 
assays were carried out were the same, (see section 5.3) indicating that no interference was 
occuring with HRP assay I. The assay was carried out using standard 96-well plates. These were 
first incubated with antisera raised in goat against HRP. The antisera was diluted 1:1000 with a 
carbonate/bicarbonate buffer of pH 9.6 and 200 pi was added to each well of the plate and 
incubated at 4°C for 12  h. The plates were washed four times using PBS-0.5% Tween-20 and 
could then be stored at -20°C for up to 4 weeks. Free sites on the solid phase were blocked by 
incubating at 37°C for 1 h with 200pl of pig serum which had been diluted 1 :1000 with PBS-0.5% 
Tween-20. The plate was washed four times with PBS-0.5%Tween-20 and 200 pi of standard or 
sample solution was added and incubated in a humid atmosphere at 37°C for 1 h. The substrate 
solution (1 OOpI) described in HRP Assay I "*20 was added to each well and incubated at 25°C for 30 
min. The reaction was stopped by adding 100 pi of 0.1M sulphuric acid to each well and the optical 
density of each well was then measured at 450 nm.
2.13 Culture of Caco-2 CeUg ^
Caco-2  cells were maintained in culture in media which was based upon Dulbecco's modified 
Eagle's medium (DMEM) and contained the following supplements; 10% foetal calf serum, 1%
200 mM glutamine, 1% non-essential amino adds, and 1% penicillin/streptomydn. The cells were 
grown at 37°C in a humidified atmosphere of 95% air and 5% CO2 . Initially 20% foetal calf serum 
was used to culture the cells, both in flasks and on filters, but this was reduced to 1 0 % when 
experiments showed that 1 0% did not affect the growth characteristics of the cells.122  
Routine cell culture was carried out using 25 cm2 225 cm2 fiasks where the Caco-2  cells were 
seeded at a density of 1 x 10  ^cell m l'*. Passages 70 and 100 were grown until confluent and then
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passaged onto millicell chambers in 6 -well plates. The inserts containing the filters were placed in 
Costar 6 -well plates and presoaked in sterile PBS for 30 min before the cells were seeded onto 
them. Then the cells were trypsinised using 0.25% trypsin and 0.2% EDTA in PBS. The cells were 
then washed twice in media (based on DMEM) and seeded so that there were 2x10® cells per 
insert. Media was placed on the basolateral side of the insert and the filter cultures maintained 
using the conditions previously described. The media, (3 ml above and 2.5 ml below the filter) was 
changed every 48 h. Initially the media was replaced every 24 h but this was not found to be 
necessary. The insert is illustrated in figure 2.1.
Humid atmosphere 95% air, 
5% carbon dioxide, 37'C
Millicell chamber.
Basolateral media
Nitrocellulose filter 0.45um L 
with cells on the apical surface.
Figure 2.1 A schematic diagram of the growth of a monolayer of Caco-2  cells in a millicell chamber. 
2.14 Measurement of Resistance across the Caco-2 monolavers ■ .102.123
The resistance measured across the filter grown monolayer of cells had previously been shown to 
be an indication of the integrity of the monolayer (see chapter 1 ). On seeding there was no 
detectable resistance and by day 4 a resistance of 200 Ohms cm‘2 was detected. 81.96,97 After 
10-15 days resistance increased to 300-500 Ohms cm'2 which was maintained until the culture had 
been grown on the filter for 35 days. 81
The method of measuring resistance across the monolayer of cells was based upon that devised by 
Steele and described by von Bonsdorff. 109 Minimum Essential Medium containing 0.1% w/v BSA 
was added to both sides of the monolayer. 5 ml were added apically and 3 ml basolaterally and the
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filter allowed to equilibriate at 25°C for 15 minutes. Salt bridges were connected to each chamber 
and a current of 100 pA applied across the monolayer. The potential difference across the 
monolayer was measured and the electrical resistance (Q cm’2) was derived from Ohm's law.
2.15 Transport Experiment Flux Measurement.
The transport of (G7co)CN-Cbl was detected by counting the ®7co present in the apical and 
basolateral media. Surface binding of (®7co)CN-Cbl was monitored by the counting of 
removed from the monolayer surface when the monolayer was washed with a pH 3 glycine buffer. 
Internalised (®7co)CN-Cbl was measured by counting the G^co in the washed cell monolayer. The 
flux of HRP was measured by assaying 10 pi aliquots of media in triplicate as described in sections
2.11 and 2.12. The concentrations of both (®7co)CN-Cbl and HRP added to the media, either as IF 
adducts or alone, were determined accurately by counting the and by the colorimetric assay 
for the HRP (see 2.11).
2 . 1 6  D M A  A s s a y  ^ ^ 4
The concentration of DNA in a sample of Caco-2  cells was measured by fluorimetric assay.** ^ 4 The 
cells were solubilized using 1 M NaOH and 100 pi of the resulting solution was removed for the 
assay. A solution of diaminobenzoic acid dihydrochloride (DABA), 0.4 mg/ml, was prepared. The 
DABA solution (100 pi) was added to the sample and incubated at 45° 0  for 1 h. The reaction was 
stopped by the addition of 3.0 ml of 0.1 M HCI and the fluoresence measured at 510 nm. A Perkin 
Elmer LS-5 fluorimeter was used with the excitation wavelength set at 400 nm and emission 
wavelength set at 510 nm. Samples were compared to a standard curve determined using calf- 
thymus DNA.
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CHAPTER 3
SYNTHESIS AND CHARACTERISATION OF ANALOGUES AND 
CONJUGATES OF CN-Cbl
Several types of analogues of CN-Cbl were prepared. These were organocobalamins (section 3.1), 
(CN,aq)Cbi (section 3.2), cyano(monocartx)xylic add)cobalamins (CN(C0 2 H)Cbl) (section 3.3), and 
cobalamin-protein conjugates (sections 3.4 and 3.5). The organocobalamins synthesised included 
a range of alkyl ligands, viz. -CH3 , -CH2CH3 , -CH2CO2H, -(CH2)2NH2 , -(CH2)3C0 2 H. These not only 
give a range of alkyl ligand size but also a variety of charged groups in the p-position, so that the 
effect of charge upon the binding of cobalamin to IF can be assessed (Chapter 4). The role of the 
side chain f was investigated using (CN,aq)Cbi and a-ribazole/ ribazole-3-phosphate, which is the 
structure of the side chain (Chapter 4). The role of the propionamide side chains, b, d, and e in IF 
binding was studied as variation in binding have been reported depending upon whether one or 
more propionamide groups was altered to a cartx)xyllc acid group. G® (CN(C0 2 H-d-)Cbl was used 
as a precursor for the synthesis of HRP and calcitonin conjugates, since the equilibrium constant for 
IF binding for the d isomer is closest to that of CN-Cbl (see chapter 4). p-Position conjugates were 
also made using (p-(CH2 )3C0 2 H)Cbl, which was chosen so that the same method of conjugation via 
a -CO2H group on the cobalamin molecule could be used. The (p-(CH2 )3C0 2 H)Cbl also provided 
the -CO2 H group far enough away from the corrin ring to prevent any interactions between the 
peripheral groups and the HRP/calcitonin when joined in the p-position. The d isomer and p- 
position cobalamins provided two sites for comparison for IF binding and transport.
3.1 Organocobalamins
The organocobalamins were synthesised using OH-Cbl as the starting material. The following 
groups were attached in the p-position: -CH3 , -CH2 CH3 , -CH2 CO2 H, -(CH2)3C0 2 H, -(CH2 )2NH2 .
The organocobalamins were synthesised by reducing the Co(lll) in OH-Cbl to Co(l). This is a strong 
nucleophile which then reacts with alkyl halides, electrophilic reagents, via an Sn2 reaction to 
produce the Co-R bond of the o r g a n o c o b a l a m i n . 2 2 - 2 6  jh e  Co-R bond is light labile and therefore
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any experiments involving organocobalamins were carried out under red light or total darkness, to 
prevent photolysis. The reactions to produce an organocobalamin from OH-Cbl are shown below:
NaBH4 R-X
Co(lll)-OH2  — 4  Co(l) > Co(lll)-R
3.1.1 Organocobalamin svnthesis 113,125
The reduction of Co(lll) to give Co(l) results in the formation of a strong nucleophile and was 
achieved using borohydride, although other reducing agents have been reported (See Chapter 1). 
A 5 mM solution of OH-Cbl was prepared and 10 ml of this solution was degassed by passage of 
nitrogen through the solution, over a 5 minute period. A 1 mM solution of cobalt nitrate Co(N0 3 )2  
(0.1 pmoles) was injected into the solution of OH-Cbl. This acts as a catalyst for the next atage which 
is reduction by borohydride. Sodium borohydrade (0.1 g 3.7 mmoles) was added and the reaction 
sealed using a rubber septum (suba-seal) with inlet and outlet pressure equilibriating needles. The 
respective alkyl halide (48 mmoles) was added via a syringe to the reduced cobalamin in the dark, 
the mixture was agitated by bubbling nitrogen through the solution and worked up by phenol/1 ,1 ,1 - 
trichloroethane extraction (see section 2.3) followed by ion-exchange chromatography (as 
described in section 2.4.). The final product was characterised by TLC system (solvent systems I 
and II) followed by UV spectroscopy (as described in sections 2.5 and 2.6).
The extraction procedure described in section 2.3 was modified for p-(CH2)3 C0 2 HCbl due to 
problems encountered with the final displacement of the cobalamin from organic layer to the 
aqueous layer. The addition of two volumes of diethyl ether to the organic layer did not displace the 
cobalamin into the aqueous layer. This can be explained by the hydrogen bonding affinity of the 
CO2  H group to the phenol being greater than the affinity between the phenol and diethyl ether. 
Therefore, the diethyl ether cannot displace the analogue back into the aqueous layer. Different 
volumes of diethyl ether were added up to a 1 0 -fold excess of the volume of the organic phase. 
None of these successfully displaced the analogue into the aquoeous layer. Other solvent 
mixtures were tested and a 2:1 mixture of diethyl ether.acetone successfully displaced the
«
cobalamin into the aqueous layer. Acetone contains a -C=0 group which is more polarised than 
the -C-0 in diethyl ether and, therefore, the hydrogen bonding affinity of acetone for phenol is 
greater than the affinity of diethyl ether for phenol. Once the analogue is displaced back into the 
aqueous phase, any organic impurities were removed by washing with diethyl ether.
3.1.2 Identification of Organocobalamins
The identification of organocobalamins relies upon techniques where very small differences in 
structure can be detected within a large molecule. These problems lead to techniques such as 
microanalysis and Infra-red being of limited use. Chromatographic techniques are of most use when 
purifying and identifying organocobalamins. Ion-exchange columns separate out different 
cobalamins, which can be shown to be pure by TLC. UV-Vis spectroscopy is useful for the 
identification of unknown organocobalamins by confirming the presence of the Co-C bond. The 
spectrum of any organocobalamin between 300 and 600 nm contains X maxima which are common 
to all organocobalamins (see table 3.1). There are three major bands a, (3, and y, which are all due 
to 7C-7Ü* transitions within the corrin macrocycle. In the starting material OH-Cbl the y-band is a sharp 
peak at 350 nm, although at pH 7.4 it is actually 352 nm, which changes to a shoulder at 
approximately 375 nm in the organocobalamins (see table 3.1). The p-band also shifts in 
organocobalamins to 470-490 nm (see table 3.1). The organocobalamins can exist in two forms 
which are dependent upon the pH of the solution and are known as the 'base-on' and 'base-off 
species. The 'base-on' species exists at a neutral and alkaline pH where the Ng of the 5',6 - 
dimethylbenzimidazole group is coordinated to the Co and occupies the lower axial a-ligand 
position. In the 'base-off form the 5'6'-dimethylbenzimidazole is protonated and the a-ligand 
position is occupied by OH2 . This form exists at low pH and the protonation of the 5',6'- 
dimethylbenzimidazole causes the p-band to shift to 450 nm (see table 3.2). The two forms are 
shown in figures 3.3-3.7.
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p-position ligand A. Maxima nm
y P a
-H2O
-H2O*
323
323
3 5 4
350
387
387
409
407
496
496
526
526
-CN 315 (323) 361 (422) 512 549
-CN* 315 (325) 361 (422) 512 549
-CH3
-CH3*
310
310
(332)
(332)
374
374
.398
398
(447)
(447)
(473)
(473)
-CH2CH3 (333) 375 398 (446) 484 525
-CH2 CH3* (332) 375 399 (447) 484 525
-(CH2)2 NH2 378 398 (447) 485 523
-(CH2)3C02H 319 327 376 396 (447) 480 523
-CH2CO2 H 318 327 378 391 (445)
CN2** 315 367 391 445 584
Table 3.1 The X maxima values for the p-position analogues prepared in this chapter, compared to 
literature data. Shoulders are shown in parenthesis.
* This data is taken from ref.20a.
** represents the dicyanocobalamin and the data is taken from ref.126.
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. p-position ligand major absorbance bands nm
-CH3 305 376 462
-CH2CH3 303 385 444
-(CH2)2 NH2 305 400 455
-(CH2)2C0 2 H 303 385 450
5'-deoxvadeonsvl . .303 376 458
Table 3.2 The major absorbance bands for the 'base-off species of organocobalamins.
The formation of the Co-C bond is also identified by two decompostion pathways. The first of these 
is photolysis of the sample in aqueous solution, which produces OH-Cbl, and the second is the 
aerobic photolytic decomposition in the presence of cyanide to produce CN-Cbl or, if the cyanide is 
in sufficient excess, the dicyanocobalamin (CN)2Cbl.
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Figure 3.1 The UV-Vis spectrum of OH-Cbl. The a, p and y-bands are notated (see table 3.1).
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Figure 3.2 The UV-VIs spectrum of CN-Cbl. The a, p and y bands notated (see table 3.1).
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Figure 3.3 UV-Vis spectrum of MeCbl. The 'base-off' and 'base-on' forms are shown. 
- - - 'base-on'form 
 'base-off'form
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Figure 3.4 UV-Vis spectrum of (P-CH2 CH3 )Cbi. The 'base-on' and 'base-off forms are shown. 
- - - "base-on' form 
■" base-off form
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Figure 3.5 The UV-Vis spectrum of (p-(CH2 )2NH2 )Cbi. The 'base-on' and 'base-off' forms are 
shown.
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Figure 3.6 The UV-Vis spectrum of (P-(CH2)3 C0 2 H)Cbi. The 'base-on' and 'base-off' forms are 
shown.
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Figure 3.7 The UV-Vis spectrum of (p-(GH2CG2 H)Cbi. The 'base-off' and 'base-on' forms are 
shown.
- - - 'base-on'form
■’base-off' form
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Figure 3.8 The UV-Vis spectrum of dicyanocobalamin. The spectrum of dicyanocobalamin and 
dicyanocobinamide are the same above 300 nm.
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3.1.3 Characterisation of Organocobalamins
The UV-Vis spectra of -CH3 , -CH2CH3 . -(CH2)2NH2 . -CH2CO2 H and -(0 H2)3CO2H cobalamins are 
shown in figures 3.3-3.7 and the X max are listed in table 3.1. The RB12 values from the TLG data 
(see section 2.5) are listed in table 3.3. Solvent systems I and II were used and literature values for 
RB12 are given in parenthesis.'*'*^
Alkyl halide Ligand Solvent 1 Solvent II
lodomethane -GH3 1.47(1.5) 1 .2 (1 .2 )
lodoethane -GH2GH3 1.51(1.6) 1 .2 (1 .2 )
Bromoacetic acid -GH2 GO2 H 0.62(0.65) 1 .1 (1 .1 )
4-Bromo 
butyric acid -(GH2)3G0 2 H - 1.1
2-Bromoethyl- 
amine hydro­
bromide -(GH2)2NH2 0.51 -
Table 3.3 RBi2 values using the two solvent systems I and II (see section 2.6). Literature values are 
shown in parenthesis.
3.2 Preparation of (GN.aq)Gbi 113.127
The procedure used was one which was based upon that of Friedrich and Bemhauer as modified by 
Thorp."* i .0 g of GN-Gbl was added to 84 ml of 0.33 M cerium(lll) nitrate hexahydrate 
(Ge(NO3)3 .6 H2 0 ). An aqueous mixture of 25 ml of 2 M sodium hydroxide, 150 ml of water, and a 
solution of 0.84 g of potassium cyanide in 12.5 ml of water were added to the reaction mixture. The 
mixture was refluxed over a steam bath for 30 min with frequent shaking. The mixture was adjusted 
to pH 8.5 using 0.88 ammonia, cooled on ice and stored overnight at 4°G. This allowed the cerous 
hydroxide to coagulate, which was then removed by filtration. The product of the reaction was 
(GN)2Gbi which was desalted using the phenol/1 ,1 ,1 -trichloroethane extraction.
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The production of (CN.aq)Cbi from (CN)2Cbi was the next stage of the preparation. The alteration of 
one axial ligand from -CN to -OH was achieved by removing HCN from the solution. The solution of 
(CN)2Cbi was kept under nitrogen, acidified with 1 M perchloric acid, and shielded from the light. 
Nitrogen was bubbled through the solution to remove any hydrogen cyanide formed. The outlet 
was connected to a series of Dreschel bottles and the stream of nitrogen bubbled through a 2  M 
solution of sodium hydroxide followed by two 2 0 % sodium hypochlorite solutions to remove 
hydrogen cyanide from the stream of nitrogen. The removal of hydrogen cyanide to give 
(CN,aq)Cbi took 2  to 4 days and the changes could be detected using UV-Vis spectroscopy of the 
neutralized species (see figures 3 .8 ,3.9 and table 3.4). The solution was neutralized using 2  M 
sodium hydroxide to a pH of 7.51, and the (CN,aq)Cbi purified using the phenol/1 ,1 ,1 - 
trichloroethane extraction (see section 2.3).
Unwanted cobalamins were removed using ion-exchange chromatography. A DEAE and a CM 
column, each 30 cm x 2 cm, were connected in series and the sample applied to the top of the 
DEAE column and eluted with water. Any CN-Cbl was eluted through both columns as CN-Cbl was 
not retarded by either column. The cobinamides produced were separated, as they were retained 
to different extents by the different columns. (CN,aq)Cbi was retained as a band at the top of the 
CM column, whilst (H2 0 ,0 H)Cbi was a slow moving band on both columns and (CN)2Cbi was 
retained by DEAE cellulose. This enabled the (CN,aq)Cbi to be easily separated from the other 
products formed. The two columns were disconnected once the (CN,aq)Cbi had moved off the 
DEAE column and elution down the CM column was continued until the (H2 0 ,0 H)Cbi was well 
separated from the (CN,aq)Cbi band. The (CN,aq)Cbi was removed from the CM column using 
1 0 '3  M perchloric acid and neutralized using 2 M sodium hydroxide. The solution was desalted by 
a phenol/1,1,1-trichloroethane extraction and freeze-dried. The (CN,aq)Cbi was shown to be pure 
by TLC. 127 The solvent used was system (I) (see section 2.5). Two spots were obtained for the 
(CN,aq)Cbi due to the presence of the two isomers, cyanoaquocobinamide and 
aquocyanocobinamide. The data is listed in table 3.5 and literature data is given in parenthesis.
43
d
d
300 350 400 450 500 550 600nm
Figure 3.9 The UV-Vis spectrum o! (CN,aq)Cbi. The a, p and y-bands are notated.
Cobinamde X maxima nm
CN2 Cbi 306 367 418 539 580
(CN,aq)Cbi 320 354 (408) 496 528
*(CN,aq)Cbi 322 355 (407) 496 528
Table 3.4 Differences in the spectra of (CN)2Cbi and (CN.aq)Cbi which are the indication of the 
formation of (CN.aq)Cbi from (CN)2Cbi.
* This data from is taken from ref. 27.
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Sample RBi2
CN-Cbl
OHCbl
(CN)OHCbi
1 (1 )
0.30(0.20)
0.46(0.5)
0.89(0.80)
Table 3.5 TLC data from the preparation of (CN,aq)Cbi. Literature data are shown in p a r e n t h e s i s . ' * ^ ^
3.3 Synthesis of fMonocarboxvlic Acid) C o b a l a m i n s ' * 2 8 , l 2 9
The three monocarboxylic acids are derived from the b,d,and e propionamide side chains. These 
were produced by acid hydrolysis of CN-Cbl. Only mildly acidic conditions, 0.4 M HCI, were used to 
prevent the cleavage of side chain f which produces (CN,aq)Cbi. The CN-Cbl (5g, 3.7 mmoles) 
were dissolved in 500 ml of 0.4 M hydrochloric acid and the solution kept in the dark for 72 h, while 
stirring at 20°C. The solution was neutralized with 1 M sodium hydroxide and extracted using 
phenol/1,1,1 trichloroethane. The volume of the solution was reduced by rotary evaporation and 
the temperature kept below 40°C to prevent decomposition. The products were passed down a 
50 cm X 3 cm, AG-1X2 Ion-exchange column in the acetate form. The slurry was prepared using 
water and the sample was applied to the top of the column; elution with water removed any 
unreacted CN-Cbl."*^9 When the eluent was no longer coloured the eluting solvent was changed to 
0.4 M sodium acetate buffer pH 4.64 and the single band was collected and directly applied to a 
second column. The second column was 50 cm x 3 cm, AG-1 X2 , and the eluting buffer was sodium 
acetate 0.4 M, pH 4.64. As the sample travelled down the column two distinct bands were 
observed. When the second of these bands was halfway down the column the eluting buffer was 
changed to a 0.4 M sodium acetate buffer of pH 5.3. The first band, due to a single CN(C0 2 H)Cbl, 
was collected and purified using the phenol/1,1 ,1-trichloroethane extraction, and the second band 
was reapplied to this column and eluted with the pH 5.3 buffer. This was repeated and two bands 
were distinguishable on the last cycle. These were collected and desalted in the same way as the 
first band. All three bands were freeze-dried and the yields were band 150%, band II 6.5% and band if t
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13.1%. Band I corresponded to CN{C0 2 H<l-)Cbl, band II to CN(C0 2 H-b-)Cbl and band III to
CN{C0 2 H-e-)Cbl (see ref. 129).
The UV-Vis spectra of all three of the cyano(monocart>oxylic acid)cobalamins were the same as CN- 
Cbl, see figures (3.2 and 3.10). These spectra were taken to show that the hydrolysis had not been 
strong enough to produce the cobinamide (see figures 3.9 and 3.10). Two methods, TLC and 
l^Cnmr, were used to identify the three monocarboxylic acids b,d, e and assess the purity of the 
samples. The TLC was carried out using silica-gel-coated plates The plates were 20 cm long and 
either 10 or 15 cm wide. Solvent system il was used and the plates were run for 2  h. The data is 
listed in table 3.5 and literature data is given in parenthesis.
§
300 450 550350 400 500 600nm
Figure 3.10 The UV-Vis spectrum of CN(C0 2 H)Cbl. The a, p, and y bands are the same as those 
for CN-Cbl, (see figure 3.2).
46
Cobalamin Rf RB12I 29
CN-Cbl 0.062 1
OHCbl 0.027 0.44(0.35-0.65)
CN(C02H-d-)Cbl 0.087 1.4(1.50
CN(C02H-b-)Cbl 0.07 1.13(1.3)
CN(C02H-e-)Cbl 0.06 0.97(0.98)
Table 3.6 TLC data for the preparation of the CN(C0 2 H)CbI.
13c nmr spectra of CN-Cbl and CN{C0 2 H-d-)Cbl in D2 O were obtained using a Brucker AC300, with 
tetramethylsilane as the external reference. The six signals, which were seen to change from the 
spectrum of CN-Cbl when compared to CN(C0 2 H)Cbl, were those due to the a and p carbons of the 
propionamide side chains, C3 0 , C31 , C41 , C4 2 , C48 , and C49 . The signal assignments made using 
13c nmr of specifically labelled cobalamins in the early 1980s 130 led to the unambiguous 
assignment of the signals. The assigments have been confirmed more recently using 2-D and 3-D 
nmr techniques, where greater resolution is now possible.l3i .132 These include NOESY, COSY, 
HOHAHA amongst others. The limited solubility of the d isomer, especially at low pH values, when 
compared to the b and e isomers has resulted in studies being confined to the b and e isomers. 
These are the two isomers which are less easily separated from the initial preparation of the 
monocarboxylic acids and therefore the remaining monocarboxylic acid, being a single isomer, is 
inferred as being the d isomer. The changes in the nmr of the six atoms mentioned above are listed 
in table 3.7. Literature data Is shown in parenthesis.
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Cartx>n atoms nmr signals for the cobalamins ppm
CN-Cbl 131.132 CN(C)2H-d-)Cbl 130
C31 34.78(35.9, 35.02) 35.92(35.90)
C30 25.88(27.0,25.99) 26.40(27.00)
C41 25.88(27.0,25.99) 27.91(27.80)
C42 32.10(29.0,27.99) 34.51(34.80)
C48 27.93(29.0,27.99) 28.80(28.90)
C49 34.48(35.6,34.69) 34.80(35.50)
Table 3.7 Signals of the I3c  nmr spectra of CN-Cbl and CN(C0 2 H-d-)Cbl.
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Cursor Frequency PPM Intensity
1 3812 23614.961 180.2823 5.338
2 3842 23571.840 178.8368 4.851
3 3902 13488.988 178.7368 6.457
3 3932 13488.989 178.7368 6.459
4 3942 13433.477 178.0991 9.234
5 3951 13497.179 177.6118 5.856
6 3993 13552.754 177.8823 2.437
7 4001 13351.637 176.3158 8.887
8 4013 13334.980 176.6812 2.399
9 4016 13330.159 176.6315 1.221
10 4067 13259.478 175.6317 2.336
11 4075 13249.190 175.5121 14.357
12 4106 13209.320 174.8727 18.237
13 4123 13181.573 174.6626 7.322
14 4128 13175.411 174.5808 4.337
15 4171 13116.250 173.7370 1.487
16 4191 13088.175 173.4719 5.428
17 4198 13078.333 173.2845 3.418
18 4579 12549.008 166.2809 3.222
19 4601 12529.217 165.8074 5.497
20 4535 12477.678 165.2215 2.143
21 4610 12464.219 165.1812 2.610
22 4651 12453.247 164.2735 11.002
23 4654 12445.585 .164.3117 6.785
24 5915 19696.665 141.7363 5.421
25 6195 19398.353 136.3913 3.196
26 6281 19189.389 125.9064 7.999
27 6285 19183.590 134.3379 2.797
28 6398 19048.218 122.3780 5.251
29 6488 10027.914 122.3671 3.252
30 6567 9787.392 120.3886 2.282
31 7028 9156.613 118.7233 1.271
32 7232 8784.253 115.7878 6.181
33 7568 8499.517 111.2280 5.107
34 7707 8199.399 107.7876 6.510
35 7729 8138.329 107.7658 1.989
36 7788 8098.243 107.2216 3.192
37 7964 7884.258 104.2721 3.722
38 7875 7878.111 102.2722 6.472
39 7973 7837.791 100.7988 2.122
40 8470 7152.479 94.7779 6.191
41 8898 6558.411 86.9928 8.278
42 9008 6412.634 84.979 9.462
43 9158 6184.125 81.9420 5.782
44 9273 6177.280 81.940 1.783
45 9556 5645.969 74.8129 8.242
46 9650 5593.323 72.9218 3.212
47 9888 5285.536 68.7110 18.030
48 10347 4548.381 60.2684 7.732
49 10492 4458.382 59.0758 14.902
50 10552 4255.008 56.5258 4.323
51 10579 4239.017 56.1697 4.269
52 10602 4194.924 55.5849 6.223
53 10693 4068.797 53.9135 2.759
54 10711 4049.755 52.5318 5.755
55 10830 3878.357 51.3902 5.325
56 10833 3874.434 51.3399 16.990
57 11207 3633.229 48.1422 4.721
58 11015 3624.759 47.3822 7.159
59 11047 3562.945 47.2241 8.628
60 11067 3555.397 47.1168 2.327
61 11167 3411.234 46.2212 5.437
62 11294 3234.538 42.8677 6.269
63 11305 3219.248 42.6567 2.258
64 11509 2937.925 38.9228 5.911
65 11616 2788.972 35.2171 16.281
66 11672 2710.842 34.9822 1.271
Cursor Frequency PPM Intensity
67 11732 2627.309 34.4817 5.130
68 11748 2604.491 34.5198 6.385
69 11867 2447.239 32.4272 5.594
70 11877 2425.911 32.1446 9.619
71 11917 2370.807 31.4145 22.568
72 11925 2358.223 31.0435 3.141
73 11977 2287.983 30.3169 1.249
74 12059 2173.795 28.8079 1.222
75 12094 2124.630 28.4127 2.196
76 12108 2106.105 27.9372 4.922
77 12188 1994.928 26.4332 3.552
78 12222 1947.478 25.8051 7.141
79 12340 1783.911 23.6777 1.255
80 12384 1722.748 22.8273 1.432
81 12545 1722.745 18.86991 11.399
82 12575 1498.059 18.86991 11.398
83 12594 1445.445 18.1129 12.711
84 12594 1427.457 18.9141 16.827
85 12735 1263.729 16.7451 8.197
86 12767 1197.967 15.7912 6.722
87 12784 1168.932 15.4778 8.191
88 12794 1154.218 15.2312 5.671
89 12806 1137.406 15.3712 12.087
90 12680 1034.963 13.7133 1.277
91 13045 987.785 10.5391 1.024
Table 3.8 The l^ c  NMR spectrum of CN-Cbl in D2O with tetramethylsilane as the external standard.
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APR19 3 6 1 . 0 0 3  
- I N
PI
in t e n s it y  - 2 .8 4 5  P MAXY - 2 2 .0 0 0 0 0
MS. LEVEL - 2 .8 4 5 NOISE - .6 9 9 8 3
1 5 0 9 3 .7 2  HZ -  1 9 9 .9 9 9 5  PPM F2 -
« CURSOR FREQUENCY PPM INTENSITY
1 3838 1 3 5 77 .359 1 7 9 .9 0 7 0 8 .0 9 3
2 3899 13492 .867 1 7 8 .7874 7 .2 3 3
3 394 1 1 3 4 34 .745 1 7 8 .0 1 7 2 0 .0 8 8
4 3958 13410 .864 1 7 7 .7 0 0 8 8 .0 6 1
5 4000 13352 .722 1 7 6 .9 3 0 4 8 .4 2 9
6 4009 13340 .704 1 7 6 .7 7 1 2 7 . 137
7 4068 13 2 58 .803 17 5 .6 8 5 9 7 .9 8 2
8 4074 13250 .005 1 7 5 .5 6 9 3 9 .8 4 8
9 4106 1 3 2 05 .846 1 7 4 .9 8 4 2 1 0 .3 1 7
10 4124 13 1 80 .770 1 7 4 .6 5 2 0 11 .8 4 6
11 4191 13087 .783 1 7 3 .4 1 9 8 9 .6 1 6
12 4599 12521.711 165.9191 8 .2 6 3
13 4641 12463 .667 1 6 5 .1 5 0 0 8 .4 9 9
14 5917 10693 .990 1 4 1 .7 0 0 8 6 .8 9 5
15 61 96 1 0 3 06 .992 1 3 6 .5 7 2 9 8 .5 1 1
16 6281 10188 .747 135.0061 10 .3 3 3
17 6394 10031 .916 13 2 .9 2 8 0 1 0 .1 0 3
18 6564 9 7 9 6 .3 3 2 1 2 9 .8064 7 .7 0 5
19 7297 8 7 7 9 .6 3 4 1 1 6 .3346 7 .7 1 4
20 7568 8 4 0 3 .3 6 8 11 1 .3 4 8 9 7 .3 9 8
21 7782 8 1 0 6 .9 7 2 1 0 7 .4 2 1 5 7 . 646
22 7969 7 8 4 7 .6 9 8 1 0 3 .9 8 6 0 9 .0 4 7
23 8467 7 1 5 6 .5 9 7 9 4 .8 2 8 6 8 .0 8 5
24 8897 6 5 5 9 .8 3 0 86 .9 2 1 1 9 .2 9 9
25 9002 6 4 1 4 .3 0 6 8 4 .9 9 2 8 1 3 .9 3 7
26 9168 6184 .211 8 1 .9 4 4 0 5 . 136
27 9173 6 1 7 7 .0 9 8 8 1 .8 4 9 7 5 .0 5 3
28 9556 5 6 4 5 .7 0 4 7 4 .8 0 8 5 7 .6 2 9
29 9661 5 5 0 0 .5 0 2 7 2 .8 8 4 5 7 .3 3 8
30 9890 5 1 8 2 .5 1 9 6 8 .6 7 1 0 6 .4 2 1
31 10350 4 5 4 4 .9 0 4 6 0 .2 2 2 3 7 . 11 1
32 1041 1 4 4 5 9 .7 2 0 5 9 .0 9 3 6 12 .6 8 5
33 10570 4 2 3 8 .9 1 0 5 6 .1 6 7 7 6 .8 5 1
34 10601 4 1 9 6 .1 4 3 5 5 .6 0 1 0 7 .6 4 3
35 10713 4 0 4 0 .8 6 6 5 3 .5 4 3 5 8 .3 7 4
36 10831 3 8 7 7 .1 3 2 5 1 .3 7 4 0 15.001
37 11013 3624 .561 4 8 .0 2 7 3 1 2 .9 0 0
38 1 1063 3 5 5 5 .3 9 3 4 7 .1 1 0 8 1 3 .8 8 2
39 1 1 167 3 4 1 0 .5 1 4 45 .1911 5 . 552
40 1 1298 3 2 2 9 .884 4 2 .7 9 7 6 6 .8 6 5
41 I 1304 3 2 2 0 .6 7 5 4 2 .6 7 5 6 6 . 859
42 11510 2 9 3 5 .3 9 2 3 8 .8 9 5 4 8 .8 0 1
43 1 1734 2 6 2 4 .5 4 2 3 4 .7 7 6 5 9 . 333
44 1 1750 2 6 0 1 .9 5 6 3 4 .^ 7 7 2 8 .7 0 5
45 1 1861 2 4 4 8 .6 2 9 32 ;456 5 .2 5 5
46 1 1879 2422.851 3 2 . .0 4 0 5 .2 1 8
47 1 1920 2 3 6 6 .2 3 9 3 1 .3 5 3 9 9 .5 3 5
48 1 1931 2 3 5 1 .0 0 7 3 1 .1 5 2 0 •’ .4 4 0
49 12106 2 1 0 8 .1 8 3 2 7 .9 3 4 5 ,4 .9 8 3
50 12218 1953 .003 2 5 .8 7 8 3 ' 8 .0 9 8
51 12550 1 4 9 2 .379 1 9 .7 7 4 8 1^ 0 .6 6 4
52 12579 1452 .318 1 9 .2 4 4 0 1 3 .9 1 0
53 12588 1439.701 1 9 .0768 1 0 .2 6 0
54 12598 1425.851 1 8 .8 9 3 3 1 4 .6 3 3
55 12718 1259.081 1 6 .6 8 3 5 .8 .8 1 9
56 12771 1 1 8 6 .0 7 0 1 5 .7 1 6 0 -1 0 .628
57 12796 I l S l . 180 1 5 .2 3 3 7 ’ 9 .8 3 4
PP CONSTANT 
SENS. LEVEL 
.0 0  HZ -
1.00000 
2 .7 9 9 3 1  
.0 0 0 0  PPM
Table 3.9 The ''^C nmr signals for CN(C02H-d-)Cbl in D2O with tetramethylsilane as the external 
standard.
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3.4 Synthesis of Cobalamin-HRP Conjugates
The CN(C0 2 H-d-)Cbl and p-((CH2 )3C0 2 H)Cbl were used to produce the HRP-cobalamin 
conjugates. The cobalamin, which was either CN(C0 2 H-d-)Cbl (10 mg, 7.4 pmoles) or p- 
((CH2 )3C0 2 H)Cbl (10 mg, 7.4 pmoles), and HRP (10 mg, 0.25 pmoles) were mixed together and 
dissolved in 1.5 ml of PBS buffer in a small stoppered polythene tube. The preparation was also 
carried out on a smaller scale. The pH was adjusted to 6.5 with 0.1 M hydrochloric acid, using a 
microsyringe and a micro-electrode and solution was cooled to 4PC. An equal mass of 1-ethyl-3(-3- 
dimethyl-aminopropyl)-carbodiimide hydrochloride (EDAC 10 mg, 0.09 mmoles) was added to the 
solution and the tube was covered in foil and stirred at 4°C for 12 hours. The foil wrapping was an 
added precaution for the CN(C0 2 H-d-)Cbl, but essential for the p-((CH2)3 C0 2 H)Cbl derivative to 
prevent photolysis.
The reaction mixture was passed down a G-25 Sephadex column (see section 2.4). This removed 
any unreacted cobalamin from the mixture of reaction products. The eluting solvent was water and
1.5 ml fractions were collected and the UV-Vis spectrum of each fraction was monitored from 250- 
600 nm. The UV-Vis spectra of CN(C0 2 H-d-)Cbl and HRP are shown in figures 3.10 and 3.13, 
where the X maxima at 361 nm for the CN(C0 2 H-d-)Cbl and 403 nm for HRP are clearly seen. The 
molar absorptivity coefficient (Emolar) for the y-band in CN(C0 2 H-d-)Cbl is 2.7 x lO t  which is very 
similar to the value of 2.8 x 10^ for the y-band in CN-Cbl.^o*  ^ The Emolar for 403 nm of HRP is 8  x 
10^. Two bands separated out as the sample travelled down the column, the first corresponding to 
a high MW fraction and the second a tow MW fraction. High MW fractions had a spectrum consistent 
with a compound containing both HRP and CN(C0 2 H-d-)Cbl with X max 403 nm (HRP) and 361 nm 
(CN-Cbl) (see figure 3.14). The first band was beige-pink in colour whereas the second band was 
pink. The second band had X max for 361 nm only and the spectrum was the same as (CN-C0 2 H-d- 
)Cbl, (see figure 3.15). Both the first and second bands eluting from the column had a  and p-bands 
characteristic of cobalamins. Band I was then freeze-dried and stored at -20°C. The typical yield 
was 70% + 20%. Figure 3.14 shows the elution profile for absorbance at 403 nm and 361 nm and 
the data is given in table 3.10. Both absorbances are found for a band eluting with a high MW. The 
second band eluting from the column was consistent with unconjugated CN-Cbl.
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Figure 3.13 The UV-Vis spectrum of HRP.
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Figure 3.14 The UV-Vis spectrum of the high MW band eluting from the G-25 column, showing the 
maxima of both HRP and GN(G0 2 H-d-)Cbl.
o
d
250 300 350 400 450 500 550 600
nm
Figure 3.15 The UV-Vis spectrum of the low MW band eluting from the G-25 column, showing a 
spectrum of GN(G0 2 H-d-)Gbl only.
55
Fraction Number Absorbance at 361 nm Absorbance at 403 nm Absorbance f361/403)
0-18 0 0 0
19 0.099 0.159 0.62
2 0 0.089 0.181 0.61
21 0.300 0.418 0.72
2 2 0.536 0.811 0 .6 6
23 0.477 0.725 0 .6 6
24 0.140 0.204 0 .6 8
25 0.060 0.080 0.75
26 0 0 0
27 0 0 0
28 0 0 0
29 0 .1 1 1 0.015 7.4
30 0.177 0.024 7.2
31 0.465 0.065 7.75
33 0.707 0 .1 0 0 7.0
35 1.057 0.146 7.2
37 1.826 0.242 7.5
39 2.272 0.300 7.5
41 2.735 0.300 7.5
43 3.200 0.423 7.6
45 4.320 0.578 7.5
47 3.300 0.450 7.3
49 2.98 0.460 7.2
51 2.050 0.270 7.2
Table 3.10 The elution profile for the absorbances at 361 and 403 nm with the ratio of absorbance 
at 361 nm/ absorbance at 403 nm. The absorbances were read at 25°C and pH of 7.1.
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Figure 3.16 The G-25 Sephadex elution profile of the HRP-(C02)CN-Cbl conjugate.
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A range of concentrations of CN-Cbl and HRP, from 10"^-10"^  M, were analysed by UV-Vis 
spectroscopy and the ratio of 361/403 nm was calculated for both, to compare the ratios with those 
obtained for the conjugate. The ratio of 361/403 nm for CN-Cbl is 7.3 and for HRP the ratio is 0.47. 
The 361/403 nm absoitance ratio was determined for an equimolar mixture of CN-Cbl and HRP 
which was 0.77.
The UV-Vis data shows that the stochiometry of binding within the conjugate (band I eluting from 
the column), is 1:1 for CN(C0 2 H)Cbl:HRP. The 361/403 nm ratio for the high MW band eluting from 
the G-25 column is approximately 1. The HRP activity of the conjugate was assessed by the 
colourimetric assay (see chapter 2). A known concentration, 1 pg pl'' ,^ was assayed and found to 
have an activity of 0.98 pg p l'\
The same method of analysis of UV-Vis spectra of the eluate from the G-25 column and comparison 
with HRP and (P-HRP-(CH2)3 C0 2 H)Cbl spectra was used to calculate the stochiometry of binding of 
HRP to cobalamin in this conjugate. The X maxima used were 313 nm and 403 nm. Separate 
solutions of HRP and (p-(CH2)3C0 2 H)Cbl were analysed for absorbance at these two maxima (see 
figures 3.6 and 3.13). A spectrum of a 1:1 mixture of (P-HRP-(CH2)3C0 2 H)Cbl and HRP was taken 
and the 313/403 ratio was calculated, and was found to be 1.0 ( see figure 3.18). The ratio for HRP 
alone was 0.20 and for (P-(CH2 )3C0 2 H)Cbl was 3.75. The elution profile for the G-25 column is 
listed in table 3.11 and illustrated in figure 3.18. There were two bands eluted and the spectra are 
shown in figures 3.19 and 3.20.
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Absorbance (313/4031Absorbance at 403 nmAbsorbance at 313 nmFraction Number
0-19
1.130.0800.090
1.000.1310.13123
0.880.0800.070025
27
29
3.700.0700.26833
3.700.0700.26735
0.080 3.890.37237
3.910.481 0.12339
4.300.0940.407
0.078 4.240.33143
0.060 4.2045 0.252
3.9547 0.162 0.041
Table 3.11 The elution profile for the absorbances at 313 nm and 403 nm for the G-25 column.
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Figure 3.17 The UV-Vis spectrum for a 1:1 Molar mixture of CN-Cbl and HRP
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Figure 3.18 The G-25 Sephadex elution profile for the absorbances at 313 nm and 403 nm for the 
G-25 column.
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Figure 3.19 The UV-Vis spectrum of the first band eluted from the G-25 column.
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Figure 3.20 The UV-Vis spectrum of calcitonin.
The HRP-(C0 2 )CN-Cbl conjugate in the form of an IF adduct was then eluted down a G-175
Sephadex column, which fractionates MW in the range 5K-200. Therefore any excess HRP will be 
separated from the IF-(HRP-C0 2 )CN-Cbl as there is a difference of 40K in MW. The eluate
absorbance at 403 nm was measured and only one peak was found which corresponded to MW of
61
approximately 100K, and was the IF complex. The procedure was also carried out for the IF-(p- 
HRP(CH2)3C02H)Cbl complex and the data is listed in table 3.12.
Fraction Number Absorbance at 403 nm
IF-(HRP-(C02)CN-Cbl IF-(P-HRP(CH2)3C02)Cbl
0-17 0 0
19 0.028 0
21 0.140 0.105
23 0.635 0.349
25 0.756 0.763
27 0.252 0.427
29 0.037 0.084
31 0 0.040
33-51 0 0
Table 3.12 The elution profile of absorbance at 403 nm for both the IF-(HRP-(C02)CN-Cbl and IF- 
(P-HRP(CH2)3C02)Cbl adducts.
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3.5 Calcitonin Conjugates
The above procedure was followed and unreacted (C02H-d-)CN-Cbl or p-(CH2 )3 (C0 2 H)Cbl and 
calcitonin were separated from the conjugate, as the MW of calcitonin was 3.5K and the G-25 
Sephadex column provided the necessary separation. Calcitonin (10 mg, 2.8 pmoles) and (GO2H- 
d-)CN-Cbl or p-(CH2)3(C02H)Cbi (10 mg, 7.4 jimoles) were added to 1 ml of buffer and the pH 
increased to 6.5 using 0.1 M sodium hydroxide. This was necessary as the solution of the calcitonin 
and (G02H-d-)GN-Cbl and p-(GH2)3(G02H)Gbi was pH 5 and this pH was found to be too low for the 
reaction to proceed. The EDAG was added and the soiution stirred for 12 h, in the dark at 4°G. The 
two absorbances which were used to monitor the eluate were 275 nm and 361 nm for the (G02H-d- 
GN-Gbl conjugate and 313 nm and 275 nm for the p-position conjugate. The elution patterns for 
the caicitonin-(G02-d-)GN-Gbl and (p-caicitonin-(GH2)3G02)Gbl are shown in figures 3.22 and 3.23 
respectively and the data is listed in tables 3.13 and 3.14. The UV-Vis spectra of the first bands 
eluted from the columns are shown in figures 3.25-3.28. The same method of comparing the ratio 
of absorbances at these wavelengths for the separated compounds with the ratios obtained for the 
conjugates was used to calculate the stochiometry of binding within each conjugate. The UV-Vis 
spectrum of calcitonin is shown in figure 3.20.
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Absorbance at 275 nmAbsorbance at 361 nm Absorbance (361/275)Fraction Number
0-25
0.09027 0.080 0.706
0.128 0.141 0.9129
0.059 0.108 0.5433
0.07435 0.160 0.46
37 0.139 0.580.240
0.177 0.5639 0.336
0.188 0.359 0.52
0.5443 0.182 0.336
45 0.154 0.279 0.55
47 0.120 0.228 0.5
49 0.200 0.500.100
0.030 0.060 0.50
Table 3.13 The elution profile for the absorbances at 361 nm and 275 nm for the G-25 column for 
the calcitonin-(C0 2 -d-)CN-CbI conjugate.
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Figure 3.21 The G-25 Sephadex elution profile for calcitonin-(C02-d-)CN-Cbl conjugate
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Absorbance (313/275)Absorbance at 275 nmAbsorbance at 313 nm
0-24
0.163 0.25925 0.63
0.255 0.640.39927
0.131 0.650.20229
33
35
2.5737 0.174 0.070
2.570.362 0.14039
0.800 0.280 2.8641
0.292 0.115 2.5843
45 0.163 0.060 2.55
47 0.100 0.004 2.59
Table 3.14 The G-25 Sephadex elution profile data for the elution from the G-25 column for the (p- 
calcitonin-{CH2)3C02)Cbl.
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Figure 3.22 The G-25 elution profile for (p-calcitonin-(CH2 )3 C0 2 )Cbl conjugate.
For the calcitonin-(C0 2 -d-)CN-Cbl conjugate (band I) eluting from the column, the mean ratio 
361/275 value was 0.70, which is significantly different from both the mean values obtained for CN- 
Cbl and calcitonin, 0.56, s.d. 2 % and 0.003, s.d. 2 %, respectively. For the (P-calcitonin(CH2)3  
(C0 2 H)-Cbl conjugate the mean value for the 313/275 ratio was 0.64 which is significantly different 
from the values obtained for the (p-(CH2 )3C0 2 )Cbl calcitonin which were, 2.85, s.d.1% and 0.31, 
s.d. 13%, respectively. These ratios show that the first band contains both calcitonin and cobalamin 
for tx)th of the conjugates. The UV-Vis spectra for the first and second bands for both G-25 column 
profiles are shown in figures 3.23-3.24.
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Figure 3.23 The UV-Vis spectrum of the first band eluted from the G-25 column for the calcitonin- 
(G0 2 -d-)CN-Cbl conjugate.
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Figure 3.24 The UV-Vis spectrum of the first band eluted from the G-25 column, for the (P- 
calcitonin-(CH2)3C0 2 )CN-Cbl conjugate
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3.6 Summary
1. The various organocobalamins synthesised were characterised according to their respective UV- 
Vis spectra and TLC data. Where possible this was compared to previously reported literature data, 
(see tables 3.1-3.3)
2. The preparation of (CN,aq)Cbi from CN-Cbl illustrates the importance of UV-Vis spectroscopy 
which is used to assess the progress of conversion of (CN2)Cbi into (CN,aq)Cbi (see figures 
3.8,3.9).
3.The preparation of the three isomers of (C0 2 H)CN-Cbl uses acidic conditions, but not as 
concentrated as to produce the (CN,aq)Cbi. The propionamide side chains hydrolyse to carboxylic 
acids under these conditions to produce a mixture of tri-, di-, and monocarboxylic acids which are 
separated using ion-exchange chromatography. The individual (C0 2 H)CN-Cbl were identified 
using NMR spectroscopy, (see figures 3.11 and 3.12).
4. The preparation of HRP and calcitonin conjugates using two different sites to attach the HRP and 
calcitonin provided four conjugates which could be compared in binding to IF (see chapter 4). All of 
the conjugates involved attachment to cobalamin via a cartx)xylic acid group and the same method 
of attachment was therefore used. Sephadex columns separated out any excess of cobalamin and 
showed that there was no unreacted HRP in the HRP conjugates when eluted from the G-25 
column (see sections 3.4 and 3.5)
5. All the four conjugates contain either HRP or calcitonin with cobalamin. The stoichiometry of 
binding is 1:1 and the conjugates were used to investigate IF binding and the IF-mediated transport 
pathway.
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CHAPTER 4
THE AFFINITY OF CN-Cbl AND ANALOGUES FOR IF.
4.1 Characteristics of IF
IF is a species specific glycoprotein consisting of a single polypeptide chain.^c Human IF has a 
MW estimated at 45-63 K, 9% of which is caitohydrate, and porcine IF a MW of 50 - 59 K ^ ,^47 
which contains 16% carbohydrate. Although there is a difference in size between the porcine 
and human IF, the amino terminal amino acid sequences are very similar .3 -^41 Overall the 
primary structures are similar and the correlation coefficient of the total amino acid content of 
porcineihuman IF is 0.96:1. This contrasts with the difference in the number of carbohydrate 
residues between human and porcine IF, which is 36 residues in the human and 55 in the 
porcine.®  ^ There have been no successful crystallisations of IF reported, so the 3-D structure is 
unknown. The high percentage of carbohydrate makes crystallisation difficult to achieve.
IF was defined by Castle as the 'intrinsic factor" meaning a factor found internally to distinguish 
it from the extrinsic factor (CN-Cbl), which is obtained externally.  ^ It is the lack of, or malfunction 
of, the IF which leads to pernicious anaemia.®  ^ Castle found that IF was present in gastric 
juice,^ and it has been the improved purification of gastric juice that has lead to studies of the 
binding of IF to CN-Cbl. 133-138 Initially the concentration of iF in a sample of de-pepsinised 
gastric juice was determined using an anli-IF antibody produced by patients suffering from 
pemicious anaemia. 117-139 j^ e  purification of IF was improved with the development of affinity 
chromatography as IF could be separated from He in gastric juice samples.i®®*i38,i40 Affinity 
chromatography involves the attachment of CN-Cbl or derivatives to a sepharose framework.
The CN-Cbl-sepharose binds all of the cobalamin binding proteins and by using a variety of 
eluants the proteins are separated. 133-138,140 y^e Ka for the formation of the IF-(CN-Cbl)
adduct is relatively high, 10® M*1 , and so the recovery of IF requires relatively severe treatment 
conditions of guanidine hydrochloride, to break the tx>nds between the IF and CN-Cbl-
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sepharose. This treatment disrupts the structure of IF which may lead to permanent damage.
To prevent permanent damage reducing the yields of pure IF, affinity columns were further 
developed and CN-Cbl-sepharose was produced where the linkage between the CN-Cbl and 
the sepharose is weak and is either temperature or photolabile . The He is removed by using 
cobinamide which binds to He but not to IF and then IF is easily detached as the cobalamin 
saturated protein adduct with no danger of dénaturation occuring.i^i A slightly different 
strategy is the attachment of an IF specific antibody to the sepharose so that only IF is retained 
by the column. This procedure was first described by Rothenberg in 1965 1^ 1 and has been 
further developed by Grasbeck in1971,1^2 and Shepherd in1984.l‘^ ®
All the IFs studied so far consist of a mixture of isoproteins. The differences between the 
isoproteins can be attributed to variation in cartx)hydrate content. The removal of carbohydrate, 
in particular sialic acid residues, leads to a reduction in the number of isoproteins present, 
particularly the acidic components. Porcine IF is a mixture of eleven isoproteins which are 
predominantly neutral in character, ranging in isoelectric points from 4.21 to 5.83. No studies 
have been carried out using the individual isoproteins as the amounts obtained would be very 
small in comparison to the mixtures found in the commercially available preparations. The data 
therefore has to be viewed as involving a mixture of isoproteins and not a chemically pure 
sample. The variability in binding of the different isoproteins has yet to be determined and so 
the effect of the different isoproteins is not known. The commercially available porcine IF is a 
mixture of isoproteins.
4.2 The binding of IF to CN-Cbl
IF has two main sites within the molecule which are important. One is the cobalamin binding site 
and the other is the ileal receptor binding site. The occupation of the cobalamin binding site by 
CN-Cbl is necessary for the uptake of IF by ileal cells, that is the binding of CN-Cbl is a 
prerequisite for binding to the ileai receptor. IF alone is unable to bind to the ileal receptor or 
inhibit the binding of IF-(CN-Cbl) to the ileal receptor, The binding of CN-Cbl to IF causes a 
decrease in the Stokes radius of the IF of 4 A 7^ This was determined by G-200 gel filtration
71
where the Stokes radius of the IF was measured before and after incubation with CN-Cbl.
Before the incubation IF had a Stokes radius of 36.6A and after complexation to CN-Cbl this 
decreased to 32.8 A . The change was detected as a change in elution relative to HSA 
monomer which had a Stokes radius of 36.1 A. The unbound IF eluted before the HSA and 
the IF-(CN-Cbl) eluted after the HSA 7^ The same shrinkage effect was observed with porcine 
ileal IF, ^7.49 where the Stokes radius of the IF-(CN-Cbl) adduct was 34.2 A and of free IF 38.7 A 
. The shrinkage on formation of the adduct was 4.5 A , similar to the 4 A found for the human 
adduct. Such a change in size suggests that a significant conformational change has occurred. 
The conformational change results in:
1 . Change in Stokes radius
2. Formation of a successful adduct which is necessary for uptake
3. Formation of a more protease resistant adduct than free IF.
IF has been shown to have only one cobalamin binding site. This was established by using 
competition experiments, similar to those described in chapter 2. The cobalamin molecules 
competing for the IF were (®7co)CN-Cbl and a bulky analogue of OH-Cbl. This analogue had 
HSA attached via the phosphate group, and had an affinity for IF not significantly different from 
OH-Cbl.l^^ The determination of the number of cobalamin binding sites on IF involved the 
addition of a 90-fold excess of OH-Cbl-HSA relative to the (®7co)CN-Cbl added. If the IF 
possessed two cobalamin binding sites, then, on elution of the mixture from a G-200 sephadex 
column, peaks would have been found corresponding to three different adducts, viz. 
(®7co)(CN-Cbl)IF-(OH-Cbl-HSA), (®7co)(CN-Cbl)-IF and OH-Cbl-HSA-IF. The radioactive adduct 
containing both (®7co)CN-Cbl and OH-Cbl-HSA would be expected to have a molecular volume 
of 2.19 X 10® A and a Stokes radius of approximately 40A. This was not detected and the only 
peak containing (®7co)CN-Cbl had an estimated Stokes radius of 33.5 A, similar to that 
previously found for the IF-(®7co)CN-Cbl adduct in a separate experiment. From this it can be 
deduced that there is only one binding site for cobalamin on IF. The method was further 
validated by using a different cobalamin binding protein, derived from Lactobacillus leichmanii, 
which was previously shown to have two binding s i t e s . T h e  same procedure, where an
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excess of OH-Cbl was mixed with a minimum concentration of (®7co)CN-Cbl was used. On 
elution of this mixture a peak with a Stokes radius of 45.3 A was found to contain (®7co)CN-Cbl. 
The increase in Stokes radius and binding of the {®7co)CN-Cbl is consistent with the presence 
of two binding sites 1^ . The stoichiometry of the binding of IF to CN-Cbl is therefore assumed 
to be 1 ;1 , and the equilibrium can be represented by the equation 1 .
CN-Cbl + IF— 2 I^F-(CNObl) 1
Temperature
°C
pH Association
constant
10®KaM-1
Reference
37 8 .0 0.06 57
38 7.4 1.4 134
34 7.4 3.0 134
30 7.4 3.8 135
26 7.4 6 .0 134
2 2 7.4 13.7 134
2 0 7.4 14.0 132
4.0 7.4 32.1 ‘(see footnote)
30 4.5 4.1 135
30 7.4 3.8 135
30 11.0 3.7 135
Table 4.1 Summary of published values of Ka for the formation of the human IF-(CN-Cbl) adduct. 
* relates to the value for porcine IF calculated from the data presented in this chapter; it 
continues the trend seen with the human IF.
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4.3 Summary of Literature Data
The association constant for the formation of the IF-(CN-Cbl) adduct is 4 x 10® M'1 at 30°C 
and 3x10® M’1 at 3 4 °C.1^7 The binding of CN-Cbl to IF is exothermic with AH® being -22.7
kcal.mole 1 and AS®-31 kcal.mole'L 1^7
The data in the literature, detailed in the previous sections, has to be considered in conjunction 
with the methods used by each group. This will help to explain some of the anomalies in the 
data. A variety of methods have been used to separate the IF-(CN-Cbl) from the free CN-Cbl. 
These methods include dialysis, sephadex columns and charcoal adsorption. Each of these 
methods may influence the results obtained, in dialysis the loss of free CN-Cbl from inside the 
dialysis tubing could result in dissociation of the adduct as the equilibrium is pushed towards the 
left. This dissociation would be particularly pertinent in the charcoal adsorption method as the 
charcoal adsorbs the free CN-Cbl from the supernatant, causing the equilibrium to be shifted 
once again to the left. The extent to which this occurs will depend upon the length of exposure 
time to the charcoal and also the time of centrifugation to pellet the charcoal. This could be 
avoided by adding an excess of IF as the charcoal does not adsorb IF, which is left in the 
supernatant and prevents the equilibrium being shifted to the left. One aspect of all of these 
techniques is that the effect they have upon the equilibrium and the absolute stability of the 
adduct is not known.
No association constant has been published for the porcine IF-(CN-Cbl) adduct. ® The value of 
Ka for human IF increases with decreasing temperature, but does not vary significantly within a 
pH range of 5 toi 1 , ranging from 3.74 - 4.1 x 10® M*1 indicating that the IF-(CN-Cbl) adduct is 
only slightly affected by changing pH (see table 4.1). The adduct is very alkali stable, and 
remains as an intact adduct up to pH12.6.1^ ® A decrease in the adduct stability is found at low 
pH and below a pH of 5 the binding to CN-Cbl is reduced and at a pH of 2 IF had denatured and 
could not be recognised by an IF specific a n t i b o d y A H °  also remains unchanged over the 
same pH range.
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The purity of the IF preparation also has to be taken into consideration when analysing the data. 
In most instances ^7,68,146,148 gastric juice, from which the IF is derived undergoes only 
minimum purification, but the total binding due to IF was determined using an an IF specific 
antibody. This determined the amount of IF present and the amount of non-IF binding could 
then be calculated. In the following work the IF used had been purified to a greater extent, 
containing a final ratio of IF:Hc of 50:1, which was determined using electrophoresis.
4.4 Effect of Alterations in the Structure of CN-Cbl on IF Affinitv
Changes in the structure of the CN-Cbl molecule cause changes in the affinity for IF, ®®> 
which is the binding protein most sensitive to changes in cobalamin structure.®  ^The other 
binding proteins. He and TC II, both bind a greater variety of CN-Cbl analogues including 
cobinamide, where the nucieotide moeity is lost which results in a total loss of binding to IF. ®® 
Several types of structural analogues can be used to probe the effect of structural variation on IF 
binding and these are:-
1. The upper axial (p-position) ligand.
2 . The lower axial (a-position) ligand.
3. Side chain analogues.
Previously published data on the binding of CN-Cbl analogues to human IF is listed in tables 4.2 
and 4.3: the results are summarised in the text. The IF competition assay used gives both a 
qualitative and quantitative assessment of IF binding of cobalamin analogues. The comparison 
of the equilibrium constants for the various analogues and IF provides a quantitative assessment 
of affinity for IF and the plots of the data from the binding assay (see 4.5 and chapter 2) provide a 
qualitative and visual assessment of the IF affinity of the analogues compared to CN-Cbl.
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Structural Alteration * IF binding
p-position ligand
•OHOFfe 100
•deoxyadenosyl 126
-S'deoxyadenosyl-TQiobulin 105
-5'deoxyadenosyl- poly-d-glutamate 37
Alteration at side-chain f and pyrrole rings
Lactone of B ring** 13
Aniide of C ring ** 125
Dicyano(CN,aq)Cb’*** 64
Hydroxy(P)albumin *** 103
Ade(CN)Cba*** 0
Component of side-chain f
Dimethylbenzimidazole**** 0
Table 4.2 The affinity for human IF of cobalamin analogues modified in the p-ligand position or a 
side-chain.
* Expressed as a % of the binding of OH-Cbl to IF,1^® literature value was available for Ka of OH- 
Cbl at 4° C.
** These are analogues where the modification is in the pyrrole rings which make up the corrin 
macrocycle. They are the alteration of the B ring to a lactone and the addition of aniline to the C 
ring.
*** These are analogues where the f side chain, the nucleotide moeity has been altered. In 
(CN2 )(CN,aq)Cbi the nucleotide phosphate has been removed and a cyano group occupies the 
lower a axial position. The hydroxy(P)albumin is OH-Cbl with HSA attached to the phosphate 
group. In Ade(CN)Cba the dimethylbenzimidazole is replaced by an adenine group.
**** This is the base which is joined to the ribose of side chain f and also occupies the lower axial 
ligand, (the a-position.).
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Analogue Rabbit IF** 
KapM-1
Human IP* 
KaPM-l
Ka***
x10®M*1
CN-Cbl(COOH) -d-* 0.3 0.00114 n.a
CN-Cbl(COOH) -e- 0 .6 0.57 n.a
CN-Cbl(COOH) -b- 0.008 0.0076 0.03
CN-Cbl(COOH)-b,d,e 0.000003 0.000013 n.a
CN(OH)(CN,aq)Cbi 0.00003 <0 .0 000 02 0 .0 0 0 1
(Ade) CN-Cba 0.015 0.19 0 .1
CN-Cbl 0.5 1.9 15.0
OH-Cbl n.a n.a 4.3
MeCbl n.a n.a 7.7
Table 4.3 Ka for analogues of cobalamins modified in the side chain or and p-position for both 
rabbit and human IF. 
n.a = no data available
‘These are the monocarboxylic acid cyanocobalamins and a single letter e.g. b denotes the 
propionamide side chain where the amide group has been altered to a carboxylic acid group. 
The tricartoxylic acid is notated as b, d, e.
** The data cited was originally in the form of a ratio of the Ka values for the analogue CN-Cbl, 
and therefore the value of Kg for the analogue can be calculated if the above data is multiplied 
by the value of Ka for CN-Cbl. Values of Ka of 0.5 pM'1 for CN-Cbl binding to rabbit IF and 1 .9 
pM'l for the binding of CN-Cbl to human IF were cited in the paper and used to calculate the Ka 
analogue values. ®®
*** This data was quoted as Kj values from which the Ka values were calculated, where Kj is the 
inhibition constant for the analogue relative to CN-Cbl
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Figure 4.1 Structure of CN-Cbl
g-p<?sitipp
Changes at the p-position, some of which are found in-vivo, have only a minimal effect upon the 
binding to IF. 143,148 yhe p-position ligand can be altered in size and charge from a small 
ligand, such as a cyano group, up to a protein molecule and still retain affinity for IF. 1"  ^ This is 
illustrated by the data listed in tables 4.2 and 4.3. This data supports the theory that the p- 
position ligand is oriented in such a manner as to project out of the IF-(CN-Cbl) complex and 
away from the IF. The various Ka values in the published literature for CN-Cbl, OH-Cbl and 
MeCbl are all within an order of magnitude of each other for any one publication. Differences do 
exist between publications and these are of three orders of magnitude. This is particularly
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noticeable in table 4.3 where ref 57 quotes Ka values as pM*i and nM'i which may be 
dependent upon the concentration and purity of IF preparation used."*^® These differences 
may reflect the different methods used; a discussion of this is detailed in section 4.2. This is 
applicable to the assay of analogues as well as CN-Cbl.
4.4.2 Alteration of the Nucleotide Moeitv
When the benzimidazole moeity is removed to give the cobinamide molecule, (cleavage at 1, 
see figure 4.1), there is a loss of IF binding, (see table 2.3), although the data relating to 
cobinamide binding is conflicting. 143,148  ^has been reported that the ability of (CN)2Cbi to 
bind to IF is 64% of that of OH-Cbl, 1^* l^but the (CN,aq)Cbi has been found to be unable to 
bind IF. 86,138 j^ e  problem in interpreting this data is that to prevent the (CN)2 Cbi changing 
into (CN,aq)Cbi there has to be an excess of cyanide ions in soiution. The effect of this upon 
the function of IF was not considered or investigated. Therefore, it is possible that the IF is 
altered or even denatured, which would render the data invalid.
The alteration of the dimethylbenzimidazole moeity by substitution of atoms and groups gives 
some information about the micro-environment of the successful IF-(CN-Cbl) complex. The 
replacement of the two methyl groups by chlorine, or their loss, results in no loss of affinity for 
IF. The addition of a benzene ring reduces binding by a factor of twenty, suggesting that the 
space occupied by the dimethylbenzimidazole is limited and not sufficiently large enough for 
another benzene ring. The replacement of the dimethylbenzimidazole by adenine and 
adenine analogues as in (Ade)CN-Cba results in a 2000-fold loss of ability to bind IF. 1^3,148 
This implies that the Cy of the Imidazole group is in a confined space and cannot accommodate 
any more atoms at this site; see table 4.4 for a summary of the effect of such alterations.
The addition of albumin via the phosphate group of OH-Cbl does not significantly effect the 
ability to bind IF; this is very surprising, considering that small changes in the nucleotide side 
chain result in loss of binding to IF. This suggests that in the IF-(CN-Cbl)complex the CN-Cbl is 
oriented such that the phosphate group is facing outward from a cleft in the IF molecule.
79
Alteration of the 5'6'dimethylbenzimidazole Rabbit IF Human IF
Ka analogue Kg analogue
NHz
[Ade]CN-Cba
pM’’’ pM'"'
0.5 1.9
0.025
0.400 1.52
0.050
0.0003 0.95
0.002 0.0009
* NH,
* N ^ N .
J  » 0.0004 0.0001
0.00003 0.0004
ÇH3
{X)c.
I
Table 4.4 The effects of structural changes in the 5*6 dimethyibenzimidazole upon IF binding
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4.4.3 The Corrin Macrocycle
The changes to the corrin macrocycle can be divided into two groups. Firstly, changes to the 
pyrrole rings which are co-ordinated to the cobalt atom and, secondly, changes in the side 
chains which are at the periphery of the corrin macrocycle. Changes to the pyrrole groups 
include the alteration of the B ring pyrroie to a lactone and the addition of an anilide to the C 
ring. These two alterations result in a complete loss of binding to iF, which shows that the 
orientation provided by the four pyrrole rings is the only orientation which allows binding to IF.
68,143,148 Alteration of the propionamide and acetamide peripheral groups in some instances 
leads to a loss of binding to IF. However, this is very specific to a particular group and when one 
propionamide group is altered to a carboxylic acid group the binding to IF can be the same as 
CN-Cbl or 300-fold less, depending upon which group is altered. The alteration of the e 
propionamide group has less effect than the b or d, but the data relating to the (C0 2 H)CN-Cbl is 
conflicting. This could be due to the individual (C0 2 H)CN-Cbl being impure, each
contaminating the other. The other problem in the past has been the correct identification of 
each individual (C0 2 H)CN-Cbl and this has now been solved by the use of l^c-NMR. The 
alteration of the c-acetamide does not result in reduced binding to IF and no other acetamide 
has been assessed for IF binding. One alteration which does cause a loss of IF binding is the 
conversion of CN-Cbl to the tricarboxylic acid CN-Cbl, where all of the propionamide groups 
have been converted to carboxyiic acid groups, (see table 4.3.).
■4.5 Investigation into IF-fCN-Cbh Binding
The sites involved in IF binding were investigated using the IF competition assay described in
4.6 and chapter 2 . Three different regions were studied as to their effect upon IF-(CN-Cbl) 
binding: the upper axial ligand (p-position); b, d, and e side chains; and the nucleotide moeity. 
The effect of covalent attachment to large molecules was also investigated. This was carried out 
using the single chain polypeptide calcitonin and the giobular protein HRP. Both of these 
molecules were attached in two positions, viz. the p-position using p-butyrate Cbl and the -d- 
side chain using (C0 2 H-d-)CN-Cbl.
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Constituent molecules of CN-Cbl, in particular a-ribazole and ribazole-3-phosphate, were 
assayed to ascertain whether any one fragment has the complete recognition site for IF. The a- 
ribazole and ribazole-3-phosphate were gifts from Dr K. Brown, Arlington, Texas. The 
competition assay of the analogues, conjugates and fragments of CN-Cbl were always 
compared to the standard assay of CN-Cbl which is described in section 4.6.
4.6 The IF ComoetitionjAssav ,
This is based upon the assay devised by Gottiieb 11 ^  with modifications described by 
Eisenhansi 1® and the experimental details are described in chapter 2. IF (3.04 pmoles) were 
incubated with a mixture of 0.07 pmoles (^^Co)CN-Cbl (hereafter denoted by [B*] ), viz in a ratio 
of 43:1, and increasing concentrations of the analogue to be tested (hereafter denoted by X) in 
250 pi of buffer at 4°C and pH 7.4. Any unbound [B*] and CN-Cbl analogues are then 
separated from any IF-adducts formed. Separation is achieved by adsorbtion of any unbound 
[B*j onto dextran-coated charcoal, which forms a pellet on centrifugation. The adducts of IF- 
[B*] and IF-(CN-Cbl analogues) and any unbound IF remain in the supernatant. The IF-[B*j 
present is measured by counting (®^Co) in the supemant. When there is only IF and [B*j in the 
assay mixture the IF-[B*] counted is considered to be the maximum binding for 3.04 pmoles of 
IF. This value of IF-(B*) is taken to be 100% and all of the competition assays are expressed as a 
reduction of the maximum binding. The equilibrium for formation of the IF-[B*j adduct is 
described below In equation 2.
The following equation represents the equilibrium between [B*]and IF.
Ka
(57Co)CNCbl + IF ^  ■ —  IF-(57Co)(CNCbl) 2.
re] [P] Kd fB-P]
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where [*B] is the concentration of unbound (^^Co)CN-Cbl
[P] is the concentration of unbound IF 
[ *B-P] is the concentration of IF-(^^Co)CN-Cbl
The association constant can be described in the terms shown below, assuming the 
stoichiometry of binding is 1 :1 ;
rB][P]
The values of [*B] and [P] can be calculated using equations 4 and 5.
*Bt = [*B] + rB-P] 4.
Pt=P]+PB-P] 5.
Where Pt and *Bt are the total added amounts of IF and (5^Co)CN-Cbl respectively.
This assay was used to calculate the Ka for the equilibrium between [B*] and cobalamin 
analogues for IF. The competition assay involved the addition of increasing concentrations of 
cobalamin analogues, X, to fixed concentrations of both IF and {^^Co)CN-Cbl. There are two 
equilibria operating which are described in equations 6  and 7.
(57Co)CN-Cbl + IF -    -^ iF-r57co)CN-Cbl 6.
P*I IPl rB-pi
X + IF  ..........  ^  IF-X 7.
M  IP) P-X]
When the competing molecule is CN-Cbl (no ®^Co), the data was taken as the standard to which
aii of the analogues are compared. A qualitative assessment of the affinity of an analogue
compared to CN-Cbl is obtained from the bindng curves which are shown in figures 4.2 to 4.10.
A quantitative assessment is provided by the calcuiation of the Ka values.
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For any assay where [B*] competes with another molecule for the available IF the Ka can be 
calculated. First of all the concentration [*B-P] has to be calculated from the % maximum 
binding, which is determined by the IF-[B‘] in the supernatant, see equation 8 .
%f^aximumb’ncing = [Cj x 100 8.
IF]
where [C] is the IF-[B*] present in the supernatant when IF(cobalamin analogue) is added,
[F] is the IF-[B*] in the supernatant when no IF(cobalamin analogue) is present, and both of 
these values are corrected for non-specific binding, which is approximately 1% of the maximum 
binding. Non-specific binding is binding of (^^Co)CN-Cbl to surfaces and molecuies other than 
IF.
/. Calculation of [*B-P]
After the unbound [B*] is adsorbed onto the dextran-charcoal and the IF complexes remain in 
the supernatant only 500 pi of the supernatant are counted. This is to prevent any charcoal 
being picked up and counted. The total volume of the supernatant is 750 pi so the cpm in the 
500 pi is multiplied by 1.5 to obtain the total IF-[B*]in the supernatant. The activity of the (^^Co) 
is such that 525 cpm corresponds to 1 fmol. Using this value the number of fmoles of IF-[B*] in 
the supernatant can be calcuiated, and thereafter the molar concentration of [P], [X-IF], [*B-P] 
and hence Ka for the analogue X.
ii. Calculation of f*B]
This is calculated using equation 5
"Bt= TB] + TBf] 5.
where *Bt = the total concentration of [B*] in the sample
[*B-P] = The concentration of iF-[B*] in the supernatant (see /).
Therefore, with the data calculated in /., it is possible to calculate [*B]
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Hi. Calculation of unbound fP1
The calculation of this value uses equation 3, rearranged as below. The value of Ka is calculated 
for the IF-[B*] binding to IF for the assay with no competing molecule and is Ka = 3.3 x lO"*® M‘1. 
Using the value of [’‘BJ calculated in ii and the [*B-P] calculated in /, [P] can be calculated using 
equation 9:
i n = i m
rBJKa
iv . Calculation of fX-P]
Now that the concentration of unbound IF has been calculated and the total amount of Pt is 
known, the concentration of [X-P] can be calculated using the equation below:
P(-P]=R-[P]  10.
V. Calculation of unbound [X]
Both the total concentration of Xt known and the concentration of IF-bound X [X-P] are known, 
so the concentration of unbound [X] can be calculated using equation 11.
M=Xt- [X -P ] 11.
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yL .Calculation of-Ka
In steps i-iv all of the values necessary for the calculation of Ka for the analogue X have been 
calculated from the raw data produced in the assay. Therefore, Ka can be calculated using 
equation 1 2 :
Ka=Cm. 1 2 .
M M
The data from the competition assay, where CN-Cbl competes with [B*] for the available IF, is 
listed in table 4.5 and Is illustrated in figure 4.2
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Concentration of 
CN-Cbl 
(M)
% Max Binding of 
(57co)CN-Cbltol
Association constant 
10-19 Ka^-1
1 X 10 G 0
%o 5.3
1 X 10'7 1.0 3.9
% a 4.3
1 X 10 8 11.2 3.2
%a 6.9
5 xlO-9 20.2 3.9
% a 7.7
2.0 X 10-9 40.6 3.2
%o 14.1
1x10-9 74.4 3.3
% a 1.7
2.6 X 10-19 102.6 3.4
% a 4.0
2x10-19 100.6 3.4
%CT 2.4
0 100 <3.3
Table 4.5 The IF competition assay for (^^Co)CN-Cbl and CN-Cbl.
The number of samples for each concentration is 60 as the data include all of the standard 
assays carried out, and each concentration is always assayed in triplicate for each assay.
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Figure 4.2 CN-Cbl IF competition assay using (^^Co)CN-Cbl and CN-Cbl (1 h incubation at 4°C). 
4.7 The Organocobalamins
The p- position, (see figure 4.1), is light labile for Co-R where R is an alkyl group. Therefore, all of 
the assays of p-position conjugates were carried out under red light. A variety of groups were 
attached in this position which were -CH3 , -CH2CO2H, -CH2 CH3 , -(CH2 )2 NH2  and -(CH2 )3C0 2 H. 
This gave a range of organocobalamins so that the effect of length of alkyl chain and charge 
could be assessed from the different functional groups in the p-position.
Generally, the organocobalamins showed only a slightly reduced affinity for IF, when compared 
to the [B*] and CN-Cbl assay. The butyrate, ethyl and acetate have different binding curves 
when compared to the cyano, hydroxy, methyl or ethylamine curves. A more quantitative 
measure of an analogue's ability to bind to CN-Cbl other than the shape of the curve is to
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calculate the Ka from the concentration at which 50% binding occurs. This is the concentration 
at which 50% of the available IF is bound by the analogue and 50% by the [B*]. Comparison of 
Ka values shows there to be only a slight loss of affinity with the change of the p-position ligand; 
the maximum Alog K is 1 (see table 4.6). The p-ligands with 2-4 carbons in the alkyl chain 
showed the anomalous curves (see figure 4.4), when compared to the curves in figure 4.3.
Cobalamin 50% binding concentration 
(Mx 109)
Association constant 
1 0 l°KaiV|-1
CN-Cbl 1.6 3.3
OH-Cbl 1.2 8 .1
MeCbl 6.0 0.70
(P-CH2C00H)Cbl 6.0 0.70
(P-CH2CH3)Cbl 7.8 0.50
(P-(CH2 )2NH2)Cbl 2.0 3.5
(P^CH2)3COOH)Cbl 7.8 0.50
Table 4.6 Comparison of 50% binding concentrations and derived values of Ka for 
organocobalamins.
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+ (p-CH2CH3)Cbl □ CN-Cbl ♦ MeCbl o OHCbl
Figure 4.3 The IF competition assay for organocobalamins I. A comparison of OH-Cbl, MeCbl, (p- 
CH2 CH3)Cbl and CN-Cbl; each point is a mean of 6 values.
The competition assay of OH-Cbl showed that the binding was qualitatively very similar to CN- 
Cbl. Values of Ka were calculated for each concentration of OH-Cbl used in the competition 
assay. The data (see table 4.7) shows that Ka does not vary significantly over the range 
studued and correspends to Ka = 8 x 10“*° M"'', which is slightly higher than for CN-Cbl itself {viz 
3.3 X 10^0 M'1).
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Concentration
(M)
% Total binding of [B*] Association Constant 
10-l9Ka /M-1
3.2x 10'7 0.5
% c 4.2
1.6 X 10-® 0.4
%CT 1.4
1 .0 x 10-8 5.0 8 .2
%G 4.9
8 x 10-8 7.6 6 .8
% a 5.3
2.0 X 10-9 33.0 7.8
% a 5.0
1.9x10-9 35.2 8 .0
% a 8 .0
1.4 X 10-9 51.6 8 .0
%CT 6.3
4x10-19 100
% a 0
Table 4.7 The IF competition assay for OH-Cbl, with values of Ka calculated for different 
concentrations of OH-Cbl used.
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Figure 4.4 The IF competition assay for organocobalamins (2 ).
o 0 -(CH2)CQ2H)Cbl
+ (WCH2)3C02H)Cbl
Two curves are given for the p-butyrateCbl to show that the difference was reproducible. Each 
point represents a mean of 6  values
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4.8 CN-Cbl [monocarboxvlic acidsi
The CN-Cbl monocarboxylic acids b, d and e were assayed as these were the precursors of the 
conjugates. The amide of one of the propionamide side chains marked b, d or e in figure 1 was 
replaced with a carboxylate group (see chapter 3). These monocartx)xylic acids were assayed 
and it was found that CN-Cbl(C0 2 H-b-) showed less affinity for IF than did the d ore 
monocartx)xylic adds. This is illustrated in figure 4.5. Ka was calculated for all three of the 
monocarboxylic acids at the 50% binding concentrations (see table 4.9). Ka was calculated for 
the entire assay of CN-Cbl(C0 2 H-d-) to see whether the value of Ka for CN-Cbl(C0 2 H-d-) 
remained constant throughout the assay (see table 4.8); the value of Ka did not vary 
significantly throughout the range of concentrations used.
Concentration
(M)
% Total tnnding of [B*] Association Constant 
10-9Ka/M-‘'
6.0 X 10-7 2 .6
% a 3 .0
6.2 X 10*8 18 .3 5 .3
% a 1 3 .4
3.0  X 10-8 3 5 .6 4 .8
% a 18.0
1.9 X 10-8 4 9 .5 4 .6
% a 10 .4
9 .6 x 1 0 - 8 7 3 .3 5.1
% a 2 .0
6 .2 x 1 0 - 9 7 9 .5 5 .5
% G 1.3
1.3 X 10-9 91 .1 4 .8
% a 9 .6
Table 4.8 The IF competition assay for CN-Cbl(C0 2 H-d-)
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Dobaiamin 50% binding concentration 
10^ /M
Association Constant 
10lOKaATl
CN-Obi 1.6 3.40
CN-Cbi(C02H-d-) 16 0.32
CN-Cbi(C0 2 H-e-) 68 0.05
CN-Cbi(C02H-b-) 120 0.03
Table 4.9 Estimation of Ka for the CN-Cbi(C02H) Isomers from the 50% binding concentrations.
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Figure 4.5 The IF competition assay for the (CN-Cbi-C02H)isomers. Each assay was carried out 
twice and each point is the mean of 6 values
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4.9 Cobalamin-protein conjugates
These were synthesised using two cobalamin precursors, viz (p-(CH2)3C02H)Cbl where the p- 
position is modified, and CN-Cbl{C02H-d-), where a side chain is modified (see section3.3). The 
CN-Cbl(C02H-d-) was used for the conjugate synthesis as the Ka for binding to IF is the nearest 
to CN-Cbl when compared to the -b and -e monocarboxylic acids. The two molecules which 
were conjugated to these CN-Cbl analogues were HRP and calcitonin; HRP is a globular protein 
and calcitonin is a single chain polypeptide. When the binding data for all of these conjugates 
are plotted as binding curves (see figures 4.6 and 4.7),the curves are similar in shape to those 
of CN-Cbl, OH-Cbl and MeCbl; the anomalous curves found for the (p-(CH2)3C02H)Cbl do not 
appear when other molecules are attached onto the p-position ligand. The Ka values for the 
four conjugates were calculated using the 50% binding concentrations and provide a 
quantitative means of comparison with the CN-Cbl(C02H -d-) and CN-Cbl (see table 4.10). The 
HRP conjugates have a greater affinity for IF than the calcitonin conjugates and this is a 20-fold 
increase for the CN-Cbl(C02H-d-) conjugates and 13-fold for the p-position conjugates.
Cbl-protein conjugate 
orCbl
50% binding concentration 
X 10-9 M
Association constant 
10-1°Ka/M-1
CN-Cbl(C02H-d-) 16 0.32
HRP(C02)Cbl 48 0.087
calcitonin (C0 2 )Cbl 800 0.0042
[P-(CH2)3C02H)Cbl 7.8 0.50
HRP-p-Cbl 6.5 0.652
calcitonin-p-Cbl 72 0.048
Table 4.10 The 50% binding concentrations and Ka values for the cobalamin conjugates.
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Figure 4.6 The IF compétition assay data for the HRP and CaicitoninCN-Cbl(C02H-d-) 
conjugates compared to CN-Cbl(C02H-d-)
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Figure 4.7 The IF competition assay data for the HRP and caicitonin(p- (CH2)3C02H)Cbl 
conjugates compared to (p-(CH2)3C0 2 )Cbl.
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4.10 Nucleotide Moeitv
The removal of the nucleoside moeity leaves the (CN.aq)Cbi molecule and ribazole-3- 
phosphate, (cleavage at position 1, see figure 4.1). The (CN.aq)Cbi, a-ribazole and ribazole-3- 
phosphate molecules were assayed to assess their affinity for IF. They were assayed alone to 
see whether any fragment contains the recognition site for IF. The (CN.aq)Cbi and a- 
ribazole/ribazole-3-phosphate were assayed together to ascertain whether any co-operativity 
was exhibited in the binding of CN-Cbl to IF. When the three molecules were assayed 
separately they exhibited no affinity for IF (see figure 4.8). The phosphate group appears to be 
of limited importance as there is no siginificant difference between the binding of the a-ribazole 
and the ribazole-3-phosphate to IF. The mixtures of 1:1 of (CN.aq)Cbi and a-ribazole/ribazole- 
3-phosphate showed an affinity for IF >20 times that of the single assays. This is illustrated in 
figure 4.8 and the data is listed in table 4.11. Further work was confined to (CN,aq)Cbi and a- 
ribazole.
Molecule Assayed 50% binding concentration 
x 103(M)
lO-^Ka/M-l
(CN,aq)Cbi >10 <0.34
a-ribazole >10 <0.34
ribazole-3-phosphate >10 <0.34
(CN,aq)Cbi+a-ribazole 0.55 6.18
(CN,aq)Cbi+ribazole-3-phosphate 0.46 7.39
Table 4.111F competition assays for (CN.aq)Cbi and a-ribazole/ribazole-3-phosphate alone and 
together.
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Figure 4.8 The mixed and separate assays of a-ribazole, ribazole-3-P and cobinamide.
4.11 Variation of (CN.aq)Cbi and a-ribazole
A series of binding assays were carried out where the concentration of either the (GN,aq)Cbi or a- 
ribazole was varied whilst the other remained constant. The aim of this variation was to determine 
whether; the binding of the mixtures of (GN.aq)Gbi and a-ribazole to IF was dependent upon the 
concentration of either the (GN.aq)Gbi or a-ribazole or both. .
The data in Table 4.12 show that the % maximum binding varies with the concentration of 
cobinamide and, at least for three concentrartions of cobinamide (viz 10'^, 10"^amd 10’  ^M), is 
essentially independent of the ribazole concentration. ).
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a-ribazole concentration 10’^M a-ribazole concentration 10-6m
Cone. (CN.aq)Cbi % Max. binding lO-SKa/M-l % Max. txnding 10-6Ka/M-1
1.2x10-2 2 1.58 nd nd
1.2x10-3 27.7 0.78 28.0 0.77
1.2x10-^ 39.0 5.3 42.0 3.9
1.2 X  10-5 84.0 3.0 88.0 2.6
1.2x10-6 100.0 nd 94.0 nd
1.2x10-7 99.0 nd 99.0 nd
1.2 X  10-6 100.0 nd 94.0 nd
1.2x10-6 100.0 nd 100.0 nd
Table 4.12 IF competition assays with fixed a-ribazole and varying (CN.aq)Cbi concentrations.
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Figure 4.9 The IF competition assay for mixtures of (CN,aq)Cbi and a-ribazole (1).
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The data of Table 4.13 and fig. 4,10 confirm that the % maximum binding is independent of 
ribazole concentration down to as least 10*6 M; increasing errors and problems of analysis 
precluded studies at still lower concentrations. Assuming (as for CN-Cbl) that one IF binds one 
cobinamide allows one to derive a value of Ka ca. 5 x 10  ^M*'' for the binding of cobinamide (in 
the presence of a minimal amount of ribazole
a-ribazole
oonc(M)
(CN.aq)Cbi concentration of 10*4m  
% Max. binding
(CN.aq)Cbi concentration of 10*5m  
% Max. binding
1.4x10*4 39.0 88.0
1.4x10*5 32.0 99.0
1.4 X 10*5 32.0 100.0
1.4 X 10*7 31.0 96.0
1.4 X 10*6 29.0 97.0
1.4x10*6 27.0 100.0
Table 4.13 IF competition assays with fixed (CN.aq)Cbi and variable a-ribazole concentrations.
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Figure 4.10 The IF competition assay for mixtures of (CN,aq)Cbi and a-ribazole (2).
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4.12 Discussion
The Ka for the binding of CN-Cbl to porcine IF is 3.3 x 10"^° M""* at 4°C. This is the first 
determination of Ka for the commercially available porcine IF. This value does not vary 
significantly over a concentration range of 10  ^M and this lack of variation suggests that the 
isoproteins within the IF sample all bind in the same way. This value of Ka is similar to the value 
for CN-Cbl binding to human IF (table 4.1). There is little difference between the process of 
binding of CN-Cbl to human and porcine IF. These values are among the highest for a non­
covale nt interaction between a ligand and macromolecule, indicating that CN-Cbl and IF are 
tightly bound.
The organocobalamins can be divided into 2 groups, those which have curves similar in shape 
to CN-Cbl and those with anomalous curves (see figures 4.3 and 4.4). Those in the first group 
are OH-Cbl and MeCbl, while the second group includes (p-(CH2 )2 NH2)Cbl, (P-CH2CG2 H)Cbl, 
(P-CH2 CH3)Cbl and (p-(CH2)3C02H)Cbl. The second group of curves are anomalous compared 
to group 1 and these differences were reproduced on several occasions, as seen by the two 
curves for (p-(CH2)3CG2H)-0bl (see figure 4.4). Despite the differences in the shape of the 
binding curves the overall differences in Ka for the p-position ligands are not significant. This is 
expressed quantitatively by Alog K being less than 1, where Alog K is the log of the difference 
between the Ka values for CN-Cbl and analogues. The charge on the p-position ligand is not 
important when considering IF binding as the different functional groupsdo not significantly 
effect binding, (Alog K<1 ). Since all of the organocobalamin assays were carried out in a dark 
room, under red light and with a light-proof box used for the incubations, there is no reason to 
suspect that any photolysis has occurred.
When HRP is conjugated to (p-(CH2)3 (CG2 H)Cbl the binding curve is not the same shape as the 
anomalous (P-(CH2 )3CG2H)Cbl but instead has the shape of the CN-Cbl curve, (cf. figures 
4.4 and 4.7). The presence of a bulky constituent prevents the anomalous curves, but only has 
a minimal effect upon Ka- The anomalies in the organocobalamin binding curves may be due to 
the different isoproteins within the porcine IF behaving differently with the organocobalamins.
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The fact that the large protein molecule in the p-position has little effect on log K shows that the 
p-position is exposed to the solution, and the space available at this site is relatively large. 
Considering all of the data relating to the p-position analogues and conjugates there are two 
explanations which could adequately explain the behaviour of the organocobalamins; tx)th 
depend upon interactions between IF and the p-position ligand. The first possibility involves 
repulsion between a hydrophilic IF isoprotein and the hydrophobic alkyl group in the p-position, 
and as the hydrophobicity of the alkyl group increased the repulsive forces increase, this is 
unlikely as the alkyl group is surrounded by the side chain groups of the corrin macrocycle, 
which are predominantly hydrophobic in nature. The more likely interaction is one of attraction, 
where one or more of the IF isoproteins has a hydrophobic region capable of interacting with the 
hydrophobic p-position ligand, but only at the expense of inducing strain in some part of the 
adduct and hence reducing log K. This would result in the equilibrium of such adducts being 
different to that which operates for IF-(CN-Cbl). The presence of these isoproteins does not 
affect the binding of CN-Cbl to IF as the p-position is occupied by the cyanide ion, which is not of 
the critical length required to interact with the specific isoproteins of IF.
The effect of adding bulky groups onto cobalamins is known to be minimal if they are added at 
the p-position, the phosphate of the nucleotide or the terminal group of the d side chain 
(see table 4.4). The minimal effect upon IF binding for the addition of bulky groups at the p- 
position and the d side chain were confirmed in this work, where all the Alog K values are <2. 
There are however, major differences between the three propionamide side chains when not 
conjugated to bulky groups (see table 4.6). These three sites in the molecule are therefore of 
differing importance with respect to IF binding. When all three groups b, d, and e are changed 
from amide groups to carboxylic acid groups there is no binding to IF. The importance of the 
individual groups has to be considered in conjunction with their identification. Until recently the 
identification of the groups was incorrect, but with more sophisticated NMR techniques the 
assignments made in 1981 have been corrected. The alteration of the d side chain to a 
carboxylic acid group results in Alog K for IF binding being only 1, whereas for the b and e side 
chains Alog K is 2 (see table 4.6).
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The similarity of the conjugates of HRP and calcitonin to CN-Cbl in terms of the binding curve 
shape and Ka value shows that there is no anomalous binding similar to the organocobalamins 
and the binding is like that of CN-Cbl. Therefore, these conjugates can be used to probe the 
transport pathway, knowing that the binding is similar to CN-Cbl.
The assay using the constituent parts of CN-Cbl, viz. (CN,aq)Cbi and a-ribazole, shows that the 
binding to IF Involves more than one site within the cobalamin molecule. This is the first known 
example where two parts of a molecule have been shown to be capable of interacting to behave 
in a similar manner to the original molecule. In order to produce the same level of activity, 
however, the concentrations of the constituent molecules is much higher than the 
concentration of the original molecule. The log K values for the individual assays of a-ribazole, 
ribazole-3-phosphate and (CN,aq)Cbi are <3, and are not detectable. The two constituent 
molecules exhibit a degree of cooperativity, in order to act in the same way as the whole 
molecule. One important detail is that the assays where a-ribazole is used with (CN,aq)Cbi do 
not differ significantly from those assays where ribazole-3-phosphate was used; this is 
illustrated by the difference in the Ka values being 5% (see tablé 4.11). The phosphate appears 
to be unimportant in the binding of CN-Cbl to IF, which is supported by the fact that a bulky 
group can be attached at this position and the OH-Cbl still binds to IF.^^ From the data in table 
4.11, it can be seen that the Ka for mixtures of (CN,aq)Cbi and a-ribazole binding is dependant 
upon (CN,aq)Cbi and a-ribazole . This was further investigated by varying either the a-ribazole 
concentration or the (CN,aq)Cbi concentration and these data are given in tables 4.12 and 4.13. 
The degree of binding in such mixtures is only dependent upon the concentration of 
(CN,aq)Cbi present and not the concentration of a-ribazole, provided it is greater than a 
minimum concentration which is less than or equal to 10 '% . When the a-ribazole concentration 
was fixed and the (CN,aq)Cbi varied over a range of 10^ M the value of Ka was 2.6 x 10^ , for
a-ribazole of 10'^ M and 2.4 x 10  ^M'”* for a-rifc>azole of 10*® M. When the values are compared 
to the Kafor CN-Cbl [viz 3.3 x lO'*  ^M'"') Alog K is 5.1. For the assays where the (CN,aq)Cbi was 
kept constant, Ka is independent of a-ribazole concentration (see table 4.13). There are two 
possible explanations for these results; firstly, that a-ribazole is very firmly bound (ie log K>9), 
and secondly, that the IF-(a-ribazole) is a weakly bound adduct. If the formation of the IF-(a-
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ribazole) produces a firmly bound adduct which is then able to bind (CN.aq)Cbi, it is difficult to 
see why the binding of CN-Cbl alone is not affected by the presence of a-ribazole in the 
solution even at a concentration 10® times that of the CN-Cbl. The proposal of a weakly-bound 
IF-(a-ribazole) adduct involves the a-ribazole fulfilling a catalytic role, and then dissociating or 
changing orientation with respect to the IF. The a-ribazole moeity in CN-Cbl would also fulfill this 
catalytic role.
The proposed scheme involves several intermediate conformations for the IF before the final 
stable adduct is formed. The binding of (CN,aq)Cbi with a-ribazole can be described by the 
following equation:
orRib (CN,aq)Cbi ^  oFb
> 1  .. ... ^  >  (CN«|)Cbi)*PSRb:^ ((CN,aq)Cbi)‘ P4
*P l, P2 . and P3 , are all intermediate IF conformations leading to ((CN,aq)Cbi)P4  which is the final 
successful adduct. A description of the proposed steps involved is given below:
The a-ribazole initially binds to the Pi conformation to form an adduct P2 Rib, in which the a- 
ribazole is weakly held by the IF (ie does not appear to bind by itself or to inhibit the binding of 
CN-Cbl). This intermediate adduct is now capable of binding (CN,aq)Cbi which results in 
(CN,aq)Cbi)P3 Rib adduct. The a-ribazole having bound to the IF to produce an adduct capable 
of binding (CN,aq)Cbi has now fulfilled the catalytic role and dissociates leaving the (CN,aq)Cbi 
bound to the IF. The P4  adduct is the final stable adduct and the a-ribazole is now free to 
initiate the process once again. The binding of IF to CN-Cbl can be explained in a similar manner 
and is described in the equation below:-
P i^  P^nucteotide) . PgCNCbl
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For the binding of CN-Cbl to IF the nucleotide side chain, more specifically the a-ribazole binds 
to the IF in the initial step. This results in a P2 (nucleotide) adduct where the CN-Cbl is only 
bound to the IF by the a-ribazole. The second step is the binding of the corrin macrocycle, but 
as the a-ribazole is part of the CN-Cbl it cannot dissociate. This binding theory also explains why 
(CN,aq)Cbi cannot bind to IF, as there is no free ribazole to initiate the binding. The role of a- 
ribazole is therefore a catalytic one; it produces the 'mature' form of IF necessary to bind 
(CN,aq)Cbi. There are several other examples of the so-called 'maturation theory', where a 
ligand activates a macromolecule and fulfills a catalytic role,^®°'^®\ In this model ribazole could 
be expected to bind to IF at high concentrations, that is when the concentration becomes 
equivalent to the effective local concentration of the nucleotide in CN-Cbl. If this catalytic role 
could also be carried out by CN", this would explain why (CN2 )Cbi has been reported to bind to 
IF. 144
4.16 Summary
1. This is the first molecule to have been dissected into two parts, which when mixed together 
act in a manner similar to the complete molecule. There is cooperative interaction between 
these two constituent molecules with the a-ribazole moeity probably binding first to the IF to 
present the IF to the (CN,aq)Cbi In an appropriate conformation.
2. By analogy the binding of CN-Cbl to IF must occur in at least 2 stages, one of which involves 
the a-ribazole of the side chain land the other the corrin macrocycle.
3. IF is the only corrinoid binding protein which is cobalamin specific. This is in effect a specificity 
for the side chain f and is apparently built-in to the binding process by involving a 'maturation' or 
initiation step. This makes the specificity much higher than it would otherwise be. Log K for CN- 
Cbl is 10 and for the (CN,aq)Cbi in the presence of a-ribazole is 5 txrt is <3 in the absence of a- 
ribazole.
4. The different isoproteins behave differently with alteration in the alkyl ligand in the p-position.
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5. The conjugates can be used to study transport without any problems as they are similar to CN- 
Cbl in their binding to IF and do not show the anomalies associated with some of the p-position 
ligands. These two positions provide an opportunity to compare two potential means of drug 
delivery.
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CHAPTER 5
THE TRANSPORT PATHWAY
5.1 The in vivo Transport Pathway
CN-Cbl is transported across the ileal epithelial cells and into the circulation by a adduct process. 
This process consists of many steps, which can be divided into three main stages. These 
stages are:
1. Uptake by the ileal cells
2. Transport across the cell
3. Release into the circulation
The uptake of CN-Cbl occurs in the distal ileum and it is here that the transfer of CN-Cbl from He 
to IF is thought to occur. CN-Cbl binds to IF after the action of pancreatic proteases upon the 
Hc-(CN-Cbl) adduct (see chapter 1). It is the IF-(CN-Cbl) adduct which is taken up by a specific 
receptor on the surface of the ileal cells and the adduct is taken up in preference to CN-Cbl 
alone and Hc-(CN-Cbl). 44,150,154 jhe formation of a IF-(CN-Cbl) adduct is a prerequisite for 
uptake and neither unbound CN-Cbl nor IF has any inhibitory effect upon this uptake, even 
when added in 100-fold excess. The IF-(CN-Cbl) adduct has been found to bind to ileal cell 
homogenates but not to cells of the jejunum, colon or proximal ileum. 31.150 The absorption 
of IF-(CN-Cbl) is therefore specific to the distal ileum only. Cells from human distal ileum are 
capable of binding human, guinea-pig, monkey and porcine IF-(CN-Cbl) complexes, with no 
significant difference in binding ability, indicating the similarity which exists between the IF and 
ileal receptors of different species. This also suggests a conservation of the structure
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of IF for different species, despite the differences in size of the porcine IF-(CN-Cbi) and human 
IF-(CN-Cbl) complexes (see chapter 4).
5.1.1 The Ileal Receptor
The IF-(CN-Cbl) is taken into the ileal cell by receptor mediated endocytosis. 84,85,153 Evidence 
for the presence of a receptor comes from both in vitro and in vivo experiments. 154,156 yhe 
binding of IF-(CN-Cbl) to villus epithelial cells shows a distinct pattern of distribution, which is 
coincidental with the presence of mature fully differentiated ileal epithelial cells.
There is much indirect evidence to indicate that the receptor binding and internalisation are the 
rate limiting steps and that the underlying limitation is the number of receptors on the cell 
surface. 30,156 increase in the uptake of IF-(CN-Cbl) by ileal epithelial cells coincides with an 
increase in the number of mature ileal epithelial cells within a given cell population but is not 
associated with an increase in cell number. 84,154,156,157 y^e increase in uptake is more rapid 
than the cell turnover rate and can also reversed as rapidly as it increases. Therefore, the 
uptake of IF-(CN-Cbl) is a property of differentiated cells. 1®^  The membrane protein associated 
with IF-(CN-Cbl) uptake has a MW of 200K and is located in the luminal membrane of ileal 
epithelial cells.43 The receptor in human, dog and porcine ileum has been located such that 
95% of the cells at the villus apex express the receptor as compared to 30-50% of cells halfway 
up the villus. More specifically, the receptor is located in the inter-microvillus pits and once it 
is there it does not move as the epithelial cells move up the villus. ^1.64 The receptor has been 
isolated from several species, including h u m a n , r a t ,  1®^  guinea-pig, dog ®3and pig 78 and 
in all these species it consists of two subunits, so-called a  and p. These two subunits are joined 
by a disulphide linkage which was demonstrated by their separation on reduction with 
dithiothreitol. The a subunit is hydrophilic and projects into the lumen of the ileum. The binding 
of IF-(CN-Cbl) is exclusive to the a-subunit, which contains the complete recognition site for the 
IF-(CN-Cbl) adduct. ®4 The structure of this subunit is very similar to IF, with a MW of 70K, 
although some estimates of MW are as high as 83K.1®® These differences may be due to loss
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of some carbohydrate, during the purification of the receptor. The structure is also similar to IF in 
that 15% of the receptor is carbohydrate, although there is a greater variety of residue types 
than is found in IF'*^ ®. All of the so-called a  subunits are able to bind IF-(CN-Cbl) whether the 
MW is estimated at 70K or 83K and therefore, all of the a subunit contains the complete 
recognition site for the binding of the IF-(CN-Cbl) adduct.
The p subunit is different to the a in both size and characteristic properties. It is insoluble in 
water and very hydrophobic in character, with a MW of 130K for the porcine receptor .160,158 
The protein is an integral part of the cell membrane and can only be extracted by the use of 
detergents. This subunit cannot bind IF-(CN-Cbl) at ail.
The binding of the human IF-(CN-Cbl) to the receptor is saturable and a value for Kd of 0.25 nM, 
where Kd is the constant for the dissociation of the IF-(CN-Cbl) adduct from the receptor, has 
been calculated for isolated guinea-pig microvillus membranes. The second order equilibrium 
constant for the attachment of IF-(CN-Cbl) is 1.3 x 10® M. The rate of binding of the IF-(CN-Cbl) 
to the receptor is rapid, taking five minutes for 70% of the added adduct to bind, although the 
half-time for dissociation of the IF-(CN-Cbl) from the receptor is thirty-five minutes. Analogues of 
CN-Cbl in the form of IF adducts have been shown to compete with IF-(CN-Cbl) for the receptor 
site and values of Kj are given, where Kj is the equlibrium constant for the inhibition of the 
binding of IF-(CN-Cbl) to the receptor by the IF-analogue adduct. The data is taken from ref. 76 
and is listed in table 5.1
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lnhit)itor inhibition constant 
KjrfVI
CN-Cbl-IF 0.3
OH-Cbl-IF 0.22
MeCbl-IF 0.29
AdoCbl-IF 0.5
(Ade)CN-Cbi-IF 0.99
Table 5.1 Estimates of Kj for the inhibition of binding of IF-(®^Co)CN-Cbl to the ileal receptor^®.
Binding of IF-(CN-Cbl) to the receptor requires the presence of calcium ions, without which the 
adduct binding is reduced by a factor of 65.60,64,147 calcium is the only divalent cation capable 
of facilitating the binding and any receptor-bound IF-(CN-Cbl) can be removed by using EDTA, 
but is reversed by the addition of calcium ions. This requirement for calcium has also been 
shown in humans.
A further requirement for the binding of IF-(CN-Cbl) to the receptor is a pH within the range of 5 
to 10, with an optimum pH of 7.5 . The receptor binding is temperature independant, as it
does not vary significantly over a temperature range of 7°C to 37°C, but, the rate of 
internalisation is dependant upon temperature. At 4°C the proportion of added IF-(CN-Cbl) 
surface bound is 99%, and at 37°C this drops to 35% with the remaining 65% inside the cells.'^® 
Once the IF-(CN-Cbl) is surface bound the next stage is internalisation into the cell.
5.1.2 Internalisation into and Transport across the Ileal Cell
Internalisation is dependant upon oxidative phosphorylation and is therefore an energy driven 
process. Isolated ileal epithelial cells accumulate IF-(CN-Cbl) with respect to time which is 
shown by carrying out incubations at 37°C for 10,30, and 60 minutes which result in 50%, 53% 
and 65% of the added IF-(CN-Cbl) being internalised. This is a fifty fold increase in
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internalisation when compared to the internalisation of CN-Cbl alone. There is evidence for 
internalisation not only of the complete IF-(CN-Cbl) adduct, but also of the receptor and for 
recycling of both the receptor and IF. The uptake of IF-(CN-Cbl) is independent of protein 
synthesis because, when the protein synthesis of the ileal epithelial cell is stopped by adding 
the protein synthesis inhibitor (v/zcycloheximide) the surface binding and uptake of IF-(CN-Cbl) 
continues. Further evidence is that the administration of a saturating dose of CN-Cbl in 
vivo followed 50 minutes later by a second dose, results in both doses being absorbed to the 
same extent. Everted ileal sacs from guinea-pig ileum take up CN-Cbl alone following a 
saturating dose of IF-(CN-Cbl), again the time of the second dose administration was 50 
minutes. 78
When radiolabelled (®®S)IF and radiolabelled (®^Co)CN-Cbl were added to isolated ileal epithelial 
cells the two radiolabels were extracted as a single peak after thirty minutes, showing that a 
stable IF-(CN-Cbl) adduct was present and the IF still bound to an IF specific antibody.
Therefore, after 30 minutes the IF-(CN-Cbl) adduct is not siginificantly changed and remains 
intact inside the cell. After 2 h the CN-Cbl was found to be free and after 4.5 h was bound to a 
different protein. This protein was not IF, but was similar to TCII in size and characteristics.
From In vivo studies, CN-Cbl is concentrated in the brush borders of the apical membrane and 
lysosomal fractions 2 h after administration, whereas after 4 h CN-Cbl is located solely in the 
cytosol with less than 10% in the lysosomal and membrane fractions. The use of 
chloroquine, a lysosomotropic agent, resulted in reduction in the CN-Cbl appearing in the 
circulation, which suggests that lysosomes are involved in the transport of CN-Cbl. Electron 
microscopic autoradiography studies show that over a period of time IF accumulates on the 
apical membrane of the ileal epithelial cells in vivo.
5.1.3 Release into the Circulation
CN-Cbl appears in the circulation attached to TCII, another cobalamin binding protein. ®® TCII is 
very different in character to IF and He as it contains no carbohydrate and consequently has
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different properties to other cobalamin binding proteins. The cobalamin in the circulation is in 
the form of MeCbl and the most likely site for the transformation of the CN-Cbl to MeCbl is the 
ileal epithelial cell.
5.1.4 Summary
1. IF derived from a particular species can be bound by the ileal receptor of a different species. 
Therefore, the IF and receptors in different species show a conservation of structure.
2. The receptor for the binding of IF-(CN-Cbl) is specific and requires the formation of a 
successful IF-(CN-Cbl) adduct before internalisation occurs. The receptor binding also requires 
calcium ions and this requirement has been located specifically to the r e c e p t o r . ® ® » 8 6
3. The receptor consists of two parts, the so-called a and p subunits. The two subunit structure 
is common to the receptors of all the species so far studied. The a subunit is hydrophilic and 
the p subunit hydrophobic in character. The porcine receptor has been shown to consist of a 
clover-leaf like structure.
4. The receptor and IF would appear to be recycled, suggesting that the transport system for IF- 
(CN-Cbl) is both conservative and efficient.®®-®®-®^
5.1.5 Aims of this Work
The aim of this part of the work is to probe the IF-mediated cobalamin pathway, and to establish 
whether there is a size exclusion on the pathway using conjugates of CN-Cbl. These 
conjugates of HRP and calcitonin are described in chapter 3 and their binding to IF is detailed in 
chapter 4. The HRP molecule is readily detected using an enzyme assay and is therefore 
useful as a probe. Calcitonin is a drug of current interest and, being much smaller, provides a
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comparison for the large MW of 40K of HRP. Calcitonin was not assayed directly and the 
conjugate was only assessed for its ability to inhibit the transport of IF-(®^Co)CN-Cbl.
5.2 Transport Studies
Published data are available for the properties of the Caco-2 cells, grown on filters in millicell 
chambers (see chapter 2 and section1.11). The characteristics common to both ileal epthelial 
cells and Caco-2 cells are the presence of tight junctions,® *^®® a well -developed brush border 
and associated enzymes,® -^®  ^transport of amino acids, bile acids,®^ .®® and IF-mediated 
transport of Cbl.®^ '®® The Caco-2 cells grown on filters form confluent monolayers and the tight 
junctions were identified using cytohistochemical staining and transcellular resistance 
measurements. 92,93,100-102 j^ e  impermeability of the tight junctions is not affected by 
temperature, showing that the monolayer remains intact at 4°C. When Caco-2 cells are grown 
on plastic substratum there is only a limited brush border and there are large spaces between 
the basolateral surfaces of the cells, due to intercellular accumulation of fluid, whereas when the 
cells are grown on filters there no spaces on the basolateral surface and the brush border is 
limited to the apical surface, but is very well developed.®®
Caco-2 cells have several active transport pathways the most important of which transport 
folate, ®® phenylalanine,^®® bile acids and IF-Cbl. ®7,107 The transport of taurocholate, a bile 
acid, is saturable and receptor-mediated. The value obtained for the Km for the binding of 
taurocholate to brush border membranes is 42.5 pM, ®^  which is very similar to the value of 37 
pM obtained for human brush border membranes.i®® The transport of IF-(CN-Cbl) is receptor 
mediated and unidirectional.The IF-(CN-Cbl) receptor was identified using Caco-2 cells grown 
on a plastic substratum, and the number of receptors per cell is estimated to be 900. ®1 
Binding to the receptor is pH independent over a range of 4.5-7.5, but below this value the 
binding of IF-(CN-Cbl) adduct to the receptor decreases rapidly with pH.®  ^ Dissociation of the 
adduct from the cell surface also occurs If EDTA is added to remove calcium, and shows that the
115
system operating in the Caco-2 cells behaves in the same way as the system found in ileal 
epithelial cells (see chapter 1 and section 5.1).
Temperature fmol of (57Co)CNCWmg DNA
surface bound Internalised
4 58.0 ( 7.7) 15.5 (1.94)
20 61.9(15.5) 38.7(3.8)
37 71.6(42.6) 374(50)
Table 5.2 The effect of temperature upon surface bindng and internalisation of IF-(57Co)CN-Cbl
The binding of the IF-(CN-Cbl) adduct is temperature Independent, which is shown by the data 
In table 5.2, which is taken from ref. 93. After incubating the cells at 4°C with IF-(CN-Cbl) the 
majority of the Cbl Is surface bound and the amount Internalised Is negligible and is less than 20 
fmol/ mg DNA. At 20°C the surface bound Cbl was the same as that at 4°C, but the Internalised 
Cbl was significantly Increased. When the temperature of the Incubation was raised to 37°C 
there was an Increase In both surface bound and Internalised, with the Internalised increasing 
10-fold in comparison to that internalised at 20°C The saturation concentration of IF-(CN- 
Cbl) for the receptors of a single 30-day old filter Isl 6 pM, and the concentration used In the 
transport studies always exceeded this. This ensured the maximum possible transport for a 
given period of time. Initially the internalisation of IF-(CN-Cbl) by monolayers on filters occurs at 
both the apical and basolateral surfaces. At 14-days monolayers on filters show specific 
internalisation of (®^Co)CN-Cbl, as the IF adduct, at both surfaces, but the basolateral 
Internalisation rapidly decreases until at 28 days the Internalisation from the basolateral surface Is 
not detectable. The apical internalisation remains constant over this period of time. These 
results are entirely consistent with the surface binding being entirely located on the apical 
surface after 28 days. The mean number of cells on a filter after 30 days in culture is 2 x 10® and 
the surface area of the filter Is 94.2 mm®.
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The specific transport of (®^Co)CN-Cbl, added as IF-(®^CoCN-Cbi), across the Caco-2 
monolayer from apical to basolateral surfaces is detectable after 20 days in culture and reaches a 
maximum level after 28 days. This level of transport is maintained until day 35, and throughout 
this time span the basolateral to apical transport is just detectable and does not increase. The 
secretion of the CN-Cbl binding protein from the basolateral surface reaches a maximum level 
after 26 days , but then rapidly declines to very low levels by day 31. This protein did not 
resemble the IF-CN-Cbl adduct or free IF, but was similar to TCII ®®. The rate of transport of 
(®^Co)CN-Cbl, measured as (®^Co) across Caco-2 cells is 12.5 molecules transported per 
minute per cell. This corresponds to a receptor turnover rate of 0.01 molecules per minute per 
cell per receptor Free CN-Cbl has been shown to cross a monolayer of Caco-2 cells 
although the rate is insignificant when compared to the rate of transport of the IF adduct.
5^ -§lrateqy
The compounds to be tested for transport ( viz. conjugates of CN-Cbl, protein) were added to 
the apical surface of 30-day old Caco-2 cell monolayers grown on filters in millicell chambers.
The conjugates were added alone, as IF adducts and as IF adducts with IF-(®^Co)CN-Cbl. This 
was to see if the route taken by the unt>ound conjugagtes was altered by formation of an IF 
adduct and whether the complexed conjugates could compete for the receptor with IF- 
(57co)CN-Cbl and inhibit the transport of (®^Co)CN-Cbl. For the HRP conjugates, the intact 
HRP was detected using an enzymatic assay (see chapter 2). An immunoadsorptive enzyme 
assay was also used to verify the results obtained and show that after incubation with Caco-2 
cells the media contained nothing which interferred with the colourimetric assay. The Caco-2 
cells were incubated with the IF complexes for 14-16 h at 37°C and in a10%C02 90% air 
atmosphere (see figure 2.1).
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The rate of transport/flux was calculated as follows:-
fmoles min'1 = fmol detected
(min incubated)
5.4 Results
5.4.1 Surface-binding and internalisation of (®^ Co)CN-Cbl
These experiments were carried using Caco-2 monolayers grown on a plastic substratum, using 
6-well plates with 2x10® cells per well, for 6 days. The cells were incubated at 4°C and 37°C for 
16 h with 3 X 10''’® M IF-(®^Co)CN-Cbl in 3 ml of media (see 2.14). The media was removed from 
the cells and the cells were washed for 5 min with pH 3.0 glycine buffer, which was removed and 
counted. The glycine buffer contained the surface-bound (®^Co)CN-Cbl; the internalised 
(®^Co)CN-Cbl was measured by solubilising the cell layer from the plastic by incubating at 20°C 
with 1 M sodium hydroxide. The cells were removed from the plastic substratum and counted 
and assayed for DNA content (see section 2.17). The results are given in table 5.3 where the 
internalisation increases more than 10-fold when the temperature is increased from 4°C to 
37°C. When cold IF-(CN-Cbl) and IF-(®^Co)CN-Cbl are added togehter the surface-binding and 
internalisation are reduced indicating that competition is occuring at the surface receptor site. 
From the internalisation data viz. approximately 280 fmoles are internalised over 16 h, the uptake 
is 4.5 molecules per cell assuming that there 2x10® cells per filter. From the data given in ref.
80 there are 900 receptors per cell on the apical surface so that the turnover rate of the receptor 
is 0.013 molecules/receptor/minute.
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Sample applied apically 
as IF adduct
Temp. °G (®^Go)GN-Gbl fmol/ mg DNA 
surface bound internalised
(57co)GN-Gbl 4 76.4 20.3
37 78.7 274
(57co)GN-Gbl-
+GN-Gbl 4 13.8 6.0
37 18.3 46.0
Table 5.3 The surface-binding and internalisation of (®^CoCN-Cbl) when added as an IF adduct 
and with 10® excess of IF(CN-Cbl).
5.4.2 Competition for Surface Binding using p-position Analogues
The p-position analogues, previously synthesised and characterised for their IF binding, were 
assessed for their ability to compete with IF-(®^Co)CN-Cbl for the cell surface receptor. The 
Caco-2 cells were grown on a plastic substratum and incubated with IF-(®^Co)GN-Cbl and IF 
adducts of the p-position analogues. The incubations were carried out at 4°C, so that surface 
binding was maximised and internalisation was minimised. After incubation the cells were 
washed with of PBS, pH 7.4 to remove all traces of the media from the cells. The cells were 
washed with pH 3 glycine buffer, which removed all of the surface bound adduct. The pH 3 
buffer was then counted using a gamma counter to determine the IF-{®^Go)CN-Cbl present.
The cells were solubilised using sodium hydroxide and then assayed to determine the DNA 
content. The data is listed in table 5.4. The IF-analogue adducts reduce the binding to the 
surface of the IF-(®^Go)GN-Gbl and also the internalisation. The binding is reduced by about 
10% when 1.3 x 10*® M p-position analogue is used. When the concentration of the analogue is 
increased 10-fold the binding of the IF-(®^Go)GN-Gbl is reduced by 90%, compared to when IF- 
(®^Go)GN-Gbl is added alone.
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p-position
analogue
Surface bound* 
(®7Co)CN-Cbl 
f mo I/mg DNA
Internalised* 
(®7Co)CN-Cbl 
fmol/mg DNA
Surface bound** 
(®7Co)CN-Cbl 
fmol/mg DNA
Internalised** 
(®7Co)CN-Cbl 
fmol/mg DNA
no analogue 62.6 14.3 nd nd
-CH3 31.6 8.4 nd nd
-CH2CH3 44.8 7.7 5.6 1.4
-(CH2)3C0 2 H 42.1 6.3 2.7 1 .6
-C H 2 CO2H 50.0 7.1 8.3 0.9
-(CH2)2NH2 45.3 6.4 nd nd
Table 5.4 The competition for the receptor at the cell surface between IF-(®^CoCN-Cbl) and IF 
adducts of p-position analogues. The concentration of IF-(®^CoCN-Cbl) added to each well was 
2.2 X 10"''® M. All values have been corrected for non-specific binding.
Two concentrations of the p-position analogue were added, as indicated in the table by * (1.3 x 
10'® M and ** ( 1.3 x 10'® M). Each value is the mean of 5 wells, nd = no data available.
5.4.3 The Transport of CN-Cbl across Caco-2 Cells
The rate of transport of (®^Co)CN-Cbl across the Caco-2  monolayer was detected by measuring 
the (®^Co) in the basolateral media. Measuring the (®^Co) in the cells on the filter gives a 
measure of the internalisation as well. The rate of transport of CN-Cbl when the IF-(®^Co)CN-Cbl 
was added apically was decreased by 90% when IF-(CN-Cbl) was added in excess. This shows 
that competition is occurring at the receptor site and that the transport shows saturation kinetics. 
The turnover rate for the receptor for IF-(®^Co)CN-Cbl binding was calculated from the data in 
table 5.3, where the uptake rate is 4.52 molecules per cell. The rate per receptor is 0.013 
molecule/receptor/minute, which is close to the rate calculated from the data in table 5.2 which 
is 0.005 molecules/receptor/minute.
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5.4.4 Do the conjugates compete with CN-Cbl when added as IF adducts?
The HRP and calcitonin conjugates were added with (®^Co)CN-Cbl to the apical surface to see if 
the transport of (®^Co)CN-Cbl was altered in the presence of these conjugates. The addition of 
HRP-Cbl conjugates in a 25-fold excess reduces the transport of (®^Co)CN-Cbl into the 
basolateral media, see table 5.5. calcitonin conjugates have a similar effect.
Sample added to the apical (®^Co)CN-Cbl transported across Caco-2 monolayer
Surface fmol nrin-1
mean s.d. (cj)
(57co)CN-Cbl 0.002 0.0001
(57co)CN-Cbl-IF 0.012 0.003
(®^Co)CN-Cbl-IF + CN-Cbl-IF 0.0009 0.0001
PCo)CN-Cbl-IF + IF(C02-d-HRP)CN-Cbl 0.0006 0.1
(®7Co)CN-Cbl-IF + HRP-p-Cbl-IF 0.001 0.00001
(®^Co)CN-Cbl-IF + calcitonin- 
(COO)CN-Cbl-IF
0.0001 0.00001
(®^Co)CN-Cbl-IF + calcitonin- 
P-Cbl-IF
0.0001 0.00001
Table 5.5 Rate of transport of (®^Co)CN-Cbl across Caco-2 cells under various conditions, wz., 
alone,as an IF adduct and In competition with IF HRP and calcitonin conjugates. The following 
concentrations were used: (®^Co)CN-Cbl, 0.6 nM: CN-Cbl, 2.5 pM; HRP conjugates, 12.5 nM; 
calcitonin conjugates, 100 nM. For the (®^Co)CN-Cbl not as an IF adduct, n=6; for the IF adduct 
of (®^Co)CN-Cbl and with IF-(CN-Cbl), n=30; for the IF-(C02-d-HRP)CN-Cbl, n=18; for IF-(HRP- 
pCbl), n=12 and for the calcitonin conjugates, n=6.
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5.4.5 HRP Flux across Caco-2 Cells
To establish that the IF was influencing the route taken by the HRP when it was conjugated to 
Cbl the route taken by HRP when added alone and as a Cbl conjugate had to be quantified. The 
flux of HRP across the monolayer was investigated by adding HRP to the apical media and 
sampling the basolateral media after incubation and incubating the basolateral media and 
sampling the apical media. This showed that the transport was t)i-directional and the same rate 
for both directions (see table 5.7). One question to be answered was; is the HRP added in the 
previous experiment past the saturation concentration for the route taken by HRP across the 
Caco-2 cell? This was determined by adding increasing concentrations of HRP to the apical 
media. From the data which are listed in table 5. and illustrated in figure 5.1 it can be seen that 
the concentration of 12.5 nM is on the plateau for the movement of HRP across a 30-day old 
Caco-2 filter.
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Conc.of HRP 
nM
HRP in basolateral media 
fmol min'i
0.28 0.011
%a 27
6.71 0.225
%a 24
7.97 0.247
%a 10
11.02 0.308
%a 12
11.62 0.596
%G 10.0
12.73 0.61
%a 7.9
63.64 0.63
%G 6.0
127.3 0.52
%0 6.0
Table 5.6 The change in flux of HRP with increasing concentration of HRP added apically. For 
the concentration of HRP12.73 nM n=12 and for all the other concentrations n=3.
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Figure 5.1 The effect of adding increasing concentrations of HRP to the apical media on 
appearance of HRP in the basolateral media. The data is listed in table 5.6.
The concentration of HRP of 12.5 nM used for the transport studies in competition with the 
(5^Go)CN-Cbl is therefore past the saturation concentration for the route taken by HRP. To 
compare the difference in HRP flux between the IF-conjugate oJducte' of HRP and HRP- 
cobalamin conjugates without IF, both were added apically to the monolayers and the (002-d- 
HRP)CN-Cbl conjugate was also added basolaterally to determine if the flux was bidirectional.
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Sample added
(A) = Apical media (B) = Basolateral media
HRP flux detected in (A) = Apical media 
fmol min'"I (B) = Basolateral media
Mean S.d. (o) n
HRP (A) 0.61(B)
(0.66)
0.26 6
HRP (B) 0.47(A)
(0.39)
0.09 6
HRP + IF(A) 0.87(B)
(0.74)
0.14 3
(C02-d-HRP)CN-Cbl (A) 0.99 (B) 
(0.90)
0.44 6
(C02-d-HRP)CN-Cbl (B) 0.47(A)
(0.39)
0.15 3
HRP-(C02-d-)CN-Cbl-IF(A) 0.03 (B) 
(0.04)
0.013 12
HRP-(C02-d-)CN-Cbl-IF + (57co)CN-Cbl-IF(A) 0.008(B)
(0.009)
0.003 12
HRP-p-Cbl(A) 0.69(B)
(0.67)
0.24 3
HRP-p-Cbl-IF(A) 0.009(B)
(0.007)
0.003 6
HRP-P-Cbl-IF + (57co)CN-Cbl-IF(A) 0.016(B)
(0.018)
0.004 6
Table 5.7 The HRP flux when 12.5 nM HRP/conjugate were added to monolayers. HRP was 
detected using the enzyme colorimetric assay described in section 2.11. The figures in 
parenthesis are the HRP detected using the HRP Assay II showing that the colorimetric assay is 
not affected by the serum or substances secreted into the media by the cells.
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5.4.6 What is the Flux Rate for HRP?
The route taken by HRP across Caco-2 cells was further probed by adding HRP to both the 
apical and basolateral media , of different monolayers. The HRP was added at 12.5 nM 
concentration and the apical to basolateral flux was 0.61 fmol min'i. When the HRP was added 
to the basolateral media , the basolateral to apical flux was 0.50 fmol min*'*. There is no 
significant difference between these two fluxes and therefore the HRP flux is bidirectional and 
the rates are effectively the same. The apical to basolateral flux of HRP was not affected to any 
significant extent when IF was present, and the flux was 0.87 fmol min*‘*(see table 5.7).
5.4.7 How does the Formation of IF-fCbl-HRP) affect the HRP Flux for HRP-Cbl?
When the conjugates were not added as IF-adducts the rates were similar to HRP alone (see 
table 5.7). When the HRP(C02-d-)-Cbl conjugate was added to the apical media of Caco-2 cells 
the rate of flux was 0.99 fmol min-1, and for the HRP-p-Cbl conjugate this was 0.69 fmol min-1. 
The basolateral to apical flux of the (C02*d-HRP)CN-Cbl was 0.47 fmol min*"*. When all of these 
data are considered with the values of a there is no significant difference between any of these 
values, viz. the flux of the conjugates alone is bidirectional.
The two conjugates were then added as IF-adducts to the apical media of Caco-2 cells where 
the flux of HRP into the basolateral media was reduced to 0.03 fmol min*"*. This was a reduction 
in flux of a factor of 33 and a reduction was also found for HRP-p-Cbl, which was a 70-fold 
reduction compared to HRP alone. The formation of an IF- conjugate adduct therefore causes a 
marked reduction in the flux of HRP.
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5.4.8 How does Competition effect the HRP Flux?
Table 5.5 shows that the presence of IF-(C02-d-HRP) CN-Cbl reduces the transport of 
(®7co)CN-Cbl. While table 5.7 shows that the converse is also true. Another experiment was 
carried out to determine whether the IF-(C02-d-HRP)CN-Cbl and IF-(57co)CN-Cbl were 
competing for the same site on the apical membrane. This was achieved by adding 12.5 nM IF- 
(C02-d-HRP)CN-Cbl to the monolayers together with increasing concentrations of IF-(^7qojcn- 
Cbl. As the concentration of IF-(57co)CN-Cbl was increased the the flux of HRP was reduced , 
(see table 5.8 and figure 5.2). This is evidence for competition between the IF adducts for the 
same site.
IF-(57Co)CN-Cbl
added
nM
HRP fmol min'"*
mean o
0.105 0.020 0.004
0.211 0.014 0.002
0.423 0.010 0.002
0.636 0.005 0.001
0.847 0.003 0.001
0 0 0-030 0 DOS
Table 5.8 The changes of HRP Flux when IF-(C02-d-HRP)CN-Cbl was added to Caco2 cells with 
increasing concentrations of IF-(57co)CN-Cbl, n = 6.
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Figure 5.2 HRP flux detected when increasing concentrations of IF-(^^Co)CN-Cbl were added 
with IF-(C02-d-HRP)CN-Cbl. The concentration of the IF-(C02-d-HRP)CN-Cbl was kept 
constant.
5.4.9 Do the HRP and Cbl remain attached when released into the basolateral media?
Thiff question was answered using conjugates of HRP-Cbl which were labelled with ^^Co at the 
centre of the corrin ring. This made it possible to trace both the Cbl and the HRP in the 
basolateral media. The (C02-d-HRP)CN-Cbl and HRP-p-Cbl were synthesised with ®^Co in the 
corrin ring (see chapter 3). A clear difference is observed between the HRP(C02)Cbl and the 
HRP-p-Cbl, with the rate of transport of the ®^Co and the flux of HRP being similar for 
HRP(C02-d-)Cbl, while for the HRP-(P-)Cbl there was a 9-fold reduction of HRP flux compared to 
S^Co. These data are listed in table 5.5.
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IF-Cbl Pco)Cbl HRP added fmol min'i transported
added added FCo)Cbl HRP
nM nM mean a mean a
CH3(57Co)Cbl 0.1 0 .0 0 2 0 .0 0 2
(57co)CN-Cbl 1.0 - 0.009 0.003 - -
HRP(C02-d-)(57co)CN-CbI 0.01 0.01 0.006 0 .0 01 0.007 0 .0 0 2
HRP-p-(57co)Cbl 0.04 0.04 0.0008 0.0008 0.007 0 .0 0 2
0 .0 2 0 .0 2 0 .001 0.0004 0.003 0 .0 0 2
Table 5.9 Comparison of HRP-(^^Co)CbI-IF and (^^Co)CN-Cbl rates of flux as assessed by 
(57co)Cbl counting and HRP analysis. All compounds added apically and n = 6 .
The Me(^^Co)Cbl was used to determine whether the CH3 ligand remained intact after transport 
through the Caco-2  monolayer. The analysis of the cobalamin secreted into the basolateral 
media proved difficult as the media components could not be separated from the cobalamin. 
The procedure described by Linnell or the clean-up of plasma samples was attempted but 
the concentration of (^^Co) was so low that the purification did not work.
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5.5 Discussion
The data presented in this chapter explores the IF-mediated cobalamin transport pathway which 
is found in Caco-2  cells. The pathway has not only been used to transport CN-Cbl across the 
cells but also other molecules such as HRP and calcitonin in the form of cobalamin conjugates 
(see table 5.3). The three steps Involved in the in vivo transport of cobalamin, namely the 
binding to IF, internalisation into and transport across the cell, and release from the serosal cell 
surface Into the circulation are discussed in 5.1. The first step, binding to IF, is studied in 
solution in chapter 4; the second step, internalisation, is studied by using Caco-2  cells at 4°C to 
study surface binding: and the third step, transport, is determined using monolayers of Caco-2 
cells at 37°C (see section 5.2). At 4°C internalisation is stopped, as seen by the data in tables 
5.2 and 5.3, where surface binding remains constant at 4°C, 20°C and 37°C. The 
intemalisation increases with temperature. Internalisation is the slow step in the process and this 
is reflected by both the number of receptors (900 per cell) and the turnover rate of the 
receptor (0.005 molecules per minute per receptor), which is not significantly different from that 
calculated from the data in the literature (0.01 molecules per minute per receptor ).94 From this 
data It is possible to estimate a time scale for the receptor recycling of 100 min (see 5.1). This 
time includes the binding to the receptor, internalisation of the adduct, release of the cobalamin 
and return of the receptor to the apical cell surface so that it can bind more IF-cobalamin. From in 
vivo work previously published the rate of receptor recycling has been estimated to be 50 
minutes (see 5.1). When the (57co)Cbl is released from the cell after incubation at 37°C, it is 
attached to a different protein which has several characteristics in common with TCII. In vivo 
cobalamin in the plasma is found predominantly as MeCbl bound to TCII, so it is logical to 
suppose that the cobalamin secreted from the basolateral surface of the Caco-2 cells is TCII 
bound.
The internalisation, transport, and release of Cbl-complexes can be studied at a steady state and 
maximum rate at 37°C, as this temperature gave the maximum internalisation of IF-(57co)CN-CbI 
and consequently the maximum transport possible (see tables 5.3 and 5.2). The IF-(57co)CN_
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Cbl adduct or conjugate adduct was added to the media on one side of the filter, either the apical 
or basolateral, and the transport of (^^CojCN-Cbl detected by counting the (^^Co) on the 
opposite side of the filter. The HRP was detected by both a colorimetric assay and an 
Immunoassay which gave the following results: 0.03 fmol min'l for HRP in (C0 2 -d-HRP)CN-Cbl 
(colorimetric) and 0.02 fmol min'"* (immunoassay). This agreement between the assays confirms 
that no component in the media or secreted by the cells interferes with the HRP activity (see 
table 5.7). The colorimetric assay was used throughout the work for convenience. The rate of 
transport of (57co)CN-Cbl is 0.012 fmol mini which is approximately half the flux of HRP which 
is observed for (C0 2 -d-HRP)CN-Cbl (0.025 fmol mini), the attachment of HRP to CN-Cbl 
does not reduce the activity of the HRP (see section 3.4.1) the IF adduct may take the same 
route as the CN-Cbl, and thé increased rate could be due to limited dissociation of the IF adduct 
which results in the release of free (C0 2 -d-HRP)CN-Cbl which can travel via a different route.
The rate of flux is similar enough to that of CN-Cbl to suggest that most of the IF-(C0 2  d- 
HRP)CN-Cbl travels via the IF-mediated pathway.
An important step of the transport process is the second step, that is the binding and 
internalisation by the receptor. Is this the rate limiting step? There is much evidence to suggest 
that it is. It has been reported that the number of receptors is 900 per cell. The comparison of 
the surface binding and internalisation at different temperatures over 16 h shows that the 
concentration of CN-Cbl inside the cell increases with temperature, (4°C<20°C<37°C) whereas 
the surface bound CN-Cbl does not alter significantly (see table 5.4). Internalisation is 
temperature-dependent and increases with temperature, yet a steady state concentration is 
surface-bound at all three temperatures and the surface receptors are therefore fully occupied. 
Therefore, the rate determining step is internalisation. The use of analogues to reduce the 
concentration of surface-bound (S7co)CN-Cbl also reduces the (57co)CN-Cbl internalised in 
parallel (see table 5.4) For a given temperature, therefore, the rate of intemalisation is 
proportional to surface-bound concentration. From previous work it has been shown that the 
rate of transport of (®^Co)CN-Cbl rises to a plateau when the added adduct is 16 pM. The 50% 
binding concentration, corresponding to the 50% of the maximum rate, is 1.0 x 1 0 l°  M, which
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converts to an apparent Kd of 1 x 1Q l° M. The Ky reported in the literature is 2.5 x IQ I® M.75 
The concentration of IF-(CN-Cbl) added for all the transport experiments in this work was 2-3 x 
1 0 l°  M which is 13-fold excess compared to the saturation concentration for the IF-mediated 
pathway in Caco-2 cells. This is not the only pathway of Caco-2 cells utilised in this work as there 
appear to be three different pathways operating depending upon the molecules added to the 
monlayer of cells. Three theoretical possibilities from the data presented in this chapter are 
detailed below:
1. This is the HRP path, which carries HRP and HRP-cobalamin conjugates which 
are not IF adducts (see table 5.3). This pathway has a saturation concentration of 
12.5 nM and is bidirectional. The mean flux of HRP through this path is 0.6 fmol 
mini (see table 5.7).
2 . This is the IF-(CN-Cbl) pathway, also saturable but at the much lower 
concentration v/z.16 pM. The transport rate is also slower viz. 0.012 fmol mini (see 
table 5.5).
3. The third pathway is one which is utilised by free CN-Cbl and is IF independent. 
The rate for this pathway is much lower than that described in 1 or 2 . This could be 
receptor-mediated using TCII receptors and may also be unidirectional. The rate is
0 .0 0 2  fmol mini.
I. HRP-oathwav
(a) The rate of Flux of HRP reaches a steady state at 12.5 x 10*  ^M (see table 5.6) and does not 
change significantly with the addition of IF (see table 5.7).
(b) The flux of HRP is not affected by covalent linkage to cobalamin alone in either the p or d 
positions (see table 5.7). The route is also bidirectional.
(c) The flux is reduced while the conjugate is present as an adduct with IF (see table 5.7).
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(d) The question arises as to the purpose of such a pathway and what other molecules, if any, 
can utilise it.
2 . IF-(CN-Cbl)
(a) The transport of IF-(57co)CN-Cbl) is reduced by the presence of IF-(CN-Cbl), IF-(p- 
(CH2 )3C0 2 -HRP)Cbl or IF(C0 2 -d-HRP)CN-Cbl in the media.
(b) The converse is also true that for an IF adduct of HRP-Cbl the HRP flux is reduced.
The reduction in HRP flux follows a simple parabolic curve (see figure 5.2) which can be 
extrapolated to 0 for high IF-(57co)CN-Cbl concentrations. From these data (see table 5.8) 
where the concentration of IF-(57co)CN-Cbl was increased and IF-(C0 2 -d-HRP)CN-Cbl kept the 
same, an estimate of the 50% receptor binding (viz. the concentration of IF-(C0 2 -d-HRP) CN- 
Cbl at which half of the receptors are occupied by the IF-conjugate adduct and half by IF- 
(57QoCN-Cbl). The concentration of IF-(C0 2 -d-HRP)CN-Cbl for 50% receptor binding is12.5 x 
10*® M. This is for an IF-(57co)CN-Cbl concentration 2 x 10io M. The ratio of these 2  values 
(125/2) is 60 which exists in favour of the binding of the IF-(^7Qo)CN-Cbl to the receptor. These 
data can be converted to an apparent K of 5 x 10® M *\ The ratio of 60 for receptor binding is 
similar to the ratio of the Ka values for binding to IF (3.3/0.087), which is approximately 40 (see 
table 4.6). Therefore the equilibrium between IF-(CN-Cbl) and IF(C0 2 -d-HRP)CN-Cbl is 
sufficiently labile compared to the slower step of intemalisation for the rate of flux across Caco-2  
cells to be determined, at least for these two compounds, by the equilibrium ratios of IF adducts 
delivered to the receptor. This would be further supported if the flux of HRP did not affect that 
of IF-(CN-Cbl) or vice versa.
A noteworthy question is - Is the IF the recognition site for this pathway and therefore the 
cause of the HRP-Cbl conjugates travelling via this route when in the form of IF adducts thus 
preventing the utilisation of the HRP pathway ? (described in 1). The question of size may also
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be a factor as the IF adduct of HRP-cobalamin is 90K, whereas the HRP and HRP-cobalamin 
conjugates are 42K so the exclusion of the IF adducts could solely on a basis of size.
Summary 
1. HRP Pathway
1. This is a saturable pathway with a saturation concentration of 12.5 x 10‘®M, which implies a 
receptor mediated channel but no slow step has as yet been identified: the flux of HRP is 0.6 
fmol m in'\ (see table 5.7).
ii. The pathway is bidirectional with the HRP passing through the cell layer unchanged and IF not 
affecting the flux (table 5.2)
ill. IF adducts are not able to use this pathway but HRP-Cbl conjugates are.
iv. If this process exists in Caco-2 cells, then it could be present in vivo, like may other pathways 
expressed by the Caco-2 cells.
2. IF-(CN-Cbl) Pathway
This is a saturable receptor-mediated pathway with a saturation concentration of 16 pM and 
mean flux of 0.01 fmol mini for a monolayer of Caco-2 cells (see section 5.1). The limitation 
of receptors to the apical surface on a 30 day old filter means that the pathway is in practice 
unidirectional. The differences in internalisation at different temperatures (see tables 5.2 and 
5.3), indicate that internalisation is the slow step. Competition studies have shown that (C02-d- 
HRP)CN-Cbl is transported via the IF-(CN-Cbl) pathway and also suggest that the conjugate 
remains intact during passage through the monolayer. This is supported by the similar rates of 
transport for the CN-Cbl and HRP moieties of the (C02-d-HRP)CN-Cbl and CN-Cbl. The p-
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position however is different and the p-position ligand appears to undergo change during 
passage across the cell, which would be consistent with the pathway in the ileal epithelial cell 
fulfilling the role of p-position alteration. This would place the site of MeCbl production in the 
ileal epithelial cell.
This is the first example of ‘piggy-back* transport where a pathway specifically designed for one 
molecule (viz. IF-(CN-Cbl) can be utilised by conjugates of that molecule to such an extent that 
intact conjugate may cross the cell layer. The route is one not usually taken by the conjugate, 
which is evident from the HRP data and it is the formation of an IF adduct which provides the key 
to this pathway.
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CHAPTER 6
SUMMARY AND CONCLUSIONS
CN-Cbl is the only known Co containing vitamin and has several different forms which act as 
cofactors for pathways which are essential to cellular metabolism. Therefore, the uptake of CN- 
Cbl into the circulation is of vital importance and the process of absorption, from ingested food 
to the circulatory system, is mediated by a series of binding proteins in a complex process. 
Absorption into the blood requires not only cobalamins in the diet but also the binding proteins 
He, IF and TCil. From the aspect of absorption across the ileal epithelial cell IF is the important 
binding protein. The passage across the ileal epithelial cell is one pathway about which little is 
known.This is partly due to the complexity of the process, and partly due to the difficulty of 
studying the system in vitro as the methods used in the past have been limited to isolated cells, 
microvillous membrane fractions and ileal gut loops. Over the past fifteen years cell lines have 
been established which express the pathways common to ileal epithelial cells "^ 4^ g^d these 
provide convenient in vitro models.
The aims of this thesis were 2-fold.
1. To determine which moeities within the cobalamin molecule are responsible for the binding to 
IF (Chapter 4)
2. To assess the viability of the IF-mediated cobalamin pathway as a means of drug delivery.
1. A variety of CN-Cbl analogues were used to identify particular moeities which cannot be 
altered without a reduction in IF binding ability of the cobalamin. The competition assay and 
subsequent calculation of the Ka values gave a quantitative assessment of IF binding. The p- 
position is not critical to IF binding, as large molecules such as HRP can be attached in this 
position without significant loss of binding (see table 4.9). There is, however, a measure of 
subtle interaction between the p-position of certain analogues and IF. This is shown by the 
anomalous binding curves of p-CH2 CH3 Cbl, p-(CH2 )2 NH2 Cbl, p-(CH2 )3 C0 2 HCbl, and p-
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CH2C02HCbl, where the shape of the curve is different from CN-Cbl (see figures 4.4 and 4.5). 
The anomalous curves may be due to different interactions of the p-position ligands with the 
different isoproteins within the IF sample (see section 4.12). The binding of CN-Cbl to IF is 
consistent over a concentration range, indicating that all of the IF isoproteins bind equally 
strongly to CN-Cbl, (see table 4.4 and figure 4.2). Although the binding data plots are 
'anomalous' the Alog K values for all of the p-position analogues is <1, where A log K = log 
K(CN-Cbl) - log K (analogue). On the basis of this data the effect of change in the p-position is 
minimal (see table 4.5). The alteration of the propionamide side chains to propionic acid groups 
is only of limited importance, with a maximum value of A log K of 2 for the b and e isomers and 1 
for the d isomer. The removal of the nucleotide side chain f to produce cobinamide has a 
profound effect upon binding and this molecule has no affinity at all for IF (see section 4.10). 
When the two parts of cobalamin, cobinamide and a-ribazole, are added together to IF, they are 
able to co-operate to mimic the behaviour of CN-Cbl (see section 4.11 and figure 4.8). CN-Cbl 
therefore, offers a unique opportunity to determine how the different parts of the molecule 
contribute to the molecular recognition between CN-Cbl and IF. The two parts of the molecule 
namely, cobinamide and a-ribazole fulfill different roles with a-ribazole acting as a catalyst (see 
section 4.12, tables 4.12 and 4.13). The binding of a-ribazole to IF could be a weak interaction 
which leads to a structural change in the IF, a change which would be consistent with the 
shrinkage observed upon the binding of CN-Cbl to IF. After the a-ribazole has fulfilled its role to 
produce the 'mature' form of IF the cobinamide could now bind to form a more stable complex. 
This process is less efficient than the similar one envisaged for CN-Cbl binding as in CN-Cbl the 
a-ribazole cannot disssociate and consequently IF cannot return to the immature form (see 
section 4.12).
2. This was carried out using Caco-2 ceils grown on filters for 30 days and testing with 4 
conjugates of cobalamin, viz. 2 each of HRP and calcitonin (see sections 3.4 and 3.5). The 
pathway was initially studied using iF-(CN-Cbl) and the transport was 0.012 fmol min"\The rates 
of flux for free HRP, HRP-Cbl conjugates and CN-Cbl across monolayers of Caco-2 cells were 
calculated and compared to the fluxes of the IF adducts. The HRP flux is saturable, but at a 
much higher concentration than the CN-Cbl transport, 12.5 nM per filter compared to 16pM for
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IF-(CN-Cbl), (see tables 5.4,5.7 and section 5.2). HRP and HRP-Cbl conjugate flux is bi­
directional and possibly the same route. The flux of HRP is not suppressed by the addition of IF, 
or by attachment to cobalamin, but is changed by the formation of an IF(HRP)-Cbl adduct (see 
table 5.4). The difference in HRP flux when the HRP moeity forms part of an adduct indicates 
that the route is different from that when the HRP-Cbl conjugate is added.iF is therefore, the 
recognition site for the IF(CN-Cbl)pathway, which agrees with previous data relating to the 
uptake of CN-Cbl (see section 5.1 )
The first step of transport is binding to the receptor, a step which is temperature independent 
and reaches steady state saturation at a low concentration (table 5.2). Internalisation is the step 
which is slow and the turnover rate for the receptor has been calculated to be 0.01 molecules 
per min per cell. This gives an estimate for the recycling of the receptor of 100 min, which is not 
dissimilar to that in vivo estimated at 50 min. IF-Cbl adducts travel by only one of three 
distinguishable pathways, the other two operate to allow the passage of HRP and CN-Cbl across 
the monolayer.
The formation of an IF-(C02-d-HRP)CN-Cbl adduct results in similar flux rates for both HRP and 
CN-Cbl, suggesting that the conjugate is not destroyed in transport across the monolayer. A 
reduction in flux of HRP occurs when an IF-(HRP- Cbl) adduct is added in conjunction with 
IF(57co)CN-Cbl and as the concentration of IF-(57co)CN-Cbl was increased the HRP flux 
decreases (see figure 5.6). These data correspond to a 1:1 binding at the receptor site and the 
ratio of binding is approximately 60 (12.5/0.2) in favour of iF-(CN-Cbl) and the apparent Ka is 5 x 
10^ M’"' . Therefore the equilibration between the IF adducts of (C02-d-HRP)CN-Cbl and CN- 
Cbl is sufficiently labile, compared to the slow step of internalisation, to be determined by the 
equilibrium ratios of IF complexes delivered to the receptor. The (C02-d-HRP)CN-Cbl 
transports the HRP intact to the basolateral media of Caco-2 cells and this shows a 'piggy-back' 
transport which could be exploited to deliver molecules across the ileal epithelial cell. The p- 
ligand position differs in that the HRP detected is less than for the (C02-d-HRP)CN-Cbl 
conjugate which would be consistent with the epithelial cell fulfilling the role of altering the p- 
position ligand. The use of the (C02-d-H)Cbl analogue has been previously shown to be
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capable of transporting orally administered compounds as conjugates across the gut The 
successful delivery of the conjugated molecules of Neomycin, BSA and LHRH was inferred from 
their bio-activity and it was assumed that they had taken the IF-mediated cobalamin pathway.
This is in agreement with the data presented here and leads to several important questions 
about the exploitation of this pathway for drug delivery. What are the limitations on the size, and 
structural properties of the molecules which can be conjugated ?What other positions within the 
cobalamin molecule can be utilised for drug delivery and, if other moeities can be used, will they 
be more versatile than the monocarboxylic acid groups ?.
The major findings of this work are:
1. The binding of cobalamin to IF is dependent upon more than one moeity within the cobalamin 
molecule, and the a-ribazole probably acts as a catalyst to induce the 'mature' form of IF.
2. IF provides the recognition site for the uptake of the IF-(CN-Cbl) adduct by the cell surface 
receptor. IF also fulfills this role for the HRP-Cbl IF adducts.
3. The HRP pathway is utilised by HRP alone and by HRP-Cbl conjugates when the conjugates 
are not IF adducts.
4. The conjugates in the (C02-d-)CbI position are less liable to be degraded In passage across 
the Caco-2 monolayer and provide a means of drug delivery although the detachment at the p- 
position may be adventageous in some instances, particuariy if the target for delivery is the ileal 
epithelial cell itself.
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Appendix 1
The % maximum binding data for the IF competition assays and the transport 
experiment data
Table 2 .2.1 Cyanocobaiamin IF Competition Assay
Concentration (M) % Maximum binding of (S7Qo)CN-Cbhin 
to IF
1 X 10"6 0
%o 5.3
1x10-7 1 .0
% a 4.3
1 X 10 '8 1 1 . 2
%G 6.9
5x10-9 2 0 . 2
% a 7.7
2x10-9 40.6
% a 14.1
1 X 10-9 74.4
% a 1.7
2.6 X 10-10 1 0 2 . 6
% a 4.0
2 X 10-10 1 0 0 . 6
% a 2.4
NB Where % a = (a/%) x 100 
%= mean 
a= standard deviation
Table2.2.2 0rganocobalamins IF Competition Assay
Concentration (M) 
Organocobalamin
% Maximum binding of (57Qo)CN-Cbl 
tofF
-OH -CH3 -CH2CO2H -C2 H5 -C2 H4NH2 -C3 H6CO2 H
3.2x10*7 0.5 0.1 0 .8 5.5 0.7 0 . 2
% CT 4.2 5.9 4.6 17.0 15.0 4.7
1.6 X 10*7 0-4 0 . 6 2 . 0 10.9 0.7 0 . 2
% a 1.4 13.0 13.0 1 .0 15.0 4.7
1.6 X 10*8 5.0 6 .2 13.8 31.9 10 .1 17.4
% a 4.9 2 2 . 0 14.0 5.5 5.6 7.3
8x10*9 7.6 9.1 51.4 46.6 13.1 48.9
%CT 5.3 7.1 23.0 12.4 1 2 .0 2.5
4x10*9 33.0 25.1 6 6 .1 67.7 2 1 . 6 57.4
% a 5.0 2.7 15.0 2 . 6 16.0 10.7
1.6 X 10*9 35.2 76.4 74.1 71.9 44.9 61.4
% o 8 . 0 6 .0 8.3 4.5 1.1 4.0
8  X 10*10 51.6 91.3 105.2 73.3 41.3 67.7
% a 6.3 4.3 7.6 2.4 1 .2 0.1
4 X 10*10 103.8 99.9 104.0 93.8 73.3 70.5
% CT 0 2.5 2.4 1 .0 1 .0 1 .0
Table 2.a3Cyano(monocarboxylicacid)cobalamins IF Competition Assay
Concentration (M) % Maximum binding of p7Qo)CN-Cbl to IF 
to Intrinsic Factor
b e
2x10*7 39.3 17.5
% a 8.4 23.0
2 x 10*8 99.6 80.0
% o 1.5 2.3
1 X 10*8 1 0 0 . 8 92.1
% a 2 . 2 2.4
6x10*9 102.9 8 8 . 2
% a 1 . 6 13.1
4 X 10*9 1 0 0 . 2 97.0
% a 4.1 3.3
2x10*9 98.9 97.4
% a 2.3 1 .8
4 X 10*19 98.7 92.5
% c 1.7 0.3
Table 2.1 •lfCyano(monocartx)xyIic acid-d-)cx)balamin |F Competition Assay
Concentration
(M)
% Maximum binding of (57co)CN-Cbl to IF
6x10*7 2 . 6
% a 3.0
6 .2 x 10*8 18.3
% a 13.4
3 X 10*8 35.6
% a 18.0
1.9x10*8 49.5
% a 10.4
9.6 X 10*9 73.3
% a 2 . 0
6.2 X 10*9 79.5
% a 1.3
1.3x10*9 91.1
% a 9.6
2 3  Cobalamin-protein conjugates
Table 2.34 CN-Cbl(C0 2 <J+IRP) If  Competition Assay
Concentration
(M) % Maximum binding of p7co)CN-Cbl to IF
4x10*7 6 . 0
% a 5.6
5.6x10*7 8 . 8
%CT 16.0
2.8x10*7 19.6
% a 0 . 2
1.1 X 10*7 29.3
% a 2.4
5.6x10*8 42.3
% a 7.8
2.8x10*9 1 0 0 . 0
% a 9.4
Table 23.1 (p-(CH2 )3C0 2 -HRP)Cbi Competition Assay
Concentration
(M)
% Maximum binding of (^7Qo)CN-Cbl to IF
2.6 X 10-7 0.1
% a 13.9
1.2x10*7 3.0
% a 4.9
6.2 X 10*8 6.1
% a 7.0
2 .6 x 10*8 11.5
% c 2.5
1.2 X 10*8 13.7
% c 25
2.6x10*9 72.1
% c 27
2x10*19 1 0 0 . 0
% c 1.4
Table^.3 /%Calcitonincyano(monocarboxylate-d-)cobalamin IF Competition Assay
Concentration
(M)
% Maximum binding of (87co)CN-Cbl to IF
2 X 10*8 1.0
% c 0.1
4x10*7 58.0
% c 2.6
2x10*7 67.0
% a 2.2
1 X 10*7 93.0
% a 1.6
5x10*8 93.0
% a 1.6
2.5x10*8 95.0
% c 1.6
1.25x10*8 100.0
% a 1.5
6.3 X 10*9 97.0
% c 1.5
1.6x10*9 98.0
% a . 1.5
Table 2 3 3  (P-(CH2)3C0 2 -Calcitonln)Cbl |F Competition Assay
Concentration
(M)
% Maximum binding of (87co)CN-Cbl to IF
2 x 10*8 0
% a 0
2x10*7 2 2 . 0
% a 6.9
1x10*7 36.0
% a 4.2
4.8x10*8 64.0
% a 2.4
2.4x10*8 99.0
% a 1 .6
1.2 X 10*8 97.0
% a 1 .6
5.6 X 10*9 95.0
% a 1 .6
2.8x10*9 1 0 1 . 0
% a 1.5
Table 23■^ ■ (CN.aq)Cbi (F Competition Assay
Concentration
(M)
% Maximum binding of (87co)CN-Cbl to IF
2x10*4 8 8 . 0
%  G 1 2 .0
2 X 10*7 97.0
%  G 2.4
7 X 10*8 92.9
%  G 0 .1
Table 23i>a-ribazole and ribazole-3-phosphate IF Competition Assay
Concentration
(M)
% Maximum binding of (87co)CN-Cbl to IF
ribazole-3-phosphate a-ribazole
2 X 10-4 63.0 88.0
% a 3.5 5.1
1.2 X 10-4 65.0
% G 2.7
2x10*8 99.5 88.0
% a 1.1 5.1
1.2x10*8 91.8
%  G 11.4
2x10*8 77.6 90.0
%  G 5.1 7.8
1.2 X 10*8 99.8 97.0
% G 3.2 3.8
2x10*7 91.2 88.0
%  G 12.2 2.4
Table 2.3.Ca-ribazole and ribazole-3-phosphate/ cobinamide variation of ratio, IF Competition 
Assay
ribazole/cobinamide % Maximum binding of (87co)CN-Cbl to IF
Molar ratio
0.25 47.0
% G 4.2
0.33 33.2
%  G 8.5
0.5 51.4
% G 1 0 . 6
1 .0 68.3
% G 14.0
Table 1.1 Transport of (^^Co)CN-Cbl across Caco-2  monolayers
Sample resistance 
Ohmn cm*2
fmoles fmolmin'l
57co CNCbl 393 9.11 0 . 0 1 2
57co CNCbl 443 5.24 0.007
57co CNCbl 433 6 . 6 0 . 0 1 0
57co CNCbl 565 8.3 0.013
57Co CNCbl 457 6 . 2 0.007
57Co CNCbl 425 6 . 2 0.007
87 Co CNCbl 480 1 2 .6 0.015
87 Go CNCbl - 2 . 6 0.005
87Co CNCbl 2.5 0.005
87Co CNCbl 3.1 0.006
87Co CNCbl 7.68 0.009
57 Co CNCbl 10 .1 0.013
87 Co CNCbl 5.8 0.007
Mean 0.0091
a(%a) 0.003(38)
Table t.2Transport IF (57co)CN-Cbl IF—CN-Cbl
resistance 
Ohmn cm*2
fmoles fmolmin-1
678 0.82 0.0010
325 0.81 0.0010
610 0.77 0.0010
542 0.42 0.0006
456 0.39 0.0006
471 0.55 0.0007
379 0.66 0.0008
0.85 0.0010
0.85 0.0010
0.65 0.0010
0.77 0.0010
0.74 0.0010
0.47 0.0006
Mean 0.0009
CT (%ct) 0.0001(11)
Table t.3 CN-Cbl(C0 2 -d+fRP) oP- (P-(CH2 )3C0 2 -HRP)Gbl 
ANJ) IF (57co)CN-Cbl
Conjugate + resistance fmoles fmolmin'V
57co CNCbl Ohmn cm*2
HRP(COi)CW 587 0.53 0.0007
HRP(COi)Cbl 791 0.52 0.0007
HRP(CO^Cbl 773 0.47 0.0006
Mean 0.0006
ct(%ct) 0.0001(17)
HRP(P)Cbl 366 0.94 0 .0 0 1
HRP(p)Cbl 497 0.92 0 .0 0 1
HRP(P)Cbl 791 0.92 0 .0 0 1
Mean 0 .0 0 1
CT (%ct) 0 .0 0 0 0 1 (0 .1 )
Table t.4 Detection of MRP in basolateral media of Caco-2 monolayer 1 pg added apically
Sample applied 
basolateral/ 
apical (B/A)
resistance 
Ohmn cm*2
fmoles fmol min'l
HRP(A) 614 248 0.318
HRP(A) 913 798 1.209
HRP(A) 1003 768 1.164
HRP(A) 687 362 0.548
HRP(A) 551 319 0.409
HRP(A) 637 567 0.727
Mean 0.729
CT (% CT) 0.380(52)
HRP(A) 408 0.425
HRP(A) 568 0.592
HRP(A) 531 0.553
HRP(A) 399 0.416
HRP(A) 481 0.501
HRP(A) 480 0.500
Mean 0.497
CT (%ct) 0.07(14)
HRP(B) 359 0.374
HRP(B) 512 0.533
HRP(B) 512 0.533
HRP(B) 569 0.593
HRP(B) 398 0.414
HRP(B) 374 0.390
Mean 0.473
ct(%ct) I 0.09(19)
Table 15 Detection of HRP into basolateral media using HRP-cobalamin conjugates across 
Caco-2 monolayers, applied apically in the absence of IF
Conjugate resistance fmoles fmoles min'1
A/B ohmn cm*2
HRP(COO)CBL(A) 456 10 1 0 1.300
HRP(COO)CBL(A) 836 369 0.559
HRPO(COO)CBL(A) 854 1019 1.544
HRP(COO)CBL(A) 1148 572 0 .8 6 6
HRP(COO)CBL(A) 474 439 0.563
Mean 0.966
ct(%ct) 0.443(46)
HRP(COO)CBL(B) 0.361
HRP(COO)CBL(B) 0.404
HRP(COO)CBL(B) 0.646
Mean 0.814
CT (%ct) 0.13
HRP(P)CBL(A) 608 743 0.952
HRP(P)CBL(A) 1265 329 0.499
HRP(p)CBL(A) 736 319 0.484
HRP(P)CBL(A) 772 543 0.822
Mean 0.689
CT (%ct) 0.235(34)
Table t.6 Detection of HRP across Caco-2  monolayers using HRP-cobalamin conjugates 
complexed to IF
Conjugate resistance fmoles fmoles min *1
ohmn cm*2
HRP(COO)CBL 475 59 0.075
HRP(COO)CBL 461 55 0.071
HRP(COO)CBL 683 7 0 .0 1 1
HRP(COO)CBL 822 1 0 0.013
HRP(COO)CBL 710 16 0.024
HRP(COO)CBL 528 5 0.008
HRP(COO)CBL 746 1 0 0.015
HRP(COO)CBL 669 21 0.031
Mean 
CT (%ct)
0.031
0.026(87)
Table I . 7  Detection of HRP In basolateral media when HRP conjugates,complexed to IF, applied 
apically with increasing amounts of ' (87co)CN-Cbl -IF
fmoles of 87co cyano 
cobalamin added
fmoles fmoles min'1
apically HRP HRP
2 1 1 18.8 0.019
c (%ct) 3.8(20) 0.004
423 13.7 0.014
CT (%CT) 2.0(14) 0 . 0 0 2
847 9.8 0 . 0 1 0
CT (%CT) 2(19) 0 . 0 0 2
1271 4.8 0.005
CT (%CT) 1.3(26) 0 .0 0 1
1695 2.49 0.003
ct(%ct) 0.4(17) 0.0004
m
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